Lysosome Ca2+ Store Refilling Mechanisms. by Garrity, Abigail G.
  
 
 
 
Lysosome Ca
2+
 Store Refilling Mechanisms 
by 
Abigail G. Garrity 
 
A dissertation submitted in partial fulfillment 
of the requirements for the degree of 
Doctor of Philosophy 
(Neuroscience) 
in the University of Michigan 
2015 
 
 
 
 
 
 
 
 
 
 
 
 
 
Doctoral Committee: 
 
Associate Professor Haoxing Xu, Chair 
Professor Richard I. Hume 
Professor Edward L. Stuenkel 
Professor Joel A. Swanson 
Professor Kristen J. Verhey 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2015 Abigail G. Garrity 
All Rights Reserved 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
To my parents, for naming me after the John Prine song “Dear Abby.”  Thank you for reminding 
me that “you are what you are, and you ain’t what you ain’t.” 
 
 
  
iii 
 
 
 
 
 
 
Acknowledgments 
 
Thank you to each unique and remarkable friend who has encouraged me to grow and expand 
my horizons, especially by doing incredible things in the world themselves. It’s been a gift to see 
and feel your impact on the world, and your love and support has been an honor to have in my 
life.  Amy, Brian, Caroline, Felicia, Jess A., Jess Z., Jini, Jo, Julia, Kanika, Kara, Kari, Maggie, 
Rachel, Renee, Sandi, and Suz, you have each inspired me through your incredible strength and I 
hope to have the chance to continue to watch you influence the world in the future.  Knowing 
that each of you had my back helped me to make it through this journey.  
 
Chapter V is dedicated to Aaron Lowenberg and Sandi Gollob, whose marriage I had the 
pleasure of officiating while I was finishing my dissertation. Aaron’s encouragement to “solve 
Alzheimer’s Disease,” helped me get through the long days to make those experiments happen, 
and while I didn’t “solve Alzheimer’s Disease,” I hope these findings contribute to the forward 
progress of the field. 
 
Finally, to my Dad, for teaching me to always do the right thing, even when it isn’t the easiest 
thing.  For reminding me that everyone puts their pants on one leg at a time. For teaching me that 
everything is relative and depends on your perspective.  And for letting me learn, on my own, all 
the most important lessons. Accomplishing meaningful things comes from dedication and hard 
work, which I learned from watching you. These lessons and more were what made this possible. 
All my love and gratitude to you, Dad.  
 
  
iv 
 
 
 
 
 
 
Table of Contents  
 
Dedication………………………...…………………………………………………...  ii 
Acknowledgments……………………………………………………………………. iii 
List of Figures………………………………………………………………………....  vi 
Abstract………………………………………………………………………………..  viii 
 
Chapter 
I. INTRODUCTION TO LYSOSOME BIOLOGY…………………….. 1 
Abstract…………………………………………………………………... 1 
Introduction………………………………………………………………. 1 
References…………………………………………………………………. 30 
 
II. THE LYSOSOME V-ATPASE AND pH GRADIENT ARE NOT  
REQUIRED FOR Ca
2+
 REFILLING TO THE LYSOSOME................ 41 
Abstract……………………………………………………………………. 41 
Introduction………………………………………………………………… 41 
Results……………………………………………………………………... 48 
Discussion…………………………………………………………………. 54 
Methods and Materials…………………………………………………….. 61 
References…………………………………………………………………. 81 
 
 
III. THE ER Ca2+ STORE IS REQUIRED FOR Ca2+ REFILLING  
TO THE LYSOSOME…………………………………………………. 85 
Abstract…………………………………………………………………… 85 
Introduction………………………………………………………………. 85 
Results……………………………………………………………………. 89 
Discussion………………………………………………………………… 92 
Methods and Materials…………………………………………………… 97 
References………………………………………………………………… 107 
 
IV. THE IP3-RECEPTOR ON THE ENDOPLASMIC RETICULUM IS 
REQUIRED FOR REFILLING LYSOSOME CALCIUM STORES… 112 
Abstract……………………………………………………………………. 112 
Introduction………………………………………………………………… 112 
Results……………………………………………………………………… 116 
v 
 
Discussion………………………………………………………………….. 120 
Methods and Materials…………………………………………………….. 126 
References………………………………………………………………….. 142 
 
V. INHIBITION OF IP3-RECEPTORS ON THE ER CAUSES A  
LYSOSOME STORAGE PHENOTYPE……………………………… 146 
Abstract…………………………………………………………………… 146 
Introduction……………………………………………………………… 147 
Results…………………………………………………………………… 148 
Discussion………………………………………………………………… 149 
Methods and Materials…………………………………………………… 154 
References………………………………………………………………… 159 
 
VI. CONCLUSIONS AND FUTURE DIRECTIONS………………………. 162 
Introduction………………………….……………………………………… 162 
References…………………………………………………………………. 169 
 
  
  
vi 
 
 
 
 
 
 
 
List of Figures 
 
Figure 
1.1 Lysosome Ion Channels and Transporters…………………………………….. 27 
1.2 Intracellular Organelles and Trafficking Networks…………………………… 28 
 
2.1 ML-SA1 application in 0 Ca
2+
 triggers Ca
2+
 from an intracellular source  
and empties lysosomal Ca
2+
 stores……………………………………………. 64  
2.2 GCaMP3-ML1 is lysosome specific…………………………………………… 66 
2.3 A new assay to assess Ca
2+
 refilling to lysosomes…………………………….. 68 
2.4 Lysosome Ca
2+
 stores refill in approximately 5 mins…………………………. 70 
2.5 GCaMP3-ML1 remains localized to lysosome membranes after stimulation…. 71 
2.6 Lysosome Ca
2+
 refilling is not cell-type specific……………………………… 72 
2.7 Lysosomes with GCaMP3-ML1 do not differ in pH………………………….. 73 
2.8 Fura-Dextran shows lysosome Ca
2+
 store refilling……………………………. 74 
2.9 Lysosome membrane permeabilization has off-target effects on the  
cytosolic Fura-2 Ca
2+
 indicator and the GCaMP3-ML1 probe………………. 75 
2.10 The endocytic and secretory pathways are not the source of Ca
2+
 to the lysosome 77 
2.11 The proton gradient and V-ATPase are not required for lysosome Ca
2+
 refilling   79 
 
3.1 ER Ca
2+
 release is significantly reduced over 5 mins in 0 Ca
2+
 extracellular  
solution………………………………………………………………………… 100 
3.2 ER SERCA inhibitors block Ca
2+
 refilling to the lysosome………………….. 101 
3.3 TPEN chelates ER Ca
2+
 and abolishes lysosome Ca
2+
 refilling………………. 103 
3.4 Transfection of IP3R-LBD-ER chronically reduced ER Ca
2+
 and also affected  
lysosome Ca
2+
 refilling………………………………………………………… 104 
3.5 Lysosomes are in close apposition to ER tubules……………………………… 105 
3.6 Model of ER-Lysosome Interaction……………………………………………. 106    
 
4.1 HEK cells have ryanodine receptors (RYRs) and IP3-receptors (IP3Rs)………. 129 
4.2 Specific IP3R antagonist Xestospongin-C prevented Ca
2+
 refilling to lysosomes. 130 
4.3 Xesto abolishes Ca
2+
 refilling to lysosomes measured with luminal Ca
2+
 
indicator Fura-Dextran…………………………………………………………. 131 
4.4 IP3R antagonist 2-APB inhibits lysosomal Ca
2+
 refilling……………………….. 132 
4.5 PLC inhibitor U73122 blocked Ca
2+
 refilling to the lysosome…………………..  133 
4.6 Ryanodine receptor blockers did not affect Ca
2+
 refilling to lysosomes………… 134 
4.7 DT40 IP3R-TKO cells show typical responses to GPN, normal acidification,  
and release and refill Ca
2+
 like WT DT40 cells…………………………………. 135 
4.8 Xestospongin-C blocked lysosome Ca
2+
 store refilling in DT40-WT but not  
IP3R-TKO cells…………………………………………………………………. 137 
vii 
 
4.9 Lysosome Ca
2+
 stores are emptied and refilled ongoingly……………………… 139 
4.10 A proposed model of Ca
2+
 transfer from the ER to lysosomes…………………. 141 
 
5.1 LAMP1 increased significantly after inhibiting ER Ca
2+
 and IP3Rs…………… 156 
5.2 LysoTracker staining showed a LSD phenotype in cells treated with IP3R  
blocker Xesto……………………………………………………………………. 157 
5.3 Autofluorescent, lipofuscin-like accumulation in cells treated with IP3R blocker  
Xesto mimics TRPML1 KO cells……………………………………………….. 158 
 
  
viii 
 
 
 
 
 
 
ABSTRACT 
 
Lysosomes are acidic intracellular vesicles containing hydrolases that degrade intracellular and 
extracellular debris delivered through endocytic trafficking and autophagy.  Lysosome function 
requires the establishment of luminal ionic homeostasis for ions including H
+
 and Ca
2+
, which 
are 1,000-5,000 times more concentrated in the lysosome lumen than in the cytosol.  Lysosomal 
H
+
 homeostasis is required to activate hydrolases and Ca
2+
 efflux through lysosomal ion channels 
serves as signals required for precise delivery of hydrolases and cargo and the timely removal of 
catabolites. Impaired lysosomal Ca
2+
 homeostasis results in lysosomal dysfunction, lysosomal 
storage diseases (LSDs), and has been implicated more broadly in neurodegenerative 
phenotypes.  The molecular mechanisms by which lysosomes acquire and refill Ca
2+
 are 
unknown.  We developed a physiological assay to monitor lysosomal Ca
2+
 store refilling using 
specific activators of lysosomal Ca
2+
 channel TRPML1 to repeatedly induce lysosomal Ca
2+
 
release.  In contrast to the prevailing view that lysosomal acidification drives Ca
2+
 into the 
lysosome, inhibiting the V-ATPase H
+
 pump did not prevent Ca
2+
 refilling.  Instead, 
pharmacological and genetic depletion or chelation of endoplasmic reticulum (ER) Ca
2+
 
prevented lysosomal Ca
2+
 stores from refilling.  More specifically, antagonists of ER IP3 
receptors rapidly and completely blocked Ca
2+
 refilling to lysosomes.  Reducing ER Ca
2+
 or 
blocking IP3 receptors resulted in a dramatic lysosome storage phenotype.  By closely apposing 
each other, the ER may serve as a direct and primary source of Ca
2+
 to the lysosome.  These 
findings may clarify seemingly overlapping ER and lysosome Ca
2+
 stores in some studies and 
shed light on why ER Ca
2+
 homeostasis is often involved in LSDs and neurodegenerative 
diseases. 
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CHAPTER I 
INTRODUCTION TO LYSOSOMAL BIOLOGY 
ABSTRACT 
Lysosomes are present in every eukaryotic cell with the exception of very few, highly 
specialized cell-types.  Lysosomes function to degrade both intracellular and extracellular 
materials in order to resupply the cell with the building blocks needed for ongoing growth and 
repair.  To serve their degradative function, lysosomes have a highly acidic lumen and a 
membrane with high carbohydrate content in order to protect the rest of the cell from the 
hydrolytic enzymes in the lysosome lumen.  Lysosomes have nutrient sensing machinery and in 
turn regulate endocytic and autophagic pathways to ensure a balance of anabolic and catabolic 
pathways in the cell.  Lysosome Ca
2+
 content is integral to their degradative capacity and their 
trafficking.  The intraluminal content of all other ions in the lysosome is also essential to many 
discrete functions as well as to overall ion homeostasis.  Lysosomes maintain membrane contact 
sites with the ER for transfer of materials and many other purposes.  Dysfunctions in ER and 
lysosome Ca
2+
 are seen in both lysosome storage disorders (LSDs) and neurodegenerative 
disorders.  Therefore the purpose of this work is to examine the possible interactions between ER 
and lysosome Ca
2+
 stores.     
 
INTRODUCTION 
There are two major degradation mechanisms in the cell, the ubiquitin-proteasome system and 
lysosomal degradation, which allow for the recycling of cellular components for reuse 
(Korolchuk et al., 2010).  The lysosome is a membrane-bound organelle that breaks down 
intracellular and extracellular components delivered via two pathways, the endocytic and 
autophagic pathways.  The endocytic pathway carries extracellular materials destined for 
degradation and the autophagic pathway delivers intracellular components.  Lysosomes are able 
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to fuse with a variety of intracellular vesicles in order to transfer materials for degradation 
including autophagosomes, late-endosomes, and phagosomes (Li et al., 2013a).  Lysosomes also 
undergo exocytosis by fusing with the plasma membrane to secrete their contents into the 
extracellular environment (Samie and Xu, 2014).  
In addition to breakdown and recycling of materials, lysosomes are highly adaptable to a 
variety of other intracellular and extracellular signals which allows them to play a role in several 
other functions. These include plasma membrane repair, cellular homeostasis, energy 
metabolism, apoptosis, and the immune response (Settembre et al., 2013).   
Dysfunction of the lysosome results in a build-up of components targeted for break down 
in the lysosome and an accumulation of lysosomes, measured by an increased number and/or 
size of lysosomes.  Dysfunction of a specific component of the lysosome results in one of almost 
60 known lysosome storage disorders (LSDs) which each have a single gene origin (Boustany, 
2013).  Lysosome dysfunction is also found in many common neurodegenerative disorders 
including Alzheimer’s, Huntington’s, and Parkinson’s diseases (Nixon et al., 2008).    
Lysosome Structure and Proteins 
The existence of about 125 different lysosomal resident proteins has been suggested, 
although only about 25 have been identified and functionally characterized. The lysosome 
membrane constituents remain poorly characterized due to the low abundance of many proteins 
and their hydrophobic properties that make purification and functional analysis difficult 
(Schroder et al., 2010).  Studying lysosomal proteomics is also made difficult due to the 
necessity to separate lysosome-specific organelle constituents from other co-purifying 
intracellular contaminants, which is more complicated for lysosomes because they serve as the 
degradation site for many cellular proteins (Schwake et al., 2013). Studying lysosomal 
hydrolases has proven less difficult, and over 60 different soluble hydrolases have been 
identified (Settembre et al., 2013). 
The lysosome membrane even contains enzymes with catabolic activity, in addition to 
hydrolytic enzymes within the lysosome lumen (Schroder et al., 2010).  The membrane-bound 
nature of the lysosome protects the rest of the cell from the highly acidic environment of the 
lysosome, conducive to its degradative function (Saftig and Klumperman, 2009). Indeed, 
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lysosome membrane rupture or leakage of lysosomal enzymes into the cytosol is involved in cell 
death pathways (Guicciardi et al., 2004).  Heavily glycosylated integral membrane proteins form 
a thick, cholesterol-poor glycocalyx on the internal leaflet of the lysosome membrane. This 
glycocalyx protects the outer part of the limiting membrane and its resident proteins from 
degradation (Settembre et al., 2013).   
Although the study of lysosome membrane proteins is difficult, several membrane 
proteins have been identified from studies of lysosome storage disorders and their functions have 
been illuminated.  Lysosome membrane proteins are targeted to the lysosome membrane using 
cytosolic targeting sequences which are typically dilucine- or tyrosine- based (Braulke and 
Bonifacino, 2009). The most common lysosomal proteins are lysosomal associated membrane 
proteins (LAMPs), lysosome integral membrane protein-2 (LIMP2), and CD63 (Fig. 1) (Saftig 
and Klumperman, 2009).  
LAMP proteins (LAMP-1 and LAMP-2) account for about 50% of all lysosome 
membrane proteins.  LAMPs are physiologically essential, as depletion of both LAMPs results in 
an embryonic lethal phenotype in mice between E14 to E16 (Eskelinen et al., 2004).  LAMPs 
have a heavily glycosylated luminal domain and a short cytosolic tail (Fig. 1) (Saftig and 
Klumperman, 2009).  Depletion of either LAMP1 or LAMP2 results in an abnormal 
accumulation of cholesterol in the lysosome lumen and redistribution of lysosomes to the cell 
periphery, but has little effect on the proteolytic capacity of lysosomes (Eskelinen et al., 2004; 
Huynh et al., 2007; Saftig and Klumperman, 2009).  LAMP proteins stabilise translocation 
machinery on lysosome membranes that allows for transport of cytosolic materials into the 
lysosome for degradation, and likely also help stabilize export machineries as well (Schwake et 
al., 2013).  LAMP proteins are also required for the targeting of many substrates to the lysosome 
during endosomal and trans-Golgi trafficking.  The presence of and glycosylation state of LAMP 
proteins are also important to lysosome fusion with phagosomes as well as with the plasma 
membrane and lysosome exocytosis (Schwake et al., 2013).  
The lysosome membrane contains transport proteins that facilitate the import of products 
destined for degradation and the export of catabolites for their reuse in the cell. Few transport 
proteins on the lysosome membrane have been identified to date, although the vacuolar H
+
-
ATPase (V-ATPase) is a well-known transporter of H
+
 ions into the lysosome lumen (Fig. 1). 
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There are also several identified ion channels on the lysosome membrane for signalling and pH 
homeostasis.  The lysosome membrane is home to the lysosomal nutrient sensing machinery 
(LYNUS) (Fig. 1), which allows the lysosome to integrate metabolic signals from the cell to 
allow lysosomal breakdown products to meet intracellular needs (Settembre et al., 2013).   
Machinery for trafficking and fusion including SNARE proteins and RABs also reside on 
the lysosomal membrane.  The Ca
2+
 sensor synaptotagmin VII (Syt-VII) and Ca
2+
 release 
channel TRPML1 are also important for lysosomal exocytosis (Fig. 1) (Samie et al., 2013). 
Lysosomal membrane glycoprotein CD63, a tetraspanin (Fig. 1), is also important for lysosomal 
targeting of lysosome membrane proteins like Syt-VII and likely acts as a scaffold protein at the 
lysosome membrane (Schwake et al., 2013).   
Transport of Lysosomal Components to the Lysosome 
Newly synthesized lysosome proteins from the rough ER are targeted to the lysosome 
through two pathways. The trans-Golgi network (TGN) to endosome pathway carries receptor 
targeted substrates, typically hydrolases, directly to the endocytic pathway for subsequent 
lysosome delivery (Fig. 2A). An indirect pathway also exists that includes transport to the 
plasma membrane and subsequent endocytic delivery (Fig. 2B).  
The most well understood TGN pathway tags newly made proteins with mannose-6-
phosphate residues that are recognised and bound by two different mannose-6-phosphate 
receptors (M6PRs) in the TGN.  Clathrin coated vesicles from the TGN containing M6PRs 
transfer hydrolases from the  TGN to endosomes (Fig. 2A), where hydrolases dissociate from 
M6PRs due to endosomal acidity  (Schroder et al., 2010).  Because hydrolases could cause 
cellular damage if active in the cytosol, tagging them with M6P allows them to be inactive 
through the endosomal pathway and protects the cell from their degradative functions.  M6PRs 
form the basis for lysosomal enzyme replacement therapy in LSDs (Settembre et al., 2013).   
M6PRs are notably absent from lysosomes and serve as one way to distinguish lysosomes 
from endosomes (Schroder et al., 2010). Thus, a commonly accepted operational definition of 
lysosomes is an acidic organelle in almost all cell types containing mature hydrolases and LAMP 
proteins that lacks M6PRs (Morgan et al., 2011).  
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Less is known about how lysosome membrane proteins like LAMPs arrive at the 
lysosome through more direct, clathrin-independent pathways (Coutinho et al., 2012). However, 
recent evidence suggests that non-clathrin coated vesicles originating in the Golgi can fuse 
directly with late-endosomes using SNARE machinery VAMP7 and hVps41 to deliver LAMP 
proteins (Fig. 2C) (Pols et al., 2013).  This more specific targeting of LAMPs may suggest that 
some lysosomal membrane proteins are delivered at progressing stages of endosome maturation 
to ensure precision around vesicular specificity and to avoid endosomal sorting processes (Pols 
et al., 2013). 
Lysosome Acidification Mechanisms 
The large, multimeric vacuolar H
+
-ATPase (V-ATPase) is the major proton pump in eukaryotic 
cells (Fig. 1).  The V-ATPase is located mainly in the endolysosomal system, but it is also 
located to a much lower extent on the plasma membrane and Golgi in some specialized cell types 
(Marshansky and Futai, 2008).  The 910 kDa V-ATPase is composed of two large multi-subunit 
complexes and functions as a rotary proton transport motor.  The soluble V1 sub-complex 
catalyzes ATP hydrolysis and is made of at least eight subunits.  The V0 sub-complex is 
embedded in the membrane to translocate protons and is composed of six subunits (Mindell, 
2012).   
The V-ATPase is important to endocytic and exocytic vesicular trafficking, possibly due 
to findings suggesting that pH is important to membrane potential and vesicular fusion. pH of 
organelles in the endocytic pathway exhibit a graded pH (Fig. 2), with lysosomes having a 
uniquely low pH between 4.0 and 4.7 (Morgan et al., 2011) 
Because each organelle maintains a signature pH, regulation of all components of the V-
ATPase is a tightly controlled process.  Both the V0 and V1 domains of the V-ATPase can 
rapidly associate and dissociate with various organellar membranes and is one way that V-
ATPase activity is regulated by the cell (Maxson and Grinstein, 2014).  The density of V-
ATPase on specific organellar membranes is another way that pH is regulated between 
compartments (Huotari and Helenius, 2011).  Even lipid composition of different membranes has 
been shown to affect the H
+
 pumping efficiency of the V-ATPase (Maxson and Grinstein, 2014).  
Subunit isoforms vary between cell and tissue types and combinations of unique isoforms 
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distinguish V-ATPase functions on specific membranes (Marshansky and Futai, 2008). For 
example, targeting of a-subunits of the V0 domain are compartment specific; the a3-isoform is 
targeted to the lysosome and sometimes the plasma membrane (Marshansky and Futai, 2008).  
Non-Canonical Functions of the V-ATPase 
The large size and variety of subunits of the V-ATPase are reflected in the many functions it is 
involved in, including pH homeostasis, coupled transport of small molecules, membrane 
trafficking, vesicle fusion, and protein degradation.  In addition, the subunits of the V-ATPase 
are also involved directly in vesicular trafficking and play roles far beyond just acidification of 
compartments. Various subunits of the V-ATPase directly interact with GTPases in an 
acidification dependent manner. Interactions with a variety of GTPases may function to regulate 
V-ATPase assembly and function (Maxson and Grinstein, 2014).  
The V-ATPase may play a role in fusion and fission by acting as a sensor and transducer 
of luminal pH (Maxson and Grinstein, 2014).  In support of this, various GTPases bind to 
vesicular membranes in an acidification-dependent manner, suggesting that the V-ATPase plays 
a role in recruitment of GTPases.  Furthermore, acidification may induce changes in V-ATPase 
conformation to facilitate GTPase docking (Hosokawa et al., 2013).  Dissipation of the pH 
gradient is known to affect various steps in the endosome maturation process, suggesting that the 
V-ATPase plays a role in recruitment, activation, and/or docking of various other factors 
(Huotari and Helenius, 2011; Maxson and Grinstein, 2014). 
Although the importance of H
+
 gradients in vesicle fusion has been demonstrated, studies 
have suggested that the V-ATPase also plays a structural role in vesicle fusion (Maxson and 
Grinstein, 2014).  The presence of a V0 domain has been shown to be required for fusion (Baars 
et al., 2007; Takeda et al., 2008), and may play a role in the development of a fusion pore (Bayer 
et al., 2003; Clare et al., 2006). Alternatively, the V0 domain may promote fusion by association 
with SNARE proteins (Strasser et al., 2011). The precise mechanism by which the V0 promotes 
fusion is still controversial and some believe it is simply the H
+
 gradient that is required for 
vesicle fusion (Maxson and Grinstein, 2014). 
The V-ATPase is also a scaffold protein at the membrane surface. The B and C subunits 
of the V1 complex of the V-ATPase have long been known to interact with actin.  The V-ATPase 
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likely regulates cytoplasmic G-actin pools and actin crosslinking and stabilization into filaments. 
Thus, the V-ATPase is thought to regulate vesicle sorting and transport by linking vesicles to 
actin filaments, potentially in response to the metabolic state and/or nutrient levels in the cell 
(Maxson and Grinstein, 2014).  The V-ATPase also binds to the Wiskott-Aldrich and scar 
homolog (WASH) which promotes actin polymerization, providing another mechanism to 
regulate actin filaments and vesicular attachments (Carnell et al., 2011).   
The V-ATPase is also part of the lysosome nutrient sensing (LYNUS) apparatus at the 
lysosome membrane, serving as a molecular switch between anabolic and catabolic processes at 
the lysosome (Fig. 1) (Zhang et al., 2014).  Mammalian target of rapamycin (mTOR) complex 1 
(MTORC1) is a serine/threonine kinase that integrates numerous signals to sense nutrient 
availability and promote cellular growth when nutrients are available (Shimobayashi and Hall, 
2014).  AMP-activated protein kinase (AMPK) senses energy stresses in the cell by monitoring 
levels of ATP and AMP.  When bound to AMP, AMPK is activated, which in turn increases 
cellular catabolic activities (Hardie et al., 2012).  The recruitment and activation of both AMPK 
and MTORC1 requires the lysosomal V-ATPase (Zoncu et al., 2011; Zhang et al., 2014), which 
may itself sense amino acid availability (Bar-Peled et al., 2012; Xu et al., 2012).  It is unclear 
what role if any luminal acidification has in amino acid sensing (Zoncu et al., 2011; Xu et al., 
2012), so the V-ATPase may have a direct role in nutrient sensing.  Nutrient status also regulates 
V-ATPase association with vesicular membranes, at least in yeast (Tabke et al., 2014).  
Furthermore, a-subunit of V0 complex interacts with enzyme 1-phosphofructokinase that 
catalyses a rate-limiting step in glycolysis (Su et al., 2008).   
The Endocytic Pathway to the Lysosome 
Endocytosis begins at the plasma membrane, where membrane invagination and subsequent 
fission takes up nutrients, proteins, lipids, solutes, receptors, macromolecules, cell debris, 
bacteria and viruses, and many other substances into vesicles (Fig. 2D).  These internalized 
vesicles, nascent endosomes (NE), then undergo a variety of membrane trafficking events that 
lead back to the plasma membrane through recycling endosomes (RE) (Fig. 2E), or to the 
lysosome for degradation. The trans-Golgi network also transports newly synthesized proteins, 
lipids, and hydrolases to late endosomes for integration into the lysosome membrane or 
degradative lumen to ensure lysosome functioning (Fig. 2A,C) (Huotari and Helenius, 2011). 
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 After internalization, early endosomes recycle back an astonishing 50-180% of the 
plasma membrane and take in and subsequently release about 30% of total cell volume in 
extracellular fluid per hour (Steinman et al., 1983).  These impressive numbers give a sense of 
how active and rapid the process of endocytosis is.  They also make it clear that the rapidity and 
constancy of endocytic trafficking provides an easy mechanism for researchers to exploit for 
internalization of various dyes and indicators used to study membrane trafficking through 
endocytic pathways.  Finally, they support the fact that stringent sorting mechanisms ensure that 
only a very select amount of internalized substrates remain internalized and are ultimately 
trafficked to the lysosome. The size of the degradative compartment increases upon stimulation 
with growth factor receptors suggesting that the pathway to the lysosome is regulated according 
to metabolic state of the cell (White et al., 2006). 
 Nascent endosomes (NE) fuse with each other (Fig. 2F) to become early endosomes (EE) 
(Fig. 2G), where a significant amount of sorting occurs to determine the final destination of 
endocytosed cargo.  A number of pathways converge upon early endosomes to transfer cargo for 
sorting.  The small GTPase Rab5 is a primary regulator of early endosome motility, cargo 
sorting, and membrane fusion (Rink et al., 2005).  Early endosomes have varied size, 
morphology, and localization in different cell types, although are mostly found in the periphery 
of the cell. They have both tubular and vacuolar domains which have varied compositions of 
membrane lipids that create membrane subdomains for different functions including cargo 
sorting and fission.  Vacuolar domains presumably contain all material destined for degradation 
(Huotari and Helenius, 2011).  Early endosomes have small amounts of Ca
2+
 that is initially lost 
during progressing acidification (Gerasimenko et al., 1998). The pH of early endosomes ranges 
from about 6.8 to 5.9 (Maxfield and Yamashiro, 1987).  
 The switch from Rab5 to Rab7 on the vacuolar membrane of early endosomes marks the 
conversion to late endosomes (LE) (Fig. 2G) and the progression of cell cargo from the cell 
periphery towards the cell center (Rink et al., 2005).  Late endosomes lack the tubular extensions 
of early endosomes and become larger in size during their maturation.  Late endosomes fuse with 
other late endosomes to form larger vesicles, receive cargo via kiss-and-run events, and 
ultimately fuse with lysosomes to transfer cargo for degradation (Fig. 2H).  Late endosomes also 
carry  numerous proteins and enzymes that become incorporated into the functional lysosome 
9 
 
(Huotari and Helenius, 2011). Late endosomes can have a pH that ranges from 6.0 to 5.0 and 
becomes progressively more acidic as they mature (Maxfield and Yamashiro, 1987).  Late 
endosomes acquire increasing amounts of Cl
-
 and Ca
2+
 compared to early endosomes and 
concentrations of other ions also change during late endosome maturation.  Rabs, membrane 
phosphoinositides, tethering proteins, and ion channels all also change during late endosome 
maturation (Huotari and Helenius, 2011).  
Intraluminal vesicles (ILVs) form within late endosomes (Fig. 2) using ESCRT 
machinery to ensure receptors are inactive (as opposed to being transported on the surface of 
endosome membranes). Intraluminal vesicles contain specific, sorted cargo.  Thus, ILVs simplify 
cargo sorting and make delivery to lysosomes efficient and accessible  (Huotari and Helenius, 
2011).  The membrane composition of intraluminal vesicles is far different from that of late 
endosomes or lysosomes and is conducive to enzyme recruitment (Huotari and Helenius, 2011).  
 From the perspective of endosome trafficking, the lysosome is the last step in this 
continuous and highly dynamic pathway. Late endosomes fuse with lysosomes to become 
endolysosomes (Fig. 2H), where the bulk of cargo degradation occurs.  The characteristic low 
pH of the lysosome facilitates the degradation of complex macromolecules for reuse in 
biosynthetic pathways. Transporters on the lysosome membrane transport these building blocks 
out of the lysosome (Xu and Ren, 2015).   
The Autophagic Pathway to the Lysosome 
Autophagy, or “self-digestion,” is the process by which intracellular components and damaged 
organelles are delivered to the lysosome via late endosomes and autophagosomes.  Basal levels 
of autophagy function to turnover cytoplasmic components that are obsolete or no longer 
functioning.  Autophagy can also be induced by nutrient starvation to increase the abundance of 
cellular building blocks for cell growth via mTOR, but can also occur in an mTOR independent 
manner (Mizushima, 2007).    
Autophagy begins through the isolation of cytosolic components in a phagopore (PP), or 
isolation membrane, which eventually closes to form a double-membrane bound autophagosome 
(AP) (Fig. 2I) (Mizushima, 2007).  Autophagosomes form at ER-mitochondria contact sites 
(Hamasaki et al., 2013), which may be the source of the newly formed membranes, although this 
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process is incompletely understood. Little is known about the specificity of materials engulfed by 
phagopores and subsequent autophagosomes; whether autophagosomes recognize some or all of 
the contents they engulf remains an unanswered question (Mizushima, 2007).   
The outer membrane of autophagosomes fuses with lysosomes to form autolysosomes 
(Fig. 2J).  It has also been suggested that autophagosomes fuse with endosomes to form 
amphisomes before fusing with lysosomes, possibly to acquire the machinery needed to fuse 
with lysosomes (Fig. 2K).  Then the inner membrane and luminal contents of autophagosomes 
are degraded by lysosome resident hydrolases (Murrow and Debnath, 2013). 
The Role of Lysosomal Ca
2+
 in Regulating Endocytosis and Autophagy  
Lysosome Ca
2+
 channel TRPML1 expression (Fig. 1) and activity has been shown to be 
upregulated in response to nutrient depletion (Wang et al., 2015b).  Ca
2+
 signalling through 
TRPML1 activates the phosphatase calcineurin which dephosphorylates TFEB, the 
transcriptional regulator of autophagy.  TFEB phosphorylation promotes its nuclear translocation 
and activation of target genes for autophagy (Medina et al., 2015).  Previous studies have 
suggested that metabolic status can regulate endocytosis (White et al., 2006), and the recent 
studies of lysosomal Ca
2+
 release through TRPML1 suggest that the lysosome regulates 
autophagy induction as well. These findings suggest that lysosomal nutrient sensing mechanisms 
have broad regulatory effects on intracellular membrane trafficking pathways, in part through 
Ca
2+
 signalling (Medina et al., 2015; Wang et al., 2015b).   
Lysosome Degradation and Recycling 
Exogenous materials destined for breakdown in the lysosome come from various sources in the 
cell that include endocytosis and pinocytosis, as well as phagocytosis for large particles.  
Intracellular materials come from macroautophagy, chaperone-mediated autophagy, and 
microautophagy (Ciechanover, 2005).  It is also becoming appreciated that the ubiquitin-
proteasome system can also target proteins for degradation in lysosomes through the autophagy 
pathway (Korolchuk et al., 2010).  
There are 60 known lysosomal hydrolases that degrade all kinds of macromolecules of 
varying sizes into monomeric components. Several activator proteins residing in the lysosome 
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matrix also exist (Settembre et al., 2013).  Furthermore, intramembrane cleaving proteases, like 
the y-secretase complex with catalytic subunits presenilin 1 and 2, can process transmembrane 
substrates (Schwake et al., 2013). 
 After macromolecules have been digested in the lysosome, soluble monomeric units 
(amino acids, monosaccharides, nucleotides) are transported back into the cytosol with specific 
transporters for reuse.  A few amino acid and sugar transporters have been identified, but surely 
there are more to be discovered.  A recent candidate for an arginine (and possibly other amino 
acids) transporter, SLC38A9 (Fig. 1), has been shown to signal to the mTOR pathway, likely to 
signal amino acid sufficiency and activate MTORC1 (Rebsamen et al., 2015; Wang et al., 
2015a).   
Insoluble lipids are transported back to the TGN through membrane fusion events (Xu 
and Ren, 2015).  Cholesterol, for example, is not degraded by lysosomal hydrolases and is 
transported out of lysosomes by cholesterol transporters NPC1 and NPC2 (Fig. 1) (Subramanian 
and Balch, 2008).    
Heavy metal ions resulting from mitophagy or metal storage proteins including Fe
2+
 and 
Zn
2+
 are transported out of the lysosome, possibly by the principal Ca
2+
 channel, TRPML1 (Fig. 
1), because lysosomal heavy metal overload results when TRPML1 is absent (Xu and Ren, 
2015).  
Lysosome Ions and Channels 
Ionic balance is tightly regulated throughout all intracellular vesicles.  Furthermore, ion channels 
and concentration gradients are one way that individual vesicles are differentiated along 
endocytic and autophagic pathways.  Notably, after vesicle fusion, concentration gradients in 
newly formed vesicles can change dramatically, as does the identity of that new compartment. 
Thus, proper function of lysosomes requires tightly regulated ionic homeostasis to ensure proper 
delivery of hydrolases and the removal of breakdown products after degradation.  Importantly, 
many ion concentrations depend on the presence and regulation of other ions in the lysosome, so 
one ion should not be taken out of the context of the balance of all ions (Xu and Ren, 2015).  
Lysosomal patch-clamping techniques have transformed the understanding of lysosome currents 
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and channels, and are responsible for most of what is known about lysosome ion channels today 
(Xu et al., 2007; Dong et al., 2008). 
H
+
: The acidic environment of the lysosome facilitates degradation by loosening structures of 
macromolecules, and is optimal for the activity of hydrolases (Pillay et al., 2002).  The H
+
 
gradient also provides a driving force for catabolite exporters on the lysosome membrane (Ruivo 
et al., 2009).   
The V-ATPase on the lysosome membrane transports 2-4 H
+
 ions per molecule of ATP 
(Marshansky and Futai, 2008), and the number of H
+
 pumped may be one way the V-ATPase 
activity is regulated on different membranes (Maxson and Grinstein, 2014). The electrogenic 
potential of the V-ATPase would cause build-up of positive charge that would prevent further 
acidification if it was not countered (Demaurex, 2002).  Additionally, at chemical equilibrium, 
the V-ATPase would lower luminal pH to ~2.6 (Grabe and Oster, 2001).  The positive membrane 
potential of the lysosome compared to the cytosol (20 to 40 mV more negative in the cytosol) 
may contribute to the driving force of proton entry into lysosomes (Morgan et al., 2011).  Thus, 
lysosomal acidification is coupled to other ion concentrations and their transporters to regulate 
ion homeostasis.   
Countercurrents to lysosome acidification have been suggested to be Cl
-
 entry (Graves et 
al., 2008) or K
+
 and/or Ca
2+
 exit in lysosomes (Steinberg et al., 2010).  Cations and anions could 
both neutralize the charge generated by acidification, but if anions alone were to do the job, 
considerable osmotic gain would occur which would cause strain on lysosome membranes and 
possibly membrane lysis.  This suggests that the counterions include at least one cation, although 
a combination of cation and anion involvement seems most plausible (Steinberg et al., 2010).  
Our studies and those of others show that changes in Ca
2+
 in the lysosome does not change the 
pH of lysosomes (Christensen et al., 2002), suggesting that Ca
2+
 alone may not be the 
countercurrent. It is likely that more than one counterion is involved, which may explain why 
there remains significant controversy.   
Na
+
: Only two studies to date have addressed Na
+
 concentrations within lysosomes. Na
+
 within 
isolated lysosomes has been shown to be ~140-150 mM based on estimations of total ion ratios 
using inductively coupled plasma mass spectrometry (ICP-MS) (Wang et al., 2012).  These 
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results suggest that Na
+
 is the major cation in the lysosome. A less direct method using null point 
titration determinations with a variety of ionophores to dissipate ion concentrations suggested 
that Na
+
 concentrations are lower, at about 20 mM (Steinberg et al., 2010).  Notably, Na
+
 in the 
lysosome is higher than cytosolic Na
+
 (~12 mM) (Xu and Ren, 2015). 
 Na
+
 channels on lysosome membranes play a role in regulating the membrane potential 
and excitability of lysosomes. TPC1 and TPC2 channels on lysosome membranes conduct Na
+
 
from the lysosome lumen to the cytosol (Fig. 1). Their maximal activation requires PI(3,5)P2 
(Wang et al., 2012; Cang et al., 2013; Cang et al., 2014).  TPC1 currents are activated in 
response to extracellular amino acid depletion and intracellular ATP removal.  TPC1 interacts 
with MTORC1 to participate in nutrient sensing. TPC1 can also sense voltage and pH changes in 
the lysosome (Cang et al., 2014).   
K
+
: Like Na
+
, K
+
 concentrations are not well studied compared to H
+
 and Ca
2+
 ions in the 
lysosome due to limited tools.  The two studies examining lysosomal K
+
 suggest 2-50 mM K
+
 in 
the lysosome, which is lower than cytosolic K
+
 (~150 mM) (Steinberg et al., 2010; Wang et al., 
2012; Xu and Ren, 2015).   
A recent study from our lab (Wang et al, under review) suggests that a new Ca
2+
 
activated K
+
 channel is important for lysosome Ca
2+
 store refilling.  While little is known about 
this new K
+
 channel, these findings suggest that despite its lower concentrations in the lysosome, 
K
+
 is important to ion homeostasis.  Lysosome membrane potential is also known to be affected 
by a yet to be identified K
+
 channel using patch-clamp techniques on enlarged lysosomes (Cang 
et al., 2014; Xu and Ren, 2015). 
Fe
2+
 and Zn
2+
: Metal bound proteins degraded in the lysosome release Cu
2+
, Fe
3+
, Fe
2+
, and Zn
2+
 
into the lysosome lumen, which is the major store for these ions in the cell. These ions are 
important to lysosome function but their functional role has yet to be fully realized. Zn
2+
 has 
been shown to be required for the activity of hydrolases, but high concentrations of Zn
2+
 have 
negative consequences, which includes inhibiting cathepsins (Xu and Ren, 2015).  Furthermore, 
depletion of Zn
2+
 blocks endosome fusion (Aballay et al., 1995).  Lysosomal Fe
2+
 is required for 
the Fenton reactions, ROS production, and the survival of lysosome resident pathogens (Xu and 
Ren, 2015).  
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TRPML1 is a nonselective cation channel that conducts Fe
2+
 and Zn
2+
 out of the 
lysosome, as well Ca
2+
, Na
+
 and K
+
 , although it does not conduct H
+
 (Xu et al., 2007; Dong et 
al., 2008).  Zn
2+
 transporters ZIP3 and ZIP8, part of the SLC39 family, are localized to the 
lysosome and serve to export Zn
2+
 out of the lysosome (Jeong and Eide, 2013).  
Cl
-
: Like H
+
, Cl
-
 concentrations increase along the endocytic pathway.  Lysosomes contain about 
80 mM Cl
-
 compared to about 5-40 mM in the cytosol (Stauber and Jentsch, 2013). Chloride 
transporter CLC-7 is present on lysosome membranes (Fig. 1) and transports 2Cl
-
 into the 
lysosome for each H
+
 out.  CLC-7 appears to be important for trafficking and/or fusion/fission 
events to and from the lysosome. Consequently, its loss results in severe pathology in mice and 
humans including accumulation of autophagic structures, osteopetrosis, and a lysosome-storage 
like phenotype (Weinert et al., 2010).  Studies suggest that CLC-7 is not the only Cl
-
 
conductance in lysosomes, the molecular identities of other transporters and channels are not yet 
known (Stauber and Jentsch, 2013).   
Although there is disagreement in the literature regarding the role of Cl
-
 in lysosome 
acidification (Steinberg et al., 2010), Cl- may have additional roles in trafficking particularly in 
regulating ion homeostasis through co-transport as well as regulating osmolarity to assist in 
vesicular volume and shape (Stauber and Jentsch, 2013).  Cl
-
 efflux may play a role in Ca
2+
 
release from the lysosome (Luzio et al., 2007), possibly for counterion transport which has been 
shown for other organelles like the ER (Scott and Gruenberg, 2011).  
Lysosome Ca
2+
 Release Channels and Ca
2+
 Signaling 
Lysosomes are a significant Ca
2+
 store in the cell, with measurements suggesting about 0.4 to 0.6 
mM total Ca
2+
 within the lysosome (Christensen et al., 2002; Lloyd-Evans et al., 2008).  Indeed, 
the concentration of Ca
2+
 in lysosomes is  higher than all other intracellular vesicles other than 
the ER (Fig. 2) (Morgan et al., 2011).  Using the fast Ca
2+
 chelator BAPTA, Ca
2+
 release from 
lysosomes has been shown to be required for late endosome-lysosome fusion in cell-free assays 
(Pryor et al., 2000),  lysosomal exocytosis (Samie et al., 2013), phagocytosis, membrane repair, 
signal transduction (Reddy et al., 2001; Lewis, 2007; Steen et al., 2007), and possibly lysosome 
reformation (Pryor et al., 2000).   
15 
 
The only known lysosomal Ca
2+
 channel is TRPML1 (Fig. 1) (Wang et al., 2014).  
Whereas human mutations of trpml1 cause type IV Mucolipidosis (ML-IV) (Sun et al., 2000), 
pathogenic inhibition of TRPML1 leads to several other LSDs (Chen et al., 1998; Shen et al., 
2012).  PI(3,5)P2 is an endogenous regulator of TRPML1 activity, and also plays a role in the 
recruitment of cytoplasmic effector proteins to regulate lysosome trafficking (Wang et al., 2014; 
Xu and Ren, 2015).  Levels of PI(3,5)P2 have been shown to increase transiently before 
lysosomal exocytosis and lysosome fusion (Li et al., 2013b; Samie et al., 2013).  Plasma 
membrane localized PI(4,5)P2 inhibits TRPML1, suggesting that TRPML1 may be inactive after 
lysosomal exocytosis when it is localized transiently to the plasma membrane (Zhang et al., 
2012).      
Ca
2+
 sensors help to ensure specificity of Ca
2+
 signalling from the lysosome.  In yeast, 
calmodulin signals the completion of vesicle docking and triggers terminal steps in vesicle fusion 
(Peters and Mayer, 1998).  In mammalian cells, the only identified Ca
2+
 sensor specific to the 
lysosome is the penta-EF-hand protein ALG-2.  ALG-2 binds to the NH-terminal cytosolic tail of 
TRPML1 and likely regulates Ca
2+
 release (Vergarajauregui et al., 2009).  Ca
2+
 sensors such as 
C2 domain–containing synaptotagmin VII (Syt-VII) are required for lysosomal exocytosis.  Syt-
VII is found on the lysosome membrane (Fig. 1) and throughout the cell (Samie et al., 2013; 
Samie and Xu, 2014).  There are likely many other Ca
2+
 sensors involved in vesicle fusion and 
fission that have yet to be identified.  
Ca
2+
 Buffering 
Ca
2+
 buffers contain a highly acidic domain that binds Ca
2+
 with a low affinity but high capacity 
(Gelebart et al., 2005).  50-90% of ER Ca
2+
 is reversibly bound by Ca
2+
 buffers such as calnexin, 
calreticulin, and calsequestrin (Michalak et al., 2002).  Little is known about Ca
2+
 buffers in 
acidic stores including lysosomes and how they regulate luminal Ca
2+
 stores as well as Ca
2+
 
release and refilling (Morgan et al., 2011; Dickson et al., 2012).  It has been suggested that some 
Ca
2+
 chelation occurs in acidic vesicles from abundant phosphate and sulphate groups in the 
lumen which are strong acids and can complex even at low pH (Morgan et al., 2011; Dickson et 
al., 2012).  Polyanionic matrices like phosphate and other proteins and small organic acids (e.g. 
oxalic acid) within acidic vesicles also play a role (Nguyen et al., 1998; Morgan et al., 2011; 
Dickson et al., 2012).  Notably, H
+
 competition at low pH reduces the affinity of Ca
2+
 buffers, 
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and as pH increases to become more neutral, the affinity of Ca
2+
 buffers for Ca
2+
 increases 
dramatically (Morgan et al., 2011; Dickson et al., 2012). 
The relationship between free and total Ca
2+
 is better understood in mitochondria when 
compared to lysosomes (Chalmers and Nicholls, 2003).  Uptake of Ca
2+
 buffering phosphate 
occurs when mitochondria take up Ca
2+
, for which the Pi transporter has been identified 
(Iacobazzi et al., 2005).   There is controversy over whether mitochondria serve as Ca
2+
 buffers 
more generally in the cell.  They are indeed able to take up significant amounts of Ca
2+
 when 
exposed to non-physiological high Ca
2+
, but whether this occurs under normal conditions has 
been doubted (Williams et al., 2013).  Mitochondria do use Ca
2+
 signalling transiently for a wide 
variety of purposes.   
Refilling of Intracellular Ca
2+
 Stores 
How intracellular Ca
2+
 stores are acquired and refill has become a topic of considerable interest 
in recent years.  Ca
2+
 store maintenance is best understood for the ER. Upon depletion of Ca
2+
 
stores in the ER, ER proteins rearrange to facilitate Ca
2+
 entry.  ER protein STIM1 is located 
diffusely throughout the ER membrane at rest, and has an EF-hand sequence on its luminal side 
which allows it to detect Ca
2+
 levels.  When Ca
2+
 levels decrease, the EF hand of STIM1 unbinds 
Ca
2+
 which allows it to oligomerize.  STIM1 oligomers then move into discrete puncta at ER-
plasma membrane contact sites (Lewis, 2007).  The exact mechanism by which STIM1 moves is 
not well understood but may be through passive diffusion or through an active, microtubule 
dependent mechanism.  Orai1 is located in the plasma membrane, and upon store depletion it 
relocalizes directly apposing STIM1 at contact sites.  STIM1-Orai1 interactions result in Ca
2+
 
release activated Ca
2+
 current (CRAC) current after ER stores have been at least 25% depleted.   
The CRAC-activating domain of STIM1 interacts with Orai1 channels through electrostatic 
interactions to open the channel.  8 STIM1 are required to maximally open the Orai1 channel.  
SERCA pumps on the ER membrane then pump Ca
2+
 into the ER at these high Ca
2+
 
microdomains.  Ca
2+
 dependent inactivation of CRAC occurs within tens of milliseconds.  After 
store refilling, both Orai1 and STIM1 redistribute throughout the ER and plasma membranes 
respectively (Lewis, 2011).  
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 While ER Ca
2+
 store refilling is well understood, how lysosomes acquire and refill their 
Ca
2+
 is less well understood.  It has been suggested that the pH gradient is important to drive 
Ca
2+
 into the lysosome (Christensen et al., 2002).  However pH affects Ca
2+
 buffering in acidic 
stores significantly (Dickson et al., 2012), suggesting that alternative mechanisms of Ca
2+
 
refilling may be at play.  Ca
2+
 refilling of lysosomes will be discussed in more detail in Chapter 
2. 
Lysosome Storage Disorders  
Impaired lysosome function is found in nearly 60 lysosome storage diseases (LSDs) whose 
underlying cause is a single gene mutation.  Although each LSD is rare, combined they are found 
in about 1:5000 births.  LSDS are typically caused by mutations in genes encoding catabolic 
enzymes, hydrolase activators, membrane proteins, or transporters (Boustany, 2013).  Using a 
classical but slightly out-dated categorization of  these diseases by accumulated material, there 
are glycogen storage diseases, glycoproteinoses, (sphingo)lipidoses,  mucopolysaccaridoses, and 
neuronal ceroid lipofuscinoses (NCLs) (Schroder et al., 2010). NCLs, also known as Batten 
Disease, is a family of eight genetically distinct neurodegenerative disorders that result in the 
accumulation of a variety of lipofuscin-like materials that exhibit autofluorescent properties 
(Jalanko and Braulke, 2009).  
LSDs share several commonalities despite having unique genetic causes.  Accumulation 
of un-degraded materials that become toxic to the cell, impaired lipid trafficking, increased 
inflammation, disturbed ER Ca
2+
 homeostasis, and enhanced cellular stress responses like the 
unfolded protein response all characterize LSDs (Boustany, 2013).   
Given the varied genes that cause LSDs, a variety of therapies have been effective in 
different diseases.  Enzyme replacement therapy, pharmacological chaperones, substrate 
reduction therapy, and ER Ca
2+
 channel blockers are currently being used to varying degrees of 
success in several LSDs (Boustany, 2013).  Virally mediated gene therapies, stem cell therapies, 
and other hypothesis driven therapies including ion channel targeting are currently being 
examined in animal models and several new treatments for LSDs will hopefully emerge 
(Boustany, 2013; Xu and Ren, 2015).    
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 About two thirds of people with LSDs have a significant neurological component that 
ranges in severity and manifestation (Parenti et al., 2014).  Brain inflammation, alteration of 
intracellular trafficking, and autophagy impairment that are secondary to lysosome dysfunction 
in LSDs are also found in common adult neurodegenerative diseases including Alzheimer’s, 
Parkinson’s, and Huntington’s diseases which all have protein accumulation in common 
(Appelqvist et al., 2013).   
Lysosomes in Neurodegenerative Diseases 
 Improper turnover of proteins and degradation is found in many common, multifactorial 
diseases like Alzheimer’s Disease, atherosclerosis, cancer, and Parkinson’s Disease (Levine and 
Kroemer, 2008; Nixon et al., 2008; Kirkegaard and Jaattela, 2009; Martinet and De Meyer, 2009; 
Schroder et al., 2010; Nixon, 2013).  This is due at least in part to deregulated autophagic flux, as 
fusion of lysosomes with autophagosomes and the degradative activity of auto-lysosomes are the 
final steps in autophagy. Even inactivation of key autophagy related genes Atg-5 or Atg-7 in 
mice results in pathological neurodegeneration (Hara et al., 2006; Komatsu et al., 2006).   
 Neurons are especially sensitive to lysosome and autophagy defects because they are: (1) 
limited in their regenerative potential; (2) post-mitotic, and therefore unable to dilute stored 
materials during cell division; (3) heavily reliant on autophagy because they lack compensatory 
metabolic pathways; (4) dependent on intracellular trafficking to move materials out of the cell 
body and into axons and dendrites (Bellettato and Scarpa, 2010; Appelqvist et al., 2013).   
 Restoring lysosome function and autophagy in mouse models of Alzheimer’s disease has 
proven to be very beneficial and may hold hope for therapeutic targets (Pickford et al., 2008; 
Caccamo et al., 2010; Butler et al., 2011; Yang et al., 2011; Bahr et al., 2012; Steele et al., 
2013a; Steele et al., 2013b). 
Altered Ca
2+
 Homeostasis in LSDs and Neurodegenerative Diseases  
Aberrant Ca
2+
 homeostasis and signalling has been implicated as a central cause of Alzheimer’s 
disease related dysfunction, particularly because it occurs long before other pathologic hallmarks 
of the disease (Pierrot et al., 2004; Stutzmann, 2007; Thibault et al., 2007; Supnet and 
Bezprozvanny, 2010; Chakroborty et al., 2012).   ER Ca
2+
 homeostasis has also been implicated 
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in LSDs and suggests an important potential target for current research.  Furthermore, the 
histopathological hallmarks of LSDs and AD, like accumulated substrates such as amyloid, can 
result in further Ca
2+
 deregulation, enhancing the disease progression in a feed-forward manner 
(Stutzmann, 2007; Demuro et al., 2010).   
 Altered ER Ca
2+
 release through RYRs has been shown to play a role in the pathogenesis 
of AD (Kelliher et al., 1999; Stutzmann et al., 2006; Chakroborty et al., 2009; Goussakov et al., 
2010; Goussakov et al., 2011; Oules et al., 2012; Peng et al., 2012).   Supporting this, altered 
RYR expression in adults with mild cognitive impairment and AD has been demonstrated 
(Bruno et al., 2012).  Additionally, IP3Rs have also been implicated in Alzheimer’s pathology 
(Stutzmann et al., 2004; Cheung et al., 2008; Cheung et al., 2010; Muller et al., 2011).   
 ER Ca
2+
 is altered in a variety of ways in LSDs. For example, Gaucher disease is 
characterized by increased Ca
2+
 release into the cytosol through ryanodine receptors (RYRs).  
GM1- and GM2-gangliosidoses have aberrant Ca
2+
 uptake into the ER due to inhibition of the 
Sarcoplasmic/Endoplasmic Ca
2+
 ATP-ase (SERCA) transporter.  Reduced expression of the 
SERCA is also found in Neimann Pick Type A (NPA) (Boustany, 2013).  Pompe disease has 
altered Ca
2+
  homeostasis that is alleviated using RYR blockers (Lim et al., 2015).  RYR 
blockers diltiazem and verapamil, which are used for treatment of hypertension, have been 
shown to restore enzyme function in patient fibroblasts from alpha-mannosidosis, Gaucher 
disease, and MPS IIIa (Mu et al., 2008; Platt and Lachmann, 2009).  
 Precise mechanisms of ER Ca
2+
 regulation and dysregulation are not yet well understood 
in LSDs and neurodegenerative disorders, but it is clear that abnormal release and altered levels 
of ER Ca
2+
 have negative consequences on lysosomes.  Furthermore, accumulated substrates in 
the ER and lysosomes further alter Ca
2+
 signalling and homeostasis.  Thus, further investigation 
into the relationship between ER and lysosome Ca
2+
 may help shed light on this phenomenon.  
Membrane Contact Sites: The ER as a Central Connector 
Membrane contact sites are ongoing links between a variety of membranes, typically between the 
ER and other organelles or the plasma membrane.  Accumulated evidence suggests that the ER 
forms membrane contact sites with the plasma membrane (Giordano et al., 2013; Malmersjo and 
Meyer, 2013), mitochondria (Rizzuto et al., 1993; Szabadkai et al., 2006; de Brito and Scorrano, 
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2008; Kornmann et al., 2009; Cardenas et al., 2010), endosomes (Alpy et al., 2013), and 
lysosomes (Kilpatrick et al., 2013; van der Kant and Neefjes, 2014).   
ER-membrane contact sites facilitate the rapid back-and-forth exchange of materials for 
synthesis without requiring specific vesicles for transport, and the rapid and discrete exchange of 
ions.  Membrane contact sites contain regulatory complexes and facilitate intraorganellar 
communication about nutrient state and bioenergetics.  Membrane contact sites are typically 5 – 
50 nm in diameter, are enriched locally with specific lipids and proteins, and are linked 
ongoingly or transiently by tethers that facilitate contact and exchange (Prinz, 2014).  
A primary function of the rough ER is synthesis of membrane and secretory proteins 
(Dallner et al., 1963).  However, the function of smooth ER, which is interspersed between areas 
of rough ER, has been more difficult to elucidate (Lynes and Simmen, 2011).  In recent years, it 
has been proposed that a primary function of smooth ER is to store Ca
2+
 and to regulate 
membrane contact sites, exchanging proteins, ions, and lipids between the ER and other 
organelles (Lynes and Simmen, 2011; English and Voeltz, 2013).    
Contact sites between the ER and plasma membrane have been shown to facilitate lipid 
synthesis, phosphatidylinositol metabolism, sterol exchange, and Ca
2+
 exchange particularly 
during store operated Ca
2+
 entry (SOCE) (English and Voeltz, 2013; Giordano et al., 2013; 
Stefan et al., 2013).  ER-plasma membrane contact sites are so stable that it is necessary to 
eliminate six different proteins to even reduce the extensive connections between the two 
membranes (Manford et al., 2012).   
ER-Golgi contact sites regulate the transfer of secreted proteins and sterols (Peretti et al., 
2008; Mesmin et al., 2013; Prinz, 2014).   
ER-endosome contact sites increase during endosome maturation (Friedman et al., 2013) 
and have been shown to play a role in receptor trafficking (Eden et al., 2010), cholesterol 
exchange (Rocha et al., 2009; Du et al., 2011; Du et al., 2012; Alpy et al., 2013; van der Kant et 
al., 2013; van der Kant and Neefjes, 2014)  and most recently the timing and position of 
endosome fission (Rowland et al., 2014).   
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Perhaps the most studied membrane contact sites are between the ER and mitochondria.  
By understanding the specifics of these contact sites, the form and function ER-lysosome contact 
sites may be better understood.  Because of this, ER-mitochondria interactions will be described 
in greater detail below.  
ER-Mitochondria Contact Sites: The Most Studied Membrane Contact Sites  
Contact sites between the ER and mitochondria are the best characterized inter-organellar 
contact sites.  Microdomains of Ca
2+
 between the IP3-releasable Ca
2+
 stores of the ER and 
mitochondria have been suggested for many years (Rizzuto et al., 1993), and as much as 20% of 
mitochondrial surface membranes are in contact with the ER (Rizzuto et al., 1998).  
Mitochondria are also proposed to shape ER Ca
2+
 signals and buffer ER released Ca
2+ 
(Rizzuto et 
al., 2004).   
GRP75 is a proteinaceous tether linking voltage-dependent anion channel (VDAC) 
channels of the outer mitochondrial membrane with IP3Rs on the ER membrane.  The GRP75-
IP3R contact site has been shown to regulate Ca
2+
 transfer between the ER and mitochondria, 
although varying the length of this tether does not affect Ca
2+
 signalling, suggesting that another 
protein plays that role (Szabadkai et al., 2006).  More recently, constitutive IP3R Ca
2+
 release 
has been shown to regulate bioenergetics of mitochondria and serve as a signal to suppress 
macroautophagy in times of nutrient abundance (Cardenas et al., 2010).  Indeed, in times of ER 
stress, mitochondria-ER contact increases (Bravo et al., 2011).  The ER has also been shown to 
regulate mitochondrial division sites (Friedman et al., 2011), which likely includes Ca
2+
 
signalling as a final trigger.   
Imaging Ca
2+
 dynamics at interorganelle contact sites between the ER and mitochondria 
has been done using drug-inducible, synthetic interorganellar linkers localized to the outer 
mitochondrial membrane and the mitochondrial-associated membrane of the ER (Csordas et al., 
2010).  This elegant study provided the first direct evidence of a high Ca
2+
 microdomain 
exceeding 10 µM at ER-mitochondria junctions, and suggested that the distance between these 
two organelles varies for different purposes and regulates Ca
2+
 transfer (Csordas et al., 2010).   
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ER-Mitochondria Contact Sites: A Model for ER-Lysosome Contact Sites? 
Our understanding of ER-mitochondrial contact sites may provide hints to contact sites 
between lysosomes and the ER.  While there are many obvious differences between 
mitochondria and lysosomes, there are particular similarities that when examined, may shed light 
on lysosomal coordination with the ER.  As such, those similarities and relevant mitochondrial 
functions will be reviewed here briefly.   
Mitochondria are known as the powerhouse of the cell, but also participate in the 
coordination and regulation of a variety of intracellular processes, particularly those requiring 
ATP.  Like lysosomes, mitochondria maintain a pH gradient, which is driven by the electron 
transport chain coupled to the production of ATP in mitochondria (Szabadkai and Duchen, 
2008).  As such, mitochondria function, like lysosome function, is tightly coupled to the 
energy/nutrient state of the cell.   
The ER requires important resources from both lysosomes and mitochondria, providing 
one mechanism by which they may modulate ER function. Numerous examples exist of 
mitochondria modulating ER function. An obvious example is the requirement of ATP from 
mitochondria for function of the SERCA pumps (Szabadkai and Duchen, 2008).  Likewise, 
lysosomes recycle all macromolecules in the cell.  As the making center of the cell, the ER 
requires a supply of building blocks from lysosomes.  
Mitochondrial-nuclear communication occurs to signal mitochondrial functional state and 
coordinate cellular bioenergetics. Although not well-understood in eukaryotic cells, it is known 
to involve Ca
2+
 (Szabadkai and Duchen, 2008).  Nuclear signalling to and from lysosomes has 
been the focus of many recent studies and has been shown involve transcription factor EB 
(TFEB) (Sardiello et al., 2009; Settembre et al., 2011; Roczniak-Ferguson et al., 2012; Settembre 
et al., 2012).   
The involvement of Ca
2+
 in lysosome-to-nucleus signalling has just been recognized to 
involve the lysosomal Ca
2+
 channel TRPML1 (Medina et al., 2015).  The importance of Ca
2+
 in 
mitochondrial functioning is illustrated by the fact that the major rate limiting steps in the citric 
acid cycle are Ca
2+
 dependent (McCormack et al., 1990).  Indeed, a major role for Ca
2+
 uptake in 
mitochondria is to regulate mitochondrial metabolism (Szabadkai and Duchen, 2008).  This is 
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supported by the fact that an increase in mitochondrial Ca
2+
 from the ER stimulated by histamine 
increases ATP production (Jouaville et al., 1999). Thus, Ca
2+
 is required for normal function of 
lysosomes and mitochondria, both of which store and signal with Ca
2+
 ongoingly.   
Ca
2+
 Exchange at ER-Mitochondria Contact Sites: A Model for Ca
2+
 Exchange at 
Membrane Contact Sites  
Mitochondria take in Ca
2+
 through a voltage dependent anion channel (VDAC) on the 
outer mitochondrial membrane (OMM), fuelled by a membrane potential about 200 mV more 
negative than the cytosol (-200mV).  VDAC was originally known for its role in channelling 
metabolites (Rizzuto et al., 2004).  Knockdown of VDAC does not change Ca
2+
 handling in the 
mitochondria as would be expected, suggesting that there may be other pore-forming channels 
that also participate in Ca
2+
 uptake, but these have not yet been identified (Szabadkai and 
Duchen, 2008).  Ca
2+
 travels to the inner mitochondrial membrane (IMM) through the 
mitochondrial calcium uniporter (MCU), which may be gated by Ca
2+ 
(Kirichok et al., 2004).  
The molecular identity and functional specifics of the MCU remained largely elusive until 
recently (Baughman et al., 2011; De Stefani et al., 2011).  Further, findings exist to support an 
additional rapid uptake mode of Ca
2+
 into the IMM (Szabadkai and Duchen, 2008).   
Mechanisms of Ca
2+
 extrusion from the mitochondria are not well understood, and may 
be coupled to Na
+
 and/or H
+
 efflux, or Ca
2+
 may possibly exit directly through the VDAC 
(Szabadkai and Duchen, 2008).  Confusion over Ca
2+
 efflux likely exists because it is coupled to 
at least one other ion, whose concentration and the overall membrane potential also play a role in 
regulating Ca
2+
 exit from mitochondria.   
The importance of ER-mitochondrial contact sites was first appreciated when it was 
discovered that mitochondria could take up Ca
2+
 released from the ER at microdomains between 
the two vesicles (Rizzuto et al., 1993).  The rate of Ca
2+
 entry and magnitude of Ca
2+
 taken into 
mitochondria corresponded with local microdomains of significantly higher Ca
2+
 when compared 
to that of the cytosolic increase due to IP3R stimulation (Rizzuto et al., 1993).  Because of these 
findings, the previously observed close apposition of mitochondria to the ER in electron 
micrographs was appreciated (Satoh et al., 1990; Takei et al., 1992).   
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About 12-20% of the outer mitochondrial membrane (OMM) is estimated to be directly 
apposing both the smooth and rough ER; these sites are often called “membrane contact sites.”  
The distance between the ER and OMM is about 10-50 nm (Csordas et al., 2006), although the 
length varies (Pacher et al., 2000).  Many contact sites exist between the ER membrane and each 
mitochondria, suggesting multiple junctions for different purposes.  Junctions between the ER 
and mitochondria display “quasi-synaptic” signal transmission, particularly for Ca2+ (Csordas et 
al., 1999).  Said another way, these close interactions allow for rapid, efficient, and specific 
exchange materials and coordination of signals.   
Ca
2+
 uptake into mitochondria occurs quickly after IP3 induced Ca
2+
 release from the ER 
at specific microdomains, or “hotspots” (Rizzuto et al., 1993; Rizzuto et al., 1998; Montero et al., 
2000; Szabadkai et al., 2004; Gerencser and Adam-Vizi, 2005).  These Ca
2+
 microdomains have 
even been shown to be resistant to BAPTA in cardiomyocytes (Dell'agnello et al., 2007).  This 
quick uptake of Ca
2+
 by mitochondria ensures that Ca
2+
  induced inactivation of IP3Rs does not 
occur and allows for more Ca
2+
 to be transmitted (Hajnoczky et al., 1999).  Knockdown of IP3 
receptors does not abolish contact between the ER and mitochondria (Csordas et al., 2006), nor 
does disruption of microtubules or intermediate filaments (Soltys and Gupta, 1992).  Even 
completely altering ER morphology with a mutation to decrease ER tubulation does not abolish 
ER-mitochondrial contact (Friedman et al., 2011).   
ER-to-mitochondria tethers are known to be proteinaceous, as they are abolished after 
proteolysis of isolated ER-mitochondrial preparations.  Ca
2+
 within the mitochondria of these 
preparations is reduced if these tethers are abolished (Csordas et al., 2006).  Intriguingly, the 
distance between the ER and mitochondria seems to be regulated by Ca
2+
 (Csordas et al., 2006).  
Moreover, specific tether GRP-75 links the ligand binding domain of IP3Rs to VDAC1 on 
mitochondrial membranes (Szabadkai et al., 2006).  Multiple different tethers exist, some of 
which have been identified (Szabadkai et al., 2006; de Brito and Scorrano, 2008; De Vos et al., 
2012), to support a variety of processes at ER-mitochondrial junctions, and abolishing just one 
does not prevent tethering of these two organelles. 
Ca
2+
 signalling between the ER and mitochondria aids in coordinating cellular energy 
needs, sensed by the ER, and couples them to their production in mitochondria  (Hayashi et al., 
2009).  Increasing IP3 and Ca
2+
 in mitochondria increases ATP production (Jouaville et al., 
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1999).  Ca
2+
 levels in the mitochondria also promote enzyme activity and protein transport 
(Hayashi et al., 2009).  Ca
2+
 is required for the transport of PtdSer synthase from the ER MAM 
to mitochondria (Kuge et al., 2001). The mitochondrial associated membrane (MAM) of the ER 
is enriched with enzymes for lipid and glucose metabolism and biosynthesis (Hayashi et al., 
2009).    Because many lipid synthesizing enzymes are Ca
2+
 dependent and lipid metabolism 
depends on ATP, it is likely that ER-mitochondria Ca
2+
 signalling regulates lipid synthesis at 
multiple steps in the process (Hayashi et al., 2009). Indeed, these complexes between the ER and 
mitochondria have been shown to be required for synthesis of cytochrome C oxidase in the 
mitochondria as well as phospho- and glycosphingolipids (Voelker, 2005).   
Ca
2+
 has also been shown to be involved in mitochondrial division (Breckenridge et al., 
2003; Cribbs and Strack, 2007). More recently, ER tubules have been shown to mark sites of 
mitochondrial division (Friedman et al., 2011), presumably at least in part for Ca
2+
 transfer.  
Mitochondrial positioning is also regulated by Ca
2+
, with two major GTPases containing EF-
hand Ca
2+
 binding domains (Fransson et al., 2006).  
Mitochondria can in turn regulate the amount of Ca
2+
 released from the ER (Jouaville et 
al., 1995). Mitochondria release cytochrome c in response to activation of apoptotic pathways 
which binds to IP3 receptors increasing Ca
2+
 flux from the ER and increasing apoptotic 
signalling.  In response to apoptotic inducing agents, the gap between the ER and mitochondria 
gets smaller (Csordas et al., 2006), because exchange of Ca
2+
 to the mitochondria from the IP3Rs 
on the ER is required for apoptosis (Wozniak et al., 2006).   
 In summary, membrane contact sites between the ER and mitochondria require Ca
2+
 and 
other tethers, coordinate multiple functions of both the ER and mitochondria, and one function is 
to provide Ca
2+
 to mitochondria.  Considering these junctions between ER and mitochondria may 
provide clues to our current and future studies to understand ER-lysosome interactions and Ca
2+
 
signalling. 
Research Objectives  
As discussed above, lysosome Ca
2+
 stores are essential to proper lysosome function and to 
trafficking in both the endosomal and autophagic pathways.  However, little is known about how 
the lysosome acquires and maintains its Ca
2+
 store, as few studies have closely examined this 
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question.  We first sought to test the hypothesis that pH is required for lysosome Ca
2+
 store 
refilling and show that it is not required for Ca
2+
 store refilling or maintenance (Chapter II).  
Then, encouraged by converging lines of evidence that the ER and lysosomes interact, we 
hypothesized that the ER Ca
2+
 store may directly refill lysosome Ca
2+
 stores.  We show that ER 
Ca
2+
 stores are required for lysosomes to maintain their Ca
2+
 stores (Chapter III).  In Chapter IV 
we examine which ER Ca
2+
 channel is important to refill lysosome Ca
2+
 stores.  Finally, we 
hypothesized that altered ER Ca
2+
 transfer to lysosomes would impair lysosome function and 
showed that by blocking ER Ca
2+
 release, a lysosome storage phenotype results (Chapter V).  
This research will facilitate a better understanding of the current literature on lysosome biology 
and provides a foundation for many future questions (Chapter VI).   
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Figure 1.1 Lysosome Ion Channels and Transporters. Lysosomes are the second largest Ca
2+
 
store in the cell, containing 0.4 – 0.6 mM Ca2+.  Lysosomes are also the most acidic organelles in 
the cell, with pH ranging from as low as 4.0 to about 4.9.  Lysosome membrane proteins LAMP1 
and LAMP2 make up 50% of lysosome membrane proteins.  CD63 and LIMP2 are also abundant 
lysosome membrane proteins, providing structural support to other transporters.  Syt-7 is a 
membrane trafficking protein that facilitates Ca
2+
 dependent fusion of membranes.  Syt-7 is 
involved in Ca
2+
 dependent lysosome exocytosis, and is stabilized by CD63.  TRPML1 is a non-
selective cation channel on the lysosome membrane that conducts Ca
2+
 as well as Fe
2+
 and Zn
2+
 
into the cell cytosol.  A putative Ca
2+
 pump likely resides on the lysosome membrane to create 
the high Ca
2+
 gradient found in the lysosome.  Cl
-
 transporter CLC-7 transfers 2 Cl
-
 into the 
lysosome lumen for each H
+
 out.  The V-ATPase on the lysosome uses ATP to pump H+ into the 
lysosome.  TPC1 and TPC2 are Na+ channels on the lysosome that release Na+ into the cytosol.  
TPC1 interacts with MTORC1 and may play a role in nutrient sensing.  The lysosome nutrient 
sensing (LYNUS) apparatus is composed of the V-ATPase and several regulator proteins that 
associate and dissociate with the V-ATPase in a nutrient dependent manner to activate 
MTORC1.  MTORC1 activation triggers anabolic processes in the cell.  Conversely, AMPK 
associates with the V-ATPase when bound to AMP, which triggers catabolic processes in the 
cell.  NPC1 in the lysosome membrane and NPC2 in the lysosome lumen are essential for 
cholesterol transport out of the lysosome.  
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Figure 1.2 Intracellular Organelles and Trafficking Networks.  This schematic view of the 
cell illustrates primary intracellular vesicles as well as known Ca
2+
 concentrations and pH (in 
red) when available. The largest contiguous organelle in the cell, the endoplasmic reticulum (ER) 
is partially illustrated here in blue forming membrane contact sites with all organelles in the cell 
and the plasma membrane. (A) Clathrin-coated vesicles from the Golgi transport M6PR 
receptors carrying lysosomal hydrolases to late endosomes.  (B)  Vesicles budded from the Golgi 
also traffic to the plasma membrane to deliver receptor bound materials destined for the 
lysosome. These will be endocytosed and trafficked to the lysosome.  (C)  Non-clathrin coated 
vesicles originating in the Golgi can also fuse with late endosomes. (D) Endocytosis begins with 
membrane invagination and budding from the plasma membrane to form nascent endosomes 
(NE).  (E) Recycling endosomes transport materials back to the plasma membrane that are not 
destined for degradation.  (F) Nascent endosomes fuse to form early endosomes (EE).  (G) Early 
endosomes mature into late endosomes through several GTPase switching steps, the final of 
which (Rab 5 to 7) marks the conversion to late endosomes (LE).  (H) Late endosomes fuse with 
lysosomes so that cargo carried in intraluminal vesicles (ILVs) can be degraded by the lysosome.  
Late endosomes also deliver lysosome membrane proteins and hydrolases to the lysosome from 
the Golgi. (I) Phagopores enclose intracellular components for degradation and upon membrane 
closure form autophagosomes (AP).  (J) Autophagosomes fuse with lysosomes for degradation 
29 
 
of intracellular materials.  (K)  Alternatively, autophagosomes fuse with late endosomes which 
subsequently fuse with lysosomes.   
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CHAPTER II 
THE LYSOSOME V-ATPASE AND pH GRADIENT ARE NOT REQUIRED FOR Ca
2+
 
REFILLING TO THE LYSOSOME 
ABSTRACT 
Ion homeostasis in the lysosome lumen regulates a variety of lysosomal processes integral to 
lysosome function.  Previous studies have suggested that the proton gradient in the lysosome, or 
the V-ATPase on the lysosome membrane, drives Ca
2+
 into the lysosome, and this is the 
prevailing view of the field.  Using a new assay of Ca
2+
 release and refilling, we show that the 
pH gradient and V-ATPase are not required for lysosome Ca
2+
 store refilling.  Instead, altering 
the pH of the lysosome may disrupt Ca
2+
 buffering in the lysosome and decrease the free, 
releasable Ca
2+
 in the lysosome lumen.  The lysosome membrane-disruptor GPN results in a pH 
induced change in the intracellular Ca
2+
 indicator Fura-2, which may have contributed to the 
misunderstanding of the relationship between pH and Ca
2+
 stores in lysosomes.  In addition to 
showing that pH is not integral for Ca
2+
  store regulation in lysosomes, we believe this work 
highlights the problems with previous methods of studying lysosome Ca
2+
, specifically that 
disrupting membrane proteins and ion homeostasis of the lysosome is problematic when 
determining physiologic Ca
2+
  stores in lysosomes.  We highlight the need for BAPTA-AM as a 
control in all intracellular Ca
2+
 assays. 
 
INTRODUCTION 
Normal function of the lysosome requires on-going maintenance of luminal ion homeostasis for 
ions like H
+
 and Ca
2+
, which are 1,000-5,000 times more abundant in the lysosome lumen than 
the cytosol (Xu and Ren 2015).  The lysosome also contains Cl
-
, Cu
+
, Fe
2+
, K
+
, Na
+
, Zn
2+
, and 
other ions (Luzio, Bright et al. 2007; Scott and Gruenberg 2011; Xu and Ren 2015),  the precise 
spatio-temporal balance of which is likely to affect lysosome function in yet to be realized ways.  
Together, these ions generate a membrane potential that has been measured to range from 20 to 
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40 mV more negative than the cytosol (-20 to -40mV) (Xu and Ren 2015).  Membrane potential 
is also likely to vary depending on the lysosome functional state.  It seems probable that 
membrane potential and specific intraluminal ion concentrations directly regulate lysosome ion 
channels and transporters and thus lysosome function as well.   
The lysosome lumen is highly acidic (pH ~4.5), driven by a vacuolar-type H
+
-ATPase 
(V-ATPase) on the lysosome membrane (Mindell 2012).  The low pH of the lysosome plays a 
role in sorting processes and activates hydrolytic enzymes for the breakdown of macromolecules 
(Yoshimori, Yamamoto et al. 1991; Luzio, Bright et al. 2007).  Improper acidification of 
lysosomes and/or a reduction in their Ca
2+ 
stores has been found in an array of lysosome storage 
disorders and neurodegenerative diseases (Maxfield 2014).  Additionally, the V-ATPase on the 
lysosome is part of the RAGulator complex for nutrient sensing at the lysosome membrane 
(Zoncu, Bar-Peled et al. 2011), suggesting that the role of the V-ATPase on the lysosome is far 
more complicated than previously thought.   
Lysosome Ca
2+
 Store Regulation 
Although direct measurement of luminal Ca
2+
 concentration is difficult, it has been shown to be 
about 0.4–0.6 mM in lysosomes (Christensen, Myers et al. 2002; Lloyd-Evans, Morgan et al. 
2008).  However, the source of Ca
2+
 to the lysosome has been misunderstood to date.  Unlike the 
major Ca
2+
 store in the cell, the endoplasmic reticulum (ER), emptying lysosome Ca
2+
 stores 
does not induce store operated Ca
2+
 entry (SOCE) (Haller, Volkl et al. 1996).  Most Ca
2+
 taken 
up through endocytosis is quickly lost during the course of endosomal acidification 
(Gerasimenko, Tepikin et al. 1998; Sherwood, Prior et al. 2007).   
Ca
2+
 Refilling to the Lysosome: The pH Hypothesis 
It is commonly thought that the Ca
2+
 gradient in the lysosome is established by an unidentified 
Ca
2+
/H
+
 exchanger or a Ca
2+
 transporter that depends on the H
+
 gradient (Morgan, Platt et al. 
2011).  However, much of the research supporting this view has been performed in highly 
specialized cell types (Lopez, Camello-Almaraz et al. 2005) or in subcellular preparations 
(Klemper 1985; Schulz, Thevenod et al. 1989; Docampo, Scott et al. 1995).  Studies in yeast and 
plant vacuoles also demonstrate a Ca
2+
/H
+
 exchanger (Pittman 2011), but these findings are 
difficult to extrapolate to mammalian lysosomes.  
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Initial studies in intact mammalian cells examined secretory granules (SG) in polarized 
pancreatic acinar cells and suggested the V-ATPase was responsible for refilling of SG Ca
2+
 
stores (Camello, Pariente et al. 2000).  These conclusions were based on their findings that a 
cytosolic Ca
2+
 gradient initiated by ER SOCE dissipates after application of the ionophore 
nigericin and the V-ATPase blocker Concanamycin-A (Con-A).  Importantly, they include no 
direct measurement of luminal Ca
2+
 or SG specific Ca
2+
 release (Camello, Pariente et al. 2000), 
making their conclusions largely speculative.  Secretory granules are significantly less acidic 
than lysosomes (pH 5.5-6.0) (Tompkins, Nullmeyer et al. 2002), are insensitive to lysosome 
specific reagents (Gerasimenko, Sherwood et al. 2006),  and have very different functions in the 
cell (Petersen 2015; Xu and Ren 2015) making it difficult to extrapolate these findings directly to 
lysosomes.  Moreover, SG Ca
2+
 stores have been shown to be releasable though IP3R agonists 
(Gerasimenko, Gerasimenko et al. 1996) like the ER, which is not true of lysosomal Ca
2+
 stores.   
Using a luminal Ca
2+
  indicator, Christensen et al. showed that by inhibiting the 
lysosomal V-ATPase with Baf-A, free Ca
2+
 levels in the lysosome lumen decreased slowly from 
0.6 mM to 285 nM, with a corresponding increase in lysosome pH (Christensen, Myers et al. 
2002).  Then, using NH4Cl, Christensen et al. also showed that cytosolic Ca
2+
 increased rapidly 
by 40 nM after increasing the pH of lysosomes (Christensen, Myers et al. 2002).   
Because these findings are consistent with studies in yeast showing that the Ca
2+
/H
+ 
exchangers establish the vacuolar Ca
2+
 gradient (Pittman 2011), this “pH hypothesis” has been 
widely accepted (Christensen, Myers et al. 2002; Cribbs and Strack 2007; Lloyd-Evans, Morgan 
et al. 2008; Calcraft, Ruas et al. 2009; Morgan, Platt et al. 2011; Shen, Wang et al. 2012).  
However, large changes of luminal pH may indirectly affect many other lysosomal processes, 
including luminal Ca
2+
 buffering (Grabe and Oster 2001), lysosomal trafficking, or the activity 
of other transporters and exchangers.  Thus, how lysosomal Ca
2+
 stores are refilled under more 
physiological conditions remains to be tested.    
Ca
2+
 Refilling to Lysosomes: The Ca
2+
 Buffer Hypothesis 
More recently, Dickson et al. similarly found that when NH4Cl was used to increase the pH of 
SGs and the ER, levels of free, luminal Ca
2+
 in both SGs and the ER decreased rapidly with a 
concomitant cytosolic Ca
2+
 increase of 40 nM.  Importantly, this change was immediately 
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reversible upon removal of NH4Cl and was observed in both SGs and the ER (Dickson, Duman 
et al. 2012).  This finding is important because even though the pH of the ER is 6.9, just slightly 
lower than the cytosolic pH, it demonstrates that any changes in pH can have major 
consequences on luminal Ca
2+
.  Using CCCP to collapse SG pH, they found a similar rapid, 
reversible change in Ca
2+
 levels that tracks with pH changes (Dickson, Duman et al. 2012).  
Based on their findings, Dickson et al proposed the “Ca2+ buffer hypothesis”, which is supported 
by the fact that Ca
2+
 buffers bind Ca
2+
 much more effectively after being deprotonated (when pH 
increases).  After inducing a non-physiologic, high pH the amount of bound/buffered Ca
2+
 in the 
lumen of both the SGs and ER increases rapidly.  This decreases free Ca
2+
 within organellar 
compartments (Dickson, Duman et al. 2012).  The concomitant small increase in Ca
2+
 in the 
cytosol may actually be due to pH changes that affect cytosolic Ca
2+
 indicators (Rudolf, 
Mongillo et al. 2003), because when both ER and SG Ca
2+
 is released through IP3-receptors or 
ryanodine receptors, the Ca
2+
 response is much higher.  These findings support the notion that 
Ca
2+
 binding proteins are sensitive to pH and affect the level of free Ca
2+
 in acidic vesicles.  
However, they do not shed light onto the source of Ca
2+
 to the lysosome.  
Tools to Study Lysosomes in Living Cells 
Lysosomes generally have a perinuclear localization around the microtubule organizing center.  
Lysosomes are difficult organelles to study due to their highly acidic lumen which can impact 
luminal indicators, particularly Ca
2+
 indicators.  However, taking advantage of the lysosome’s 
terminal location in the endocytic pathway and lysosome membrane proteins has enabled many 
methods to probe lysosome function.  
Utilizing Endocytic Pathways to Examine Lysosomes 
As the terminal compartment of the endocytic and phagocytic pathways, probes incubated in the 
cell culture medium will reach and accumulate within lysosomes after several hours.  
Fluorescent-dye dextran conjugates are the most useful in studies of lysosomes because they are 
relatively resistant to degradation by lysosomes.  Different dextran conjugates can be used to 
measure pH and Ca
2+
 within the lysosome.  There are limitations to this method in certain cell 
types that have low rates of fluid phase uptake, but this does not impede studies in most cell 
types (Pryor 2012).   
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 Membrane-resident receptors that are endocytosed such as the EGF receptor are another 
way of utilizing the endocytic pathway to study lysosomes.  Tools such as fluorescent BODIPY-
Lactosylceramide can also be incorporated into the plasma membrane and its trafficking to and 
from the lysosome can be studied (Pryor 2012).   
Membrane Permeable Dyes to Study Lysosomes 
Membrane permeant dyes can also be used to study lysosomes.  LysoTracker probes consist of a 
fluorphore attached to a weak base that is only partially protonated at neutral pH.  LysoTracker 
dyes are readily membrane permeant at neutral cytosolic pH and are highly selective for 
lysosomes, particularly when compared to other dyes neutral red or acridine orange dyes (Pryor 
2012).  Their pH sensitivity allows them to be used to measure the impact of a particular cell 
treatment on pH maintenance(Chazotte 2011).  LysoTracker dyes can also be used to measure 
the size of lysosome compartments, which are enlarged in LSD phenotypes, and are a tool used 
to screen efficacy of treatments of LSDs (Xu, Liu et al. 2014).  LysoTracker probes can be 
visualized at a variety of different wavelengths and require very short incubation times (15-30 
mins) and low loading concentrations ~50 nM in order to effectively label lysosomes (Chazotte 
2011).   
 Fluorescently Tagged Proteins  
Transfecting cells with fluorescently tagged proteins membrane proteins is a convenient and less 
costly way to study lysosomes.  Ideally, fluorescent tags reside on the cytosolic side of the 
lysosome membrane to avoid the need to use protease inhibitors to prevent the degradation of 
luminally-located tags by lysosome hydrolases.  Furthermore, fluorescent tags should be inserted 
in a manner that avoids the interference with lysosome targeting sequences.  Because LAMP 
proteins make up 50% of lysosome membrane proteins and have a cytosolic tail that can be 
tagged (Schwake, Schroder et al. 2013), they are commonly tagged to GFP or mCherry to 
provide a quick and easy way to visualize lysosomes (Pryor 2012).  A similar method can be 
used to tag lysosomal ion channels which also reside on the membrane like TRPML1. 
 Stable Cell Lines for Expression of Lysosomal Proteins 
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Generating cell lines stably expressing lysosome membrane proteins with fluorescent tags 
provides greater control over expression levels.  Stable cell lines also avoid saturating 
membranes with excessive exogenous protein and can avoid off-target effects of overexpression.  
This method also prevents any side-effects resulting from reagents used for transient transfection 
(Pryor 2012).   
Tools to Manipulate Lysosome pH 
Because pH is easy to manipulate given the currently available antagonists and other tools, the 
effects of pH on lysosome function are well studied.  The V-ATPase can be inhibited by various 
macrolide antibiotics.  The highly specific Bafilomycin-A (Baf-A) and Concanamycin-A (Con-
A) are two such macrolides that have made substantial contributions to the study of acidic 
compartments (Marshansky and Futai 2008).  Both Baf-A and Con-A bind to and inhibit the 
rotation of the V0 domain in order to prevent H
+
 translocation.  Bafilomycin is impressively 
specific to the V-ATPase over other ATPases in the cell (Bowman, Siebers et al. 1988).   
 Tools to Examine Lysosome Ca
2+
  
Like pH, tools to study intracellular Ca
2+
 are abundant, although many of them are still not ideal 
for examining the highly acidic lumen of the lysosome.  Many Ca
2+
 indicators are sensitive to 
pH, which should be considered in all analyses (Rudolf, Mongillo et al. 2003).  The most 
commonly used tools, GPN and NAADP, have major limitations that prevented us from using 
them in our current study.  Luminal Ca
2+
 indicators have been used previously, but also have 
limitations.  Finally, lysosome membrane targeted Ca
2+
 indicators are increasing in popularity 
because they are not affected by low luminal pH.  
 NAADP is a Ca
2+  
mobilizing messenger that has been suggested to be lysosome specific 
(Churchill, Okada et al. 2002; Calcraft, Ruas et al. 2009), although this finding is controversial 
(Gerasimenko, Maruyama et al. 2003; Gerasimenko, Sherwood et al. 2006; Steen, Kirchberger et 
al. 2007; Wang, Zhang et al. 2012).  Furthermore, NAADP is difficult to use because it is 
membrane impermeable, and not useful for a real-time refilling assay requiring repeated 
application because of its strong desensitization (Morgan, Platt et al. 2011).  
47 
 
The most common and longest-standing method of examining lysosomal Ca
2+
 is to 
disrupt lysosomal membranes using glycyl-L-phenylalanine 2-naphthylamide (GPN) (Jadot, 
Colmant et al. 1984; Berg, Stromhaug et al. 1994; Haller, Dietl et al. 1996; Haller, Volkl et al. 
1996; Steinberg, Huynh et al. 2010; Morgan, Platt et al. 2011).  GPN is a membrane-permeable 
di-peptide that readily diffuses into lysosomes.  GPN is cleaved by the lysosome-specific 
exopeptidase Cathepsin C, which causes the accumulation of osmotically active products in the 
lysosome lumen, drawing water into the lysosome (Jadot, Colmant et al. 1984; Berg, Stromhaug 
et al. 1994; Steinberg, Huynh et al. 2010).  This results in a transient permeabilization of the 
lysosome membrane (Berg, Stromhaug et al. 1994).  The membrane permeability caused by GPN 
results in the leakage of small solutes into the cytosol including ions, changes in the pH (Fig 
2.8B), changes in Ca
2+
 buffering within lysosomes, and in certain experimental conditions, 
membrane damage (Berg, Stromhaug et al. 1994; Kilpatrick, Eden et al. 2013).  Short treatments 
with GPN are thought to be reversible after removal of GPN from the bath solution.  Lysosome 
membranes reseal within minutes, demonstrated by their ability to take up acidotropic dyes 
quickly after GPN removal (Steinberg, Huynh et al. 2010). 
Fura-Dextran (Christensen, Myers et al. 2002) and low-affinity Rhod-Dextran (Lloyd-
Evans, Morgan et al. 2008) have been used previously in the only studies to directly  examine 
lysosomal Ca
2+
 content.  However, the Kd of many dextrans is affected by the low pH of the 
lysosome (Christensen, Myers et al. 2002) and accuracy can only be achieved if the variable falls 
within one degree of magnitude on either side of the probe’s Kd (Christensen, Myers et al. 2002; 
Pryor 2012).  Notably, many dextrans are no longer produced because this method of analysis is 
being forgone for newer Ca
2+
 and pH indicators (based on my conversations with Invitrogen).  
For example, the Ca
2+
 sensitive, low-affinity Rhod-Dextran (Lloyd-Evans, Morgan et al. 2008) is 
no longer available, making direct comparisons to previous data increasingly difficult.   
Genetically Encoded Ca
2+
 Indicators 
In place of many luminal indicators and their associated difficulties, genetically encoded Ca
2+
 
indicators are increasingly popular for studies of lysosome Ca
2+
 release unimpeded by lysosome 
pH.  Our lab developed a lysosomally targeted, genetically encoded  Ca
2+
 probe by fusing 
GCaMP3 to the N-terminus of TRPML1 (Fig. 2.1A) (Shen, Wang et al. 2012).  GCaMP3-ML1 
is localized on the cytosolic side of the lysosome membrane, thereby allowing Ca
2+
 release from 
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the lysosome to be measured without being affected by the highly acidic lysosome lumen.  We 
have since established a stable cell line to allow for precise targeting and expression of our 
GCaMP3-ML1 probe in order to study lysosome Ca
2+
 release.   
Utilizing lysosomal associated membrane protein-1 (LAMP1), a fluorescence resonance 
energy transfer (FRET)-based Ca
2+
 sensor was also developed to measure lysosome Ca
2+
 release, 
LAMP1-YCaM (McCue, Wardyn et al. 2013).  LAMP1-YCaM has shown similar findings to 
our GCaMP3-ML1 that will be discussed further in Chapter 3. 
Focus of the Present Study 
The mechanisms of Ca
2+
 store refilling to the ER have been elucidated in recent years 
(Lewis 2011).  However, studies examining the source of Ca
2+
 refilling to the lysosome are 
minimal and often speculative, as described above.  The suggestion that the proton gradient in 
the lysosome is responsible for maintaining and/or refilling lysosome Ca
2+
 stores may have  
mislead many findings, and must be confirmed with newer assays.  This study first sought to 
determine whether the pH gradient in the lysosome was required for Ca
2+
 refilling to the 
lysosome to resolve a yet unproven theory in the field.  
RESULTS 
Genetically encoded Ca
2+
 sensor fused to lysosomal TRPML1 to detect intracellular Ca
2+
 
release  
To measure lysosomal Ca
2+
 release without directly disrupting intraluminal ion homeostasis, we 
tagged the lysosomal Ca
2+
 channel TRPML1 with the genetically encoded Ca
2+
 indicator 
GCaMP3 (Fig. 2.1A).  We generated HEK293 cell lines stably-expressing GCaMP3-ML1 
(HEK-GCaMP3-ML1 cells) in order to avoid off-target effects of over-expression and 
transfection.  We used ML-SA1, a membrane-permeable synthetic agonist of the lysosome Ca
2+
 
channel TRPML1 (Shen, Wang et al. 2012) to release Ca
2+
 stores (Fig 2.1).  Bath application of 
ML-SA1 (30s) in a zero (< 10 nM) Ca
2+
 external solution produced robust lysosomal Ca
2+
 
release measured by GCaMP3 fluorescence (F/F0 > 0.5; Fig. 2.1B).   
Throughout all experiments, lysosomal Ca
2+
 release was recorded in a 0 Ca
2+
 
extracellular solution, marked in blue across the top of each graph, to ensure responses were 
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from an intracellular source (Fig. 2.1B).  Importantly, the fast, intracellular Ca
2+
 chelator 
BAPTA also blocked the response to ML-SA1 (Fig. 2.1C).  This confirms that the GCaMP3-
ML1 response to ML-SA1 in a 0 Ca
2+
 solution was specifically measuring intracellular Ca
2+
 
release. 
ML-SA1 application for 30s depleted lysosome Ca
2+
 stores 
Notably, repeat applications of ML-SA1 in 0 Ca
2+
 directly after the first response evoked 
a much smaller or no Ca
2+
 response, suggesting that Ca
2+
 stores were largely released after first 
application (Fig. 2.1B).  Upon second application, a significantly smaller response was 
sometimes evoked, which may be due to unbuffering of previously buffered Ca
2+
 stores in the 
lysosome, or to immediate refilling of Ca
2+
 stores.  The response to ML-SA1 declined after 30s 
even during prolonged application (1m 30s) (Fig 2.1D), further supporting the notion that stores 
were emptied after ML-SA1 application.   
To rule out channel desensitization, we transfected HEK cells with the plasma-membrane 
targeted TRPML1 mutant (TRPML1-4A).  TRPML1 conducts Ca
2+
 into the cytosol regardless of 
what membrane it resides on, so we used the cytosolic Ca
2+
 indicator Fura-2 to measure Ca
2+
 
entry through TRPML1-4A from the extracellular solution into the cytosol.  Unlike TRPML1 in 
0 Ca
2+
, TRPML1-4A showed repeatable Ca
2+
 responses of similar magnitude (Fig. 2.1E).  This 
demonstrates that in unlimited Ca
2+
 conditions, the Ca
2+
 response to ML-SA1 by TRPML1 is of 
the same magnitude.  Taken together, these findings indicate that ML-SA1 applied to HEK-
GCaMP3-ML1 cells releases Ca
2+
 from an intracellular source that is largely depleted after a 30s 
application.  
Lysosome specificity of GCaMP3-ML1 
To confirm lysosome specificity, we assessed the location of the GCaMP3-ML1 probe.  The 
GCaMP3-ML1 probe co-localized well with lysosomal associated membrane protein-1 
(LAMP1) (Fig. 2.2A), but not with markers for the ER (Fig. 2.2B), mitochondria (Fig. 2.2C), or 
early endosomes (Fig. 2.2D).  Pre-treatment with the lysosome-disrupting reagent GPN (Berg, 
Stromhaug et al. 1994) also abolished the naïve response (Fig. 2.2E), further supporting the 
specificity of the response.  GPN is only broken down by Cathepsin-C in lysosomes, which 
results in osmotic lysis of lysosome membranes.  Importantly, as membranes begin to reform, 
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responses to ML-SA1 returned gradually (Fig. 2.2E).  Ca
2+ 
release was also completely blocked 
by the TRPML-specific, synthetic antagonists ML-SI1 or ML-SI3 (Samie, Wang et al. 2013) 
(Fig. 2.2F).  Collectively, these findings support the conclusion that responses to ML-SA1 in 
HEK-GCaMP3-ML1 cells are lysosome specific. 
A physiological assay to monitor lysosomal Ca
2+
 refilling 
Under physiological conditions, lysosome Ca
2+ 
stores are utilized for normal signalling processes 
in the cell and require ongoing refilling to maintain the store.  To determine the source of Ca
2+ 
to 
the lysosome, we developed a new assay that allowed us to directly activate TRPML1, a Ca
2+ 
channel on the lysosome, to deplete the original, “naïve” Ca2+ store.  This allowed us to apply 
pharmacological agonists and antagonists directly during refilling to determine the source of 
Ca
2+
.  This refilling assay is shown in Fig. 2.3A and a detailed timeline is provided in Fig. 2.3B.  
Responses were very consistent, and the second and third ML-SA1 responses are often slightly 
higher than the first, naïve response (F/F0 ~ 1.4; Fig. 2.3C).  Unless otherwise specified, each 
figure represents an average of 30-40 cells; Fig. 2.3D shows an un-averaged trace illustrating 
each individual cell’s response to ML-SA1.  Importantly, repeatable responses to ML-SA1 were 
also observed in the presence of La
3+
 (Fig. 2.3E), a membrane-impermeable Ca
2+
 channel 
blocker (Dong, Cheng et al. 2008).  For the remainder of experiments, however, we applied ML-
SA1 in a 0 Ca
2+
 solution.  
Lysosome Ca
2+
 stores refill completely in 5 mins 
In order to precisely modulate store refilling, we needed to fully understand the time-course of 
refilling.  Refilling was largely abolished without a washout in 2mM Tyrode’s, likely due to a 
scarcity of releasable ER Ca
2+ 
that will be discussed in further detail in Chapter 3 (Fig. 2.4A).  
Increasing the time interval of Tyrode’s washout between consecutive applications of ML-SA1 
allowed for greater refilling to occur, observable by the magnitude of the response to ML-SA1.  
After 1 minute in Tyrode’s, refilling began but was not complete (Fig. 2.4B).  There was little 
difference between 5 min of refilling and 8 min of refilling (Fig. 2.4C), and we concluded that it 
takes approximately 5 min to fully refill lysosome Ca
2+
 stores (Fig. 2.4D).  We chose 5 min of 
refilling time for the rest of our experiments, which allowed sufficient time to apply agonists and 
antagonists in Tyrode’s solution to assess the source of Ca2+ refilling.  
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The GCaMP3-ML1 probe measures Ca
2+
 from the same lysosomes throughout experiments  
To rule out the possibility that the probe trafficked to other compartments after first stimulation, 
we conducted live-cell imaging experiments to show that the GCaMP3-ML1 probe remained in 
the lysosome after ML-SA1 treatment (Fig. 2.5A).  Importantly, the probe still responded to 
ionomycin (Fig. 2.5B), a Ca
2+ 
ionophore, and the number of lysosomes did not change after ML-
SA1 stimulation (Fig. 2.5A).  These findings also support the fact that our measurements were 
not from the generation of new lysosomes, but from refilling of the original, “naïve” Ca2+ store 
in lysosomes.  Taken together, these results ensure that lysosomal Ca
2+
 stores can be emptied and 
refilled repeatedly and consistently in a time-dependent manner.   
Ca
2+
 refilling to lysosomes is not cell type specific 
Similar Ca
2+
 refilling of lysosomes was also observed in GCaMP3-ML1-transfected Cos-7 cells 
(Fig. 2.6A), human fibroblasts (Fig. 2.6B), and DT40 chicken B cells (Fig. 2.6C).  These 
findings and additional results from our lab in primary mouse macrophages and mouse 
myoblasts suggest that Ca
2+
 refilling is not cell type specific.  
Taken together, the aforementioned findings support the use of our lysosome-specific 
GCaMP3-ML1 probe and the use of ML-SA1 as a way to release Ca
2+
 stores from lysosomes.  
These tools together allow for precise and physiological way to assay the refilling mechanisms of 
lysosomes.   
The pH of GCaMP3-ML1 containing lysosomes is not different 
The expression of GCaMP3-ML1 on lysosome membranes does not significantly change the pH 
of lysosomes, as LysoTracker co-localizes strongly with GCaMP3-ML1 containing lysosomes 
(Fig 2.7A).   
An intraluminal Ca
2+
 indicator, Fura-Dextran, confirms that lysosome Ca
2+
 stores can be 
emptied by ML-SA1 and refill in a time-dependent manner 
To confirm that lysosomal Ca
2+
 stores can be emptied and refilled using an alternative 
method, we measured lysosomal Ca
2+
 with the Ca
2+
 indicator Fura-Dextran.  When Fura-Dextran 
is pulsed into cells and then chased in indicator-free medium, it is endocytosed and then 
52 
 
trafficked to lysosomes (Christensen, Myers et al. 2002), evidenced by its presence inside 
LAMP1-positive vesicles (Fig. 2.8A).  Application of the lysosome specific membrane 
permeabilizer GPN resulted in a small but observable decrease in the luminal Ca
2+
 indicator, 
further confirming lysosome specificity (Fig. 2.8B).  Furthermore, ML-SA1 application in a 0 
Ca
2+
 solution to HEK cells transfected with TRPML1-mCherry also decreased the luminal Ca
2+
 
indicator signal (Fig 2.8C).  These findings confirm that GPN and ML-SA1 act on the same 
LAMP1-positive Ca
2+
 source intracellularly, and that lysosome stores can be emptied and 
refilled consistently.  The luminal signal increased after first application of both ML-SA1 and 
GPN, possibly as a result of store refilling.  The second application of both ML-SA1 and GPN 
did induce a slightly smaller response, possibly due to the increase in Fura-Dextran signal 
without a change in the amount of Ca
2+
 released.  Because these experiments were used to 
confirm the ability to release and refill Ca
2+
 stores to lysosomes as a control for our GCaMP3-
ML1 assay, these possibilities were not explored further. 
GPN is a lysosome-specific membrane-permeabilizer resulting in leakage of intraluminal 
contents into the cytosol and pH changes 
GPN is a membrane permeable substrate broken down solely by Cathepsin-C in the 
lysosome.  After breakdown, it accumulates in the lysosome, which causes osmotic rupture of 
the lysosome membrane, resulting in the leakage of solutes from the lysosome lumen into the 
cytosol (Fig. 2.9A,B). GPN abolishes LysoTracker staining after short-term treatment (1 min) 
(Fig. 2.9B).  Pre-treatment with GPN abolished the initial, “naïve” response to ML-SA1, 
confirming the GCaMP3-ML1 probe’s lysosome specificity (Fig. 2.4B).  After pre-treatment, 
subsequent ML-SA1 responses returned gradually during lysosomal-membrane resealing (Fig. 
2.4B).  Additionally, using the Ca
2+
 indicator Fura-2 in untransfected HEK293T cells, GPN can 
be used to induce repeated responses, suggestive of Ca
2+
 refilling (Fig. 2.9C).  Responses do 
begin to dwindle, possibly as a result of membrane damage (Berg, Stromhaug et al. 1994; 
Kilpatrick, Eden et al. 2013).     
GPN is a useful tool to confirm lysosome specificity of intracellular assays, but it has 
limitations that may have confounded previous findings in the literature.  We found that GPN 
induced a signal in Fura-2 that persisted in untransfected HEK293T cells pre-treated with 
membrane permeable BAPTA-AM in order to chelate intracellular Ca
2+ 
(Fig. 2.9D).  When 
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compared to ATP and GPN responses without BAPTA (Fig 2.9E), it is clear that the response to 
ATP is completely abolished, whereas a portion, albeit small, of the GPN response persists (Fig. 
2.9D compared to 2.9E).  These findings suggest that the membrane permeabilization induced by 
GPN results in a decreased cytosolic pH due to the leakage of the acidic contents of the lysosome 
lumen,  which results in an increase in the signal of the Ca
2+
 indicator Fura-2.  The portion of the 
GPN response resulting from a pH change may have been misinterpreted in the literature as 
entirely due to Ca
2+
 release.  It is more likely that the GPN effect represents a combination of 
Ca
2+
 and pH effects on the Fura-2 signal.   
In HEK-GCaMP3-ML1 cells pre-treated with membrane-permeable BAPTA-AM, GPN 
induced a non-specific increase of GCaMP3 fluorescence that persisted in the presence of the 
Ca
2+
 chelator BAPTA (Fig. 2.9F).  GFP-based Ca
2+
 indicators are known to be particularly 
sensitive to pH (Rudolf, Mongillo et al. 2003) and this limited the use of GPN in GCaMP3-based 
assays.  These findings suggest that using GPN to confirm the presence of lysosomal Ca
2+
 may 
be misleading, and therefore we used ML-SA1 induced Ca
2+
 release as a more precise measure 
of lysosome Ca
2+
 stores and release.  
The secretory and endocytic pathways are not required for lysosome Ca
2+
 refilling 
Inhibition of endocytosis using dynasore (Fig. 2.10A,E) and organelle mobility using 
cytoskeleton inhibitors such as nocodazole (Fig. 2.10B,E) and trichostatin A (Fig. 2.10C.E) did 
not block Ca
2+
 refilling to the lysosome.  Furthermore, Golgi disruption using Brefeldin-A 
(Lippincott-Schwartz, Yuan et al. 1989; Dolman, Gerasimenko et al. 2005) also had no effect on 
refilling (Fig. 2.10D,E).   
K
+
 homeostasis is important for lysosome Ca
2+
 refilling 
Interestingly, impairing K
+
 homeostasis with the ionophore nigericin (Markin, Sokolov et al. 
1975; Feinstein, Henderson et al. 1977; Fruth and Arrizabalaga 2007) abolished the response to 
ML-SA1 and lysosomal Ca
2+
 refilling (Fig. 2.11A).  Hence, the secretory and endocytic 
pathways are not directly involved in Ca
2+
 refilling, although cation homeostasis is important to 
lysosome Ca
2+
 store maintenance. 
The pH gradient and V-ATPase are not required for lysosome Ca
2+
 refilling  
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Previous findings suggest that the pH gradient in the lysosome may be important to Ca
2+
 
refilling.  However, few studies have thoroughly investigated this possibility.  Bafilomycin-A 
(Baf-A) and Concanamycin-A (Con-A) are specific inhibitors of the V-ATPase and increase the 
pH of the lysosome (Bowman, Siebers et al. 1988; Yoshimori, Yamamoto et al. 1991; Drose, 
Bindseil et al. 1993; Futai, Oka et al. 2000).  V-ATPase inhibitors have been shown to increase 
the pH of lysosomes above 6.5, which is the upper limit of pH indicators for acidic vesicles 
(Steinberg, Huynh et al. 2010).  These effects were confirmed in our hands.  Both Baf-A and 
Con-A abolished LysoTracker staining within minutes after application (Fig. 2.11B).   
Surprisingly, acute application of Baf-A did not affect the subsequent response to ML-
SA1, and had little effect on refilling (Fig. 2.11C).  Pre-treatment with Baf-A for 1, 3 (Fig. 
2.11D,E), or 16 hrs also did not significantly affect lysosome Ca
2+
 store refilling.  Similarly, pre-
treatment with Con-A also had no effect on Ca
2+ 
refilling of lysosomes, measured either by ML-
SA1 in HEK-GCaMP3-ML1 cells (Fig. 2.11F,G) or by GPN in HEK293T cells (Fig. 2.11H).  
These findings suggest that contradictory to previous conclusions, the pH gradient and V-
ATPase are not required to refill lysosome Ca
2+
 stores.  Interestingly, disrupting both H
+
 and K
+
 
ion homeostasis did affect refilling.  These data raise the possibility that an unidentified 
transporter or exchanger dependent on K
+
 plays a part in supplying Ca
2+
 to lysosomes.   
DISCUSSION 
A new, more physiological lysosome Ca
2+
 refilling assay  
By fusing a genetically-encoded Ca
2+
 sensor directly to a lysosomal Ca
2+
 channel, we have 
developed a robust and sensitive method to directly measure lysosomal Ca
2+
 release independent 
of intraluminal pH.  Our assay allows for time-lapse examination of the depletion and refilling 
processes of lysosome Ca
2+
 stores.  It also allows for acute (< 5 min) application of various 
pharmacological reagents, which has many advantages over prolonged treatments used in 
previous studies.   
Our refilling assay demonstrates that Ca
2+
 stores in the lysosome refill maximally in 
approximately 5 minutes, and they can be released and refilled repeatedly, a phenomenon that is 
not cell type specific.  Our GCaMP3-ML1 probe shows good co-localization with late 
endosome/lysosome marker LAMP1, but does not co-localize with markers of the ER, 
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mitochondria, and early endosomes.  The initial response to ML-SA1 is abolished after pre-
treatment with the lysosome disrupting agent, GPN, and as membrane reformation occurs, 
subsequent responses to ML-SA1 increase.  All Ca
2+
 release measurements were performed in a 
0 Ca
2+
 extracellular solution to ensure the response was from an intracellular Ca
2+
 source.  
Supporting this, the intracellular Ca
2+
 chelator BAPTA abolishes the response to ML-SA1.  The 
membrane-impermeable TRPML blocker La
3+
 in Tyrode’s solution reproduces the effects of 
ML-SA1 application in 0 Ca
2+
, ruling out extracellular Ca
2+
 influx.  Collectively, these data 
support the lysosome specificity of our GCaMP3-ML1 & ML-SA1 assay.  
Lysosome Ca
2+
 stores were maximally released after 30s application of ML-SA1.  In 
support of this, repeat applications of ML-SA1 on the plasma-membrane targeted channel mutant 
TRPML1-4A showed that the magnitude of Ca
2+
 response did not change when Ca
2+
 is unlimited 
(in 2 mM extracellular solution).  When compared to ML-SA1 applied to GCaMP3-ML1 in a 0 
Ca
2+
 solution, which shows a depleted response after 30s even during prolonged application, 
these findings support the suggestion that intracellular stores are depleted.  Because there was a 
small response to ML-SA1 immediately after the first response, stores may not be completely 
depleted.  It seems likely that after the release of Ca
2+
 from the lysosome lumen, there is an 
unbuffering of lysosome Ca
2+
 which allows for more Ca
2+
 to be released.  Alternatively, refilling 
could have begun immediately after release.  While these are difficult to test, lysosome Ca
2+
 
stores were not considered refilled unless they were within 75% of the naïve response.  This 
ensured that even if stores were not completely depleted after the first application, we were still 
able to detect when stores were refilled.    
GCaMP3-ML1 was not trafficked elsewhere, nor were new lysosomes formed, which 
was observed in live-cell imaging experiments using ML-SA1 and then ionomycin, a Ca
2+
 
ionophore.  Importantly, during repeated applications of ML-SA1, no significant changes were 
observed in the size, location, or number of lysosomes.  Thus, we are measuring Ca
2+
 release 
from the same lysosomes during the course of our experiments. 
An alternative assay using Fura-Dextran confirms lysosome Ca
2+
 store refilling 
In an additional assay, we used the Ca
2+
 indicator Fura-Dextran in lysosomes as a further 
confirmation that lysosomal stores can be emptied and refilled repeatedly.  Fura-Dextran did load 
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only LAMP1 positive vesicles, but only a few LAMP1 positive vesicles were filled despite high 
concentrations of dye loaded.  Indeed, the Kd of Fura-Dextran is not ideal for the highly acidic 
lysosome lumen (Christensen, Myers et al. 2002).  The signal from Fura-Dextran was also small, 
which might make it difficult to observe small differences in refilling.  However, it provided a 
lysosome-specific control to our GCaMP3-ML1 assay.  These findings support our findings that 
lysosome Ca
2+
 stores are emptied completely and refilled, and there is no change in the 
lysosomal source of Ca
2+
 being measured. 
Endocytic and secretory pathways are not required for lysosome Ca
2+
 store refilling 
Our findings support the conclusion that the secretory and endocytic pathways are not 
required for lysosome Ca
2+
 refilling.  While secretory vesicles do fuse with lysosomes to deliver 
hydrolases and other integral lysosome proteins (Huotari and Helenius 2011), we showed that 
abolishing the Golgi had no effect on lysosome Ca
2+
 stores.  Endocytosis and microtubule 
inhibitors also did not affect lysosome Ca
2+
 stores.  Previous findings show that Ca
2+
 is lost after 
endocytosis during the initial acidification of endosomes (Gerasimenko, Tepikin et al. 1998).  
Luminal ion concentrations vary between different endocytic vesicles to support their individual 
functions, and are likely to be changing ongoingly (Scott and Gruenberg 2011).  Ion 
concentrations including H
+
, Cl
-
, and Ca
2+
 differ with vesicle identity and are all higher in 
lysosomes than early endocytic vesicles.  Thus, ion homeostasis is dynamically regulated and 
changes throughout the endocytic pathway, supporting our findings that ion concentrations are 
not maintained from endocytosis until lysosome maturation.   
GPN causes lysosome membrane permeabilization and a pH artefact and is not ideal to 
measure lysosome Ca
2+
 stores 
GPN proved to be an advantageous control to ensure lysosome specificity, but not ideal for 
accurately measuring lysosome Ca
2+
 specifically.  When GPN is used with the cytosolic Ca
2+
 
indicator Fura-2, it results in a signal that is not completely due to Ca
2+
 release because it was 
not abolished by BAPTA loading.  Instead, GPN produces a signal in Fura-2 that is likely a 
combination of Ca
2+
 and pH.  Depending on the length of application and permeabilizing agent, 
lysosome membrane permeabilization can cause dramatic cytosolic pH changes, acidifying the 
cytosol to a pH of about 6.0-6.6 (Appelqvist, Johansson et al. 2012).  It is possible that the signal 
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resulting from pH alone has obscured previous findings in the literature, especially those 
utilizing ER Ca
2+
 inhibitors (Lloyd-Evans, Morgan et al. 2008), which will be discussed further 
in Chapter 3.  GPN should still be used as a control to ensure for lysosome specificity.  If 
cytosolic Ca
2+
 indicator Fura-2 must be used with GPN, a more detailed analysis should be 
performed to subtract the pH signal and isolate Ca
2+
.   
GPN disrupts homeostasis of all lysosomal ions by causing osmotic lysis of lysosome 
membranes, which certainly affects multiple on-going processes in the lysosome.  In fact, 
permeabilization of lysosomes with the lysosomotropic reagent MSDH initiates a cell-death 
pathway (Li, Yuan et al. 2000).  Lysosomal enzymes have been shown to be involved in 
programmed cell death (Guicciardi, Leist et al. 2004; Zuzarte-Luis, Montero et al. 2007; 
Kreuzaler, Staniszewska et al. 2011) and even partially permeabilizing lysosome membranes can 
cause apoptosis and necrosis (Turk, Stoka et al. 2002).  Microinjection of lysosome specific 
Cathepsins into cells can also induce apoptosis (Roberg, Kagedal et al. 2002; Bivik, Larsson et 
al. 2006; Schestkowa, Geisel et al. 2007).  While our GPN application was short (<1 min) and 
most lysosomal enzymes require acidic environments below pH 5.7 to be active (Appelqvist, 
Johansson et al. 2012), it is possible that GPN has off-target effects that effect cell health.  
Therefore, the consequences of permeabilizing lysosome membranes are incompletely 
understood and are likely more consequential than previously understood.  We believe that using 
a more physiological and direct method of Ca
2+
 release from lysosomes, especially one that is 
not affected by lysosome pH, will allow a clearer picture of Ca
2+
 release and refilling of the 
lysosome Ca
2+
 stores.   
BAPTA-AM should be used in all intracellular Ca
2+
 assays 
BAPTA-AM did not completely block the signal caused by GPN in Fura-2.  It also did not block 
the odd signal caused by GPN on the GCaMP3-ML1 probe.  This quickly indicated to us that 
GPN causes signals not due to Ca
2+
 on Ca
2+
 indicators.  However, BAPTA-AM controls are 
rarely performed in the literature.  These data support the necessity of using BAPTA-AM as a 
control in all lysosome Ca
2+
 release assays. 
Lysosome Ca
2+
 refilling assay reveals pH does not affect lysosome Ca
2+
 stores 
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Using our powerful refilling assay, we found that in contrast to previous conclusions, dissipating 
the proton gradient in the lysosome has little or no impact on naïve Ca
2+
 stores or their refilling.  
Secondary changes in lysosomal Ca
2+
 buffering and changes to other ion concentrations as a 
result of pH changes are likely to be the cause of incorrect interpretation of previous findings in 
the literature.  In addition, the observed sensitivity of lysosomal Ca
2+
 stores to various 
pharmacological treatments using cytosolic Ca
2+
 indicators may have contained a contaminating 
pH component that can be easily misinterpreted. 
The Ca
2+
 buffer hypothesis explains effects of pH on Ca
2+
 stores  
A compelling study demonstrated that in secretory granules, increasing luminal pH changed the 
Ca
2+
 buffering capacity of SG lumen and therefore free [Ca
2+
]SG, and caused a minimal (~ 40 
nM) increase in cytosolic Ca
2+
 (Dickson, Duman et al. 2012).  Their precise measurement of 
luminal and cytosolic Ca
2+
 allowed them to determine that after pH changes, very little Ca
2+
 is 
lost from vesicle lumen.  Instead, Ca
2+
 remains within vesicles and is bound by intraluminal Ca
2+
 
buffers, thereby decreasing free, releasable Ca
2+
.  Their findings very closely replicate those by 
Christiensen et al. demonstrating that while free Ca
2+
 decreases in the lysosome, the amount 
released into the cytosol is minimal (Christensen, Myers et al. 2002).  This “buffer hypothesis” 
can explain the reported pH-dependence of lysosomal Ca
2+
 in some studies (Camello, Pariente et 
al. 2000; Christensen, Myers et al. 2002; Lopez, Camello-Almaraz et al. 2005; Morgan, Platt et 
al. 2011).   
Studying ions while inhibiting important lysosome functions is not ideal 
It is important to consider that the V-ATPase has other functions beyond just lysosomal pH that 
are just beginning to be understood.  For example, the V-ATPase and its activity are required for 
amino acid sensing at the lysosome membrane (Zoncu, Bar-Peled et al. 2011).  These findings 
raise the possibility that inhibition of the V-ATPase has additional repercussions beyond just pH 
that may have confounded previous findings in the literature.  Studies inhibiting the function of 
any integral membrane protein on the lysosome to study lysosome ion gradients are not ideal.   
The lysosome contains substantial amounts of Ca
2+
 and H
+
, but also Cl
-
, Cu
+
, Fe
2+
, K
+
  
Na
+
, and Zn
2+
 (Wang, Zhang et al. 2012; Xu and Ren 2015).  Although H
+
 and Ca
2+
 are 
commonly studied due to the availability of tools to measure these ions, all ions in the lysosome 
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are important to lysosome function.  It seems likely that disrupting one ion in the lysosome 
lumen would disrupt the homeostasis of all ions in the lysosome.  This is supported by the 
multitude of already identified channels and pumps in the lysosome membrane that are 
dependent on the presence of other ions.  For example, it is known that acidification of the 
lysosome lumen must be coupled to the flux of other ions to prevent a run up of membrane 
potential that inhibits the V-ATPase (Steinberg, Huynh et al. 2010).  Thus, even acidification 
requires a “counterion flux.”  Ionic concentrations also vary as endosomes traffic and mature 
(Scott and Gruenberg 2011).  Furthermore, even small imbalances in ionic charge can result in 
dramatic changes in membrane potential (Ishida, Nayak et al. 2013). There are numerous studies 
demonstrating that concentrations of luminal ions affect discrete cellular processes.  For 
example, luminal chloride concentrations higher than 82mM inhibit a Ca
2+
 channel on the 
endosome (Saito, Hanson et al. 2007).    
Consequently, any studies that directly inhibit the ion flux of a particular vesicle cannot 
conclusively determine the concentration of any other ion in that particular vesicle.  It seems 
likely that many studies that attribute findings to the disruption of the pH gradient may not result 
from simply the change in luminal H
+
, but may be secondary to the change in other ion 
concentrations due to a widespread change in the electrochemical gradient, or a disruption of a 
particular ion transporter or exchanger (Scott and Gruenberg 2011).  It has proven difficult, and 
it may be impossible, to uncouple the effects of each ion on the proper function of the lysosome 
due to their interdependence.  This at least requires that several assays on any particular 
organelle be utilized to ensure they all converge on the same result.  
Potential mechanisms for Ca
2+
 refilling to lysosomes 
Our findings are in direct contrast with the common belief that lysosome Ca
2+
 stores depend on 
the proton gradient and/or the V-ATPase (Fig. 2.10).  Our findings confirm largely ignored 
findings from isolated lysosomes that the Ca
2+
 uptake mechanism is different than the V-ATPase 
that acidifies the lysosome lumen (Ezaki, Himeno et al. 1992).   
While the literature has focused on the role of H
+
 in maintaining lysosome Ca
2+
 stores, it 
has not considered the actual source of Ca
2+
.  A high affinity uptake system that could operate at 
the extremely low levels of cytosolic Ca
2+
 (100 nM) would be required on the lysosome if an 
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intracellular source of Ca
2+
 was not utilised.  Indeed, endoplasmic reticulum (ER) Ca
2+
 stores are 
maintained by the high affinity Sarcoplasmic/Endoplasmic reticulum Ca
2+
-ATP-ase (SERCA) 
pumps, but these do not reside on lysosomes (Lewis 2007).  Given the close proximity of the ER 
to endosomes and lysosomes (Friedman, Dibenedetto et al. 2013), it is interesting to consider 
that both Ca
2+
 stores would use high affinity Ca
2+
 pumping mechanisms, because this would put 
them in direct competition with each other.   
Our findings do not rule out the possibility that the pump is ATP dependent (Klemper 
1985), but they do support the hypotheses first proposed in isolated lysosome studies that Ca
2+
 
may come from an intracellular source (Lemons and Thoene 1991; Ezaki, Himeno et al. 1992; 
Adachi, Arai et al. 1996).  A low affinity uptake mechanism was suggested many years ago from 
a study of isolated lysosomes (Lemons and Thoene 1991), but would require a source of Ca
2+
 
that could provide much higher concentrations of Ca
2+
  than cytosolic Ca
2+
.  Further 
investigation into the molecular identity of Ca
2+
 pumps on the lysosome is warranted (Patel and 
Docampo 2010), but based on our results, H
+
 ions are not required for Ca
2+
 transport into the 
lysosome.  
A role for K
+
 in Ca
2+
 homeostasis in the lysosome? 
The finding that nigericin, a K
+
/H
+
 antiporter, but not V-ATPase inhibitors Baf-A and Con-A 
that abolish the H
+
 gradient in the lysosome, inhibit lysosomal refilling is suggestive of a role for 
K
+
 in store maintenance or refilling.  K
+
 fluxes are thought to provide a counterion flux to Ca
2+
 
release in the ER (Kuum, Veksler et al. 2014).  Importantly, recent and yet unpublished findings 
from our lab suggest the presence of a new K
+
 channel on the lysosome membrane that, when 
inhibited, prevents Ca
2+
 refilling to the lysosome.  Thus, a K
+
 gradient in the lysosome is 
required for Ca
2+
 store refilling of lysosomes, potentially through its regulation of lysosome 
membrane potential (Wang et al, under review in Science). 
Limitations of the present studies 
The study of lysosome Ca
2+
 stores has been limited due to the low pH of the lysosome lumen, 
which limits the use of many Ca
2+
 indicators.  The use of our GCaMP3-ML1 probe, located on 
the cytosolic side of the lysosome membrane, allowed us to overcome this limitation.  The 
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experiments using Fura-Dextran were not calibrated and corrected for the low pH of the 
lysosome lumen, and therefore we did not use them to directly measure the luminal Ca
2+
 content 
of the lysosome.   
 Our studies involve the overexpression of a lysosome Ca
2+
 channel, which is an 
important limitation.  Ca
2+
 release from lysosomes is likely of a smaller magnitude when 
TRPML1 is not overexpressed.  Thus, overexpression of TRPML1 likely impacts the timecourse 
of lysosome Ca
2+
 store emptying as well as store refilling.  
 Whether lysosome Ca
2+
 stores are completely emptied in 30s of ML-SA1 application is 
difficult to elucidate.  While there is no further Ca
2+
 release after 30s and the Ca
2+
 signal on 
GCaMP3-ML1 diminishes even during longer applications of ML-SA1, it is possible that there is 
still Ca
2+
 in the lysosome because there was a small response during the second application of 
ML-SA1 immediately following the first.  Some Ca
2+
 refilling may have occurred within this 
time.  However, the most likely explanation is that after Ca
2+
 release from the lysosome, 
releasable Ca
2+
 stores increase due to an unbuffering of Ca
2+
 within the lysosome lumen.  
The primary Ca
2+
 store is the ER 
 Given that lysosomal H
+
 ions specifically were not required for Ca
2+
 refilling to 
lysosomes, we next sought to determine the source of Ca
2+
 to the lysosome.  Because the ER is 
the largest intracellular Ca
2+
 store in the cell, we hypothesized that it may be the source of Ca
2+
 
to the lysosome. 
 
METHODS AND MATERIALS 
Molecular biology. Genetically-encoded Ca
2+
 indicator GCaMP3 was fused directly to the N-
terminus of ML1 (GCaMP3-ML1) (Shen, Wang et al. 2012).  The pECFP-ER plasmid was 
obtained from CLONTECH.  LAMP1-mCherry was made by fusing mCherry with the C 
terminus of LAMP1.  All constructs were confirmed by DNA sequencing.  
Mammalian Cell Culture.  HEK293 cells stably expressing GCaMP3-ML1 (HEK-GCaMP3-
ML1 cells) were generated using the Flip-In T-Rex 293 cell line (Invitrogen).  Human fibroblasts 
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were obtained from the Coriell Institute for Medical Research (NJ, USA).  All cells were 
cultured in a 37˚C incubator with 5% CO2.  HEK293T cells, HEK-GCaMP3-ML1 cells, Cos-7 
cells, and human fibroblasts were cultured in DMEM F12 (Invitrogen) supplemented with 10% 
(vol/vol) FBS or Tet-free FBS.   
Human fibroblasts were transiently transfected using the Invitrogen Neon electroporation 
kit (1200V, 1 pulse, 30 s.) with 100µg GCaMP3-ML1.  HEK293T cells, HEK-GCaMP3-ML1 
cells, and Cos-7 cells were transfected using Lipofectamine 2000 (Invitrogen).  All cells were 
used for experiments 24-48 hrs after transfection.   
Confocal imaging.  Live imaging of cells was performed on a heated and humidified stage using 
a Spinning Disc Confocal Imaging System.  The system includes an Olympus IX81 inverted 
microscope, a 100X Oil objective NA 1.49 (Olympus, UAPON100XOTIRF), a CSU-X1 scanner 
(Yokogawa), an iXon EM-CCD camera (Andor).  MetaMorph Advanced Imaging acquisition 
software v.7.7.8.0 (Molecular Devices) was used to acquire and analyze all images.   
LysoTracker (50 nM; Invitrogen) was dissolved in culture medium and loaded into cells 
for 30 min before imaging as described previously (Chazotte 2011).  MitoTracker (25nM; 
Invitrogen) was dissolved in the culture medium and loaded into cells for 15 min before imaging.  
Coverslips were washed 3 times with Tyrode’s and imaged in Tyrode’s.   
GCaMP3-ML1 Ca
2+
 imaging.  GCaMP3-ML1 expression was induced in Tet-On HEK-
GCaMP3-ML1 cells with 0.01µg/mL doxycycline 20-24h prior to experiments.  GCaMP3-ML1 
fluorescence was monitored at an excitation wavelength of 470 nm (F470) using a EasyRatio Pro 
system (PTI).  Cells were bathed in Tyrode’s solution containing 145 mM NaCl, 5 mM KCl, 2 
mM CaCl2, 1 mM MgCl2, 10 mM Glucose, and 20 mM Hepes (pH 7.4).  Lysosomal Ca
2+
 release 
was measured in a zero Ca
2+
 solution containing 145 mM NaCl, 5 mM KCl, 3 mM MgCl2, 10 
mM glucose, 1 mM EGTA, and 20 mM HEPES (pH 7.4).   Ca
2+
 concentration in the nominally 
free Ca
2+
 solution is estimated to be 1–10 μM.  With 1 mM EGTA, the free Ca2+ concentration is 
estimated to be < 10 nM based on the Maxchelator software (http://maxchelator.stanford.edu/).  
Experiments were carried out 0.5 to 6 hrs after plating.   
Fura-2 Ca
2+
 imaging. Cells were loaded with Fura-2 (3 µM) and Plurionic-F127 (3 µM) in the 
culture medium at 37˚C for 45-60 min, and then culture medium was replaced for 30 min to 
63 
 
allow sufficient de-esterification of intracellular AM esters.  Florescence was recorded using the 
EasyRatio Pro system (PTI) at two different wavelengths (340 and 380 nm) and the ratio 
(F340/F380) was used to calculate changes in intracellular [Ca
2+
].  All experiments were carried 
out 1.5 to 6 hrs after plating.  
Reagents.  All reagents were dissolved and stored in DMSO or water and then diluted in 
Tyrode’s and 0 Ca2+ solutions for experiments.  Con-A and Doxycycline were from Sigma; GPN 
was from Santa Cruz; LysoTracker, MitoTracker, Fura-2 and Plurionic F-127 were from 
Invitrogen; Baf-A was from L.C. Laboratories; ML-SA1 was from Chembridge.  
Data analysis.  Data are presented as mean ± SEM. All statistical analyses were conducted using 
GraphPad Prism.  Paired t-tests were used to compare the average of three or more experiments 
between treated and untreated conditions.  A value of P <0.05 was considered statistically 
significant.  
 
  
64 
 
 
Figure 2.1  ML-SA1 application in 0 Ca
2+
 triggers Ca
2+
 from an intracellular source and 
empties lysosomal Ca
2+
 stores.  (A) GCaMP3 fused to the N-terminus of TRPML1.  When 
TRPML1 agonist ML-SA1 is applied, Ca
2+
 release from the lysosome is measured directly.  (B)  
Second application of ML-SA1 directly after first application shows a dramatically reduced Ca
2+
 
response. Trace represents the average of 30-40 HEK GCaMP3-ML1 cells from one coverslip. 
(C) After 30 min pre-treatment with 20 µM BAPTA-AM, individual responses of HEK-
GCaMP3-ML1 cells to ML-SA1 are abolished, demonstrating that the signal is due to Ca
2+
. (D) 
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Prolonged application of ML-SA1 demonstrates the Ca
2+
 signal depletes and no more Ca
2+
 is 
available to be released. (E) HEK cells transfected with TRPML1-4A (mutation in lysosome 
targeting sequence) results in TRPML1 expression on the plasma membrane.  In 2mM Ca
2+
 
external solution, ML-SA1 can be applied repeatedly in cells with TRPML1-4A and induce 
similar Ca
2+
 responses.   
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Figure 2.2  GCaMP3-ML1 is lysosome specific.  (A) Cos7 cells transfected with Lysosome 
Associated Membrane Protein 1 (LAMP1) and GCaMP3-ML1.  (B) Cos7 cells transfected with 
CFP-ER and GCaMp3-ML1.  (C) Cos7 cells transfected with GCaMp3-ML1 and loaded with 
MitoTracker (25 nM) for 15 min.  (D) Cos7 cells transfected with Early Endosome Antigen 
1(EEA-1) and GCaMp3-ML1.  (E)  ML-SA1 application to HEK-GCaMP3-ML1 cells after pre-
treatment with lysosome specific substrate GPN in the bath solution to induce osmotic swelling 
of lysosome membranes. (F) TRPML1 inhibitor ML-SI3 co-applied with ML-SA1 during the 
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second ML-SA1 application.   Scale bar for panels A-D represents 15 µm. Panels E, and F 
represent the average of 30-40 HEK GCaMP3-ML1 cells from one coverslip. 
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Figure 2.3  A new assay to assess Ca
2+
 refilling to lysosomes. (A) In HEK293 cells stably 
expressing GCaMP3-ML1 (HEK-GCaMP3-ML1 cells), bath application of the TRPML1 
channel agonist ML-SA1 (20 µM) in a 0 Ca
2+
  (<10 nM) external solution induced an increase in 
GCaMP3 fluorescence (F470).  After 5 minutes of washout, repeated applications of ML-SA1 
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induced responses that were similar to the first one.  Data represents the average of 30-40 cells 
on one coverslip. (B) An illustrated timecourse of the first two applications of ML-SA1 
highlighting the “naïve” vs refilled response and the Tyrode’s washout period as refilling. (C) 
The average Ca
2+
 responses of three ML-SA1 applications at intervals of 5 min (n=26 
coverslips).   Data represent mean ± SEM  (D) Raw traces of ML-SA1 induced GCaMP3 Ca
2+
 
responses of individual HEK-GCaMP3-ML1 cells on one coverslip. (E) GCaMP3 induced ML-
SA1 responses after pre-treatment and on-going application of membrane impermeable TRPML1 
blocker La
3+ 
(100 µM). Data represents the average of 30-40 cells on one coverslip. 
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Figure 2.4 Lysosome Ca
2+
 stores refill in approximately 5 mins.  (A) Third ML-SA1 
application in 0 Ca
2+
 external solution reduces the response.  (B) After 1 minute of Ca
2+
 refilling 
to the lysosome, application of ML-SA1 resulted in a second response that was smaller than the 
first.  (C) There was little difference between responses to ML-SA1 after 5 and 8 minutes of 
refilling.  (D) Time dependence of lysosomal Ca
2+
  refilling. Panels A-D represent the average of 
30-40 HEK-GCaMP3-ML1 cells from one coverslip. 
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Figure 2.5  GCaMP3-ML1 remains localized to lysosome membranes after stimulation.  (A) 
Live cell imaging of HEK-GCaMP3-ML1 cells at basal level and after application of ML-SA1 
(20 uM) and Ionomycin (10 µM). Scale bar represents 15 µm. (B)  Average of 30-40 cells from 
one coverslip of Ca
2+
 imaging of HEK-GCaMP3-ML1 cells after first application of ML-SA1 
and then subsequent application of Ionomycin. 
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Figure 2.6  Lysosome Ca
2+
 refilling is not cell-type specific.  (A) Cos7 cells transfected with 
GCaMP3-ML1.  Repeated applications of ML-SA1 (20 µM) after refilling demonstrates Ca
2+
  
refilling in these cells.  (B) Human fibroblasts electroporated with GCaMP3-ML1.  Repeated 
applications of ML-SA1 (20 µM) after refilling demonstrates Ca
2+
  refilling.  (C) Repeated 
applications of ML-SA1 (20 µM) after refilling demonstrates Ca
2+
  refilling in DT40 chicken B 
cells electroporated with GCaMP3-ML1. All panels represent the average of 15-20 cells from 
one coverslip. 
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Figure 2.7  Lysosomes with GCaMP3-ML1 do not differ in pH.  (A) Cos7 cells transfected 
with GCaMP3-ML1 show strong colocalization with LysoTracker, suggesting their acidity is not 
changed by the presence of the GCaMP3-ML1 probe.   
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Figure 2.8 Fura-Dextran shows lysosome Ca
2+
 store refilling.  (A) After 12h pulse of Fura-
Dextran in cell culture medium followed by a 4-6h chase, Fura-Dextran localized within LAMP1 
positive vesicles.  Scale bar represents 15 µm.  (B) Repeated applications of GPN induced a 
reduced signal from Fura-Dextran, indiciating a decrease in Ca
2+
 within the lysosome lumen.  
(C) Repeated applications of ML-SA1 (50 µM) in 0 Ca
2+
 decreased the Fura-Dextran within the 
lysosome lumen. Panels B and C represent the average of 30-40 cells from one coverslip 
representing n=3 experiments for GPN and ML-SA1. 
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Figure 2.9 Lysosome membrane permeabilization has off-target effects on the cytosolic 
Fura-2 Ca
2+
 indicator and the GCaMP3-ML1 probe.  (A) GPN induces osmotic 
permeabilization of lysosome membranes which results in a leakage of luminal ions and possibly 
other contents into the cytosol.  (B) GPN abolishes LysoTracker staining in HEK293T cells, 
indicating it increases the pH of the lysosome lumen. ML-SA1 does not change LysoTracker 
staining. Scale bar represents 15 µm.  (C) GPN can be applied repeatedly in HEK293T cells.  
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(D) Pre-treatment for 2h with 20 µM BAPTA-AM abolishes the response to ATP which releases 
Ca
2+
 from the ER through IP3-receptors, but not GPN in HEK293T cells.  (E) Typical responses 
to ATP and GPN in HEK293T cells.  (F) Pre-treatment and co-application of 50uM BAPTA-AM 
does not abolish the GPN induced signal on GCaMP3 in HEK-GCaMP3-ML1 cells, suggesting 
that pH is causing an artefact on the GCaMP3-ML1 probe due to membrane permeabilization by 
GPN.  Panels C and F represent the average of 30-40 cells from one coverslip.  
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Figure 2.10  The endocytic and secretory pathways are not the source of Ca
2+
 to the 
lysosome.  (A) Co-application of 50 µM Dynasore, the dynamin GTPase inhibitor, during 
repeated applications of ML-SA1 does not block Ca
2+
 refilling to the lysosome.  (B) Pre-
treatment and co-application of microtubule inhibitor (5 µM) nocodazole does not prevent 
lysosomal Ca
2+
 refilling.  (C) Co-application of microtubule inhibitor Trichostatin-A (125 nM) 
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after pre-treatment for 30 min. does not abolish Ca
2+
 refilling of lysosome stores.  (D) Golgi 
inhibitor Brefeldin-A does not block Ca
2+
 refilling after pre-treatment and co-application.  All 
panels represent the average of 30-40 HEK-GCaMP3-ML1 cells from one coverslip.  (E) 
Quantification of 1
st
, 2
nd
, and 3
rd
 ML-SA1 responses after control (Ctrl) (n=3), dynasore (Dyna) 
(n=2), brefeldin-A (BFA) (n=2), nocodazole (Noc) (n=4), and trichostatin-A (TSA) (n=3).  For 
all pharmacological treatments, there were no significant differences between each response after 
treatments compared to controls.   
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Figure 2.11 The proton gradient and V-ATPase are not required for lysosome Ca
2+
 
refilling.  (A) K
+
 ionophore nigericin (10 µM, 5 min.) blocks refilling to lysosomes, which 
quickly returns after removal of nigericin.   (B) V-ATPase inhibitors Bafilomycin-A (Baf-A) and 
Concanamycin (Con-A) quickly (<1 min.) abolished LysoTracker staining in HEK293T cells.  
(C) Acute application of Baf-A (5 µM) for 5 min during refilling did not abolish Ca
2+
 refilling to 
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lysosomes.  (D) Prolonged application of Baf-A (5 µM, 3h and in bath solutions) did not block 
Ca
2+
 refilling to lysosomes.  (E) Quantification of 1
st
 (p value= 0.11), 2
nd
 (p= 0.01), and 3
rd
 (p= 
0.004) ML-SA1 responses upon Baf-A treatment (n=8) compared to control traces (n=6).  (F) 
Prolonged treatment (1h) with Con-A did not prevent lysosomes from refilling their Ca
2+ 
stores.  
(G) Quantification of 1
st
 (p= 0.90), 2
nd
 (p= 0.33), and 3
rd
 (p= 0.66) ML-SA1 responses with Con-
A pre-treatment (n=3).  (H) Con-A did not reveal differences in Ca
2+
 refilling responses to 
repeated applications of GPN in untransfected HEK293T cells.  Panels A, C, D, F, and H are the 
average of 30-40 cells from one representative coverslip/experiment.  The data in panels E and G 
represent mean ± SEM from at least three independent experiments.  All experiments were 
performed in HEK-GCaMP3-ML1 cells. 
  
81 
 
REFERENCES  
Adachi, T., K. Arai, et al. (1996). "A comparative study of (Ca(2+)-Mg2+)-ATPase on the 
lysosomal membrane and ecto-ATPase on the plasma membrane from rat liver." 
Biological & pharmaceutical bulletin 19(10): 1291-1297. 
Appelqvist, H., A. C. Johansson, et al. (2012). "Lysosome-mediated apoptosis is associated with 
cathepsin D-specific processing of bid at Phe24, Trp48, and Phe183." Annals of clinical 
and laboratory science 42(3): 231-242. 
Berg, T. O., E. Stromhaug, et al. (1994). "Use of glycyl-L-phenylalanine 2-naphthylamide, a 
lysosome-disrupting cathepsin C substrate, to distinguish between lysosomes and 
prelysosomal endocytic vacuoles." The Biochemical journal 300 ( Pt 1): 229-236. 
Bivik, C. A., P. K. Larsson, et al. (2006). "UVA/B-induced apoptosis in human melanocytes 
involves translocation of cathepsins and Bcl-2 family members." The Journal of 
investigative dermatology 126(5): 1119-1127. 
Bowman, E. J., A. Siebers, et al. (1988). "Bafilomycins: a class of inhibitors of membrane 
ATPases from microorganisms, animal cells, and plant cells." Proceedings of the 
National Academy of Sciences of the United States of America 85(21): 7972-7976. 
Calcraft, P. J., M. Ruas, et al. (2009). "NAADP mobilizes calcium from acidic organelles 
through two-pore channels." Nature 459(7246): 596-600. 
Camello, C., J. A. Pariente, et al. (2000). "Role of proton gradients and vacuola H(+)-ATPases in 
the refilling of intracellular calcium stores in exocrine cells." Current biology : CB 10(3): 
161-164. 
Chazotte, B. (2011). "Labeling lysosomes in live cells with LysoTracker." Cold Spring Harbor 
protocols 2011(2): pdb prot5571. 
Christensen, K. A., J. T. Myers, et al. (2002). "pH-dependent regulation of lysosomal calcium in 
macrophages." Journal of cell science 115(Pt 3): 599-607. 
Churchill, G. C., Y. Okada, et al. (2002). "NAADP mobilizes Ca(2+) from reserve granules, 
lysosome-related organelles, in sea urchin eggs." Cell 111(5): 703-708. 
Cribbs, J. T. and S. Strack (2007). "Reversible phosphorylation of Drp1 by cyclic AMP-
dependent protein kinase and calcineurin regulates mitochondrial fission and cell death." 
EMBO reports 8(10): 939-944. 
Dickson, E. J., J. G. Duman, et al. (2012). "Orai-STIM-mediated Ca2+ release from secretory 
granules revealed by a targeted Ca2+ and pH probe." Proceedings of the National 
Academy of Sciences of the United States of America 109(51): E3539-3548. 
Docampo, R., D. A. Scott, et al. (1995). "Intracellular Ca2+ storage in acidocalcisomes of 
Trypanosoma cruzi." The Biochemical journal 310 ( Pt 3): 1005-1012. 
Dolman, N. J., J. V. Gerasimenko, et al. (2005). "Stable Golgi-mitochondria complexes and 
formation of Golgi Ca(2+) gradients in pancreatic acinar cells." The Journal of biological 
chemistry 280(16): 15794-15799. 
Dong, X. P., X. Cheng, et al. (2008). "The type IV mucolipidosis-associated protein TRPML1 is 
an endolysosomal iron release channel." Nature 455(7215): 992-996. 
Drose, S., K. U. Bindseil, et al. (1993). "Inhibitory effect of modified bafilomycins and 
concanamycins on P- and V-type adenosinetriphosphatases." Biochemistry 32(15): 3902-
3906. 
Ezaki, J., M. Himeno, et al. (1992). "Purification and characterization of (Ca2+-Mg2+)-ATPase 
in rat liver lysosomal membranes." Journal of biochemistry 112(1): 33-39. 
82 
 
Feinstein, M. B., E. G. Henderson, et al. (1977). "The effects of alterations of transmembrane 
Na+ and K+ gradients by ionophores (nigericin, monensin) on serotonin transport in 
human blood platelets." Biochimica et biophysica acta 468(2): 284-295. 
Friedman, J. R., J. R. Dibenedetto, et al. (2013). "ER-endosome contact increases as endosomes 
traffic and mature." Molecular biology of the cell. 
Fruth, I. A. and G. Arrizabalaga (2007). "Toxoplasma gondii: induction of egress by the 
potassium ionophore nigericin." International journal for parasitology 37(14): 1559-1567. 
Futai, M., T. Oka, et al. (2000). "Luminal acidification of diverse organelles by V-ATPase in 
animal cells." The Journal of experimental biology 203(Pt 1): 107-116. 
Gerasimenko, J. V., Y. Maruyama, et al. (2003). "NAADP mobilizes Ca2+ from a thapsigargin-
sensitive store in the nuclear envelope by activating ryanodine receptors." The Journal of 
cell biology 163(2): 271-282. 
Gerasimenko, J. V., M. Sherwood, et al. (2006). "NAADP, cADPR and IP3 all release Ca2+ 
from the endoplasmic reticulum and an acidic store in the secretory granule area." Journal 
of cell science 119(Pt 2): 226-238. 
Gerasimenko, J. V., A. V. Tepikin, et al. (1998). "Calcium uptake via endocytosis with rapid 
release from acidifying endosomes." Current biology : CB 8(24): 1335-1338. 
Gerasimenko, O. V., J. V. Gerasimenko, et al. (1996). "Inositol trisphosphate and cyclic ADP-
ribose-mediated release of Ca2+ from single isolated pancreatic zymogen granules." Cell 
84(3): 473-480. 
Grabe, M. and G. Oster (2001). "Regulation of organelle acidity." The Journal of general 
physiology 117(4): 329-344. 
Guicciardi, M. E., M. Leist, et al. (2004). "Lysosomes in cell death." Oncogene 23(16): 2881-
2890. 
Haller, T., P. Dietl, et al. (1996). "The lysosomal compartment as intracellular calcium store in 
MDCK cells: a possible involvement in InsP3-mediated Ca2+ release." Cell calcium 
19(2): 157-165. 
Haller, T., H. Volkl, et al. (1996). "The lysosomal Ca2+ pool in MDCK cells can be released by 
ins(1,4,5)P3-dependent hormones or thapsigargin but does not activate store-operated 
Ca2+ entry." The Biochemical journal 319 ( Pt 3): 909-912. 
Huotari, J. and A. Helenius (2011). "Endosome maturation." The EMBO journal 30(17): 3481-
3500. 
Ishida, Y., S. Nayak, et al. (2013). "A model of lysosomal pH regulation." The Journal of general 
physiology 141(6): 705-720. 
Jadot, M., C. Colmant, et al. (1984). "Intralysosomal hydrolysis of glycyl-L-phenylalanine 2-
naphthylamide." The Biochemical journal 219(3): 965-970. 
Kilpatrick, B. S., E. R. Eden, et al. (2013). "Direct mobilisation of lysosomal Ca2+ triggers 
complex Ca2+ signals." Journal of cell science 126(Pt 1): 60-66. 
Klemper, M. S. (1985). "An adenosine triphosphate-dependent calcium uptake pump in human 
neutrophil lysosomes." The Journal of clinical investigation 76(1): 303-310. 
Kreuzaler, P. A., A. D. Staniszewska, et al. (2011). "Stat3 controls lysosomal-mediated cell 
death in vivo." Nature cell biology 13(3): 303-309. 
Kuum, M., V. Veksler, et al. (2014). "Potassium fluxes across the endoplasmic reticulum and 
their role in endoplasmic reticulum calcium homeostasis." Cell calcium. 
Lemons, R. M. and J. G. Thoene (1991). "Mediated calcium transport by isolated human 
fibroblast lysosomes." The Journal of biological chemistry 266(22): 14378-14382. 
83 
 
Lewis, R. S. (2007). "The molecular choreography of a store-operated calcium channel." Nature 
446(7133): 284-287. 
Lewis, R. S. (2011). "Store-operated calcium channels: new perspectives on mechanism and 
function." Cold Spring Harbor perspectives in biology 3(12). 
Li, W., X. Yuan, et al. (2000). "Induction of cell death by the lysosomotropic detergent MSDH." 
FEBS letters 470(1): 35-39. 
Lippincott-Schwartz, J., L. C. Yuan, et al. (1989). "Rapid redistribution of Golgi proteins into the 
ER in cells treated with brefeldin A: evidence for membrane cycling from Golgi to ER." 
Cell 56(5): 801-813. 
Lloyd-Evans, E., A. J. Morgan, et al. (2008). "Niemann-Pick disease type C1 is a sphingosine 
storage disease that causes deregulation of lysosomal calcium." Nature medicine 14(11): 
1247-1255. 
Lopez, J. J., C. Camello-Almaraz, et al. (2005). "Ca2+ accumulation into acidic organelles 
mediated by Ca2+- and vacuolar H+-ATPases in human platelets." The Biochemical 
journal 390(Pt 1): 243-252. 
Luzio, J. P., N. A. Bright, et al. (2007). "The role of calcium and other ions in sorting and 
delivery in the late endocytic pathway." Biochemical Society transactions 35(Pt 5): 1088-
1091. 
Markin, V. S., V. S. Sokolov, et al. (1975). "Nigericin-induced charge transfer across 
membranes." The Journal of membrane biology 25(1-2): 23-45. 
Marshansky, V. and M. Futai (2008). "The V-type H+-ATPase in vesicular trafficking: targeting, 
regulation and function." Current opinion in cell biology 20(4): 415-426. 
Maxfield, F. R. (2014). "Role of endosomes and lysosomes in human disease." Cold Spring 
Harbor perspectives in biology 6(5): a016931. 
McCue, H. V., J. D. Wardyn, et al. (2013). "Generation and characterization of a lysosomally 
targeted, genetically encoded Ca(2+)-sensor." The Biochemical journal 449(2): 449-457. 
Mindell, J. A. (2012). "Lysosomal acidification mechanisms." Annual review of physiology 74: 
69-86. 
Morgan, A. J., F. M. Platt, et al. (2011). "Molecular mechanisms of endolysosomal Ca2+ 
signalling in health and disease." The Biochemical journal 439(3): 349-374. 
Patel, S. and R. Docampo (2010). "Acidic calcium stores open for business: expanding the 
potential for intracellular Ca2+ signaling." Trends in cell biology 20(5): 277-286. 
Petersen, O. H. (2015). "Ca signalling in the endoplasmic reticulum/secretory granule 
microdomain." Cell calcium. 
Pittman, J. K. (2011). "Vacuolar Ca(2+) uptake." Cell calcium 50(2): 139-146. 
Pryor, P. R. (2012). "Analyzing lysosomes in live cells." Methods in enzymology 505: 145-157. 
Roberg, K., K. Kagedal, et al. (2002). "Microinjection of cathepsin d induces caspase-dependent 
apoptosis in fibroblasts." The American journal of pathology 161(1): 89-96. 
Rudolf, R., M. Mongillo, et al. (2003). "Looking forward to seeing calcium." Nature reviews. 
Molecular cell biology 4(7): 579-586. 
Saito, M., P. I. Hanson, et al. (2007). "Luminal chloride-dependent activation of endosome 
calcium channels: patch clamp study of enlarged endosomes." The Journal of biological 
chemistry 282(37): 27327-27333. 
Samie, M., X. Wang, et al. (2013). "A TRP channel in the lysosome regulates large particle 
phagocytosis via focal exocytosis." Developmental cell 26(5): 511-524. 
84 
 
Schestkowa, O., D. Geisel, et al. (2007). "The catalytically inactive precursor of cathepsin D 
induces apoptosis in human fibroblasts and HeLa cells." Journal of cellular biochemistry 
101(6): 1558-1566. 
Schulz, I., F. Thevenod, et al. (1989). "Modulation of intracellular free Ca2+ concentration by 
IP3-sensitive and IP3-insensitive nonmitochondrial Ca2+ pools." Cell calcium 10(5): 
325-336. 
Schwake, M., B. Schroder, et al. (2013). "Lysosomal membrane proteins and their central role in 
physiology." Traffic 14(7): 739-748. 
Scott, C. C. and J. Gruenberg (2011). "Ion flux and the function of endosomes and lysosomes: 
pH is just the start: the flux of ions across endosomal membranes influences endosome 
function not only through regulation of the luminal pH." BioEssays : news and reviews in 
molecular, cellular and developmental biology 33(2): 103-110. 
Shen, D., X. Wang, et al. (2012). "Lipid storage disorders block lysosomal trafficking by 
inhibiting a TRP channel and lysosomal calcium release." Nature communications 3: 731. 
Sherwood, M. W., I. A. Prior, et al. (2007). "Activation of trypsinogen in large endocytic 
vacuoles of pancreatic acinar cells." Proceedings of the National Academy of Sciences of 
the United States of America 104(13): 5674-5679. 
Steen, M., T. Kirchberger, et al. (2007). "NAADP mobilizes calcium from the endoplasmic 
reticular Ca(2+) store in T-lymphocytes." The Journal of biological chemistry 282(26): 
18864-18871. 
Steinberg, B. E., K. K. Huynh, et al. (2010). "A cation counterflux supports lysosomal 
acidification." The Journal of cell biology 189(7): 1171-1186. 
Tompkins, L. S., K. D. Nullmeyer, et al. (2002). "Regulation of secretory granule pH in insulin-
secreting cells." American journal of physiology. Cell physiology 283(2): C429-437. 
Turk, B., V. Stoka, et al. (2002). "Apoptotic pathways: involvement of lysosomal proteases." 
Biological chemistry 383(7-8): 1035-1044. 
Wang, X., X. Zhang, et al. (2012). "TPC proteins are phosphoinositide- activated sodium-
selective ion channels in endosomes and lysosomes." Cell 151(2): 372-383. 
Xu, H. and D. Ren (2015). "Lysosomal physiology." Annual review of physiology 77: 57-80. 
Xu, M., K. Liu, et al. (2014). "A phenotypic compound screening assay for lysosomal storage 
diseases." Journal of biomolecular screening 19(1): 168-175. 
Yoshimori, T., A. Yamamoto, et al. (1991). "Bafilomycin A1, a specific inhibitor of vacuolar-
type H(+)-ATPase, inhibits acidification and protein degradation in lysosomes of cultured 
cells." The Journal of biological chemistry 266(26): 17707-17712. 
Zoncu, R., L. Bar-Peled, et al. (2011). "mTORC1 senses lysosomal amino acids through an 
inside-out mechanism that requires the vacuolar H(+)-ATPase." Science 334(6056): 678-
683. 
Zuzarte-Luis, V., J. A. Montero, et al. (2007). "Lysosomal cathepsins in embryonic programmed 
cell death." Developmental biology 301(1): 205-217. 
 
 
85 
 
 
  
 
CHAPTER III 
THE ER Ca
2+
 STORE IS REQUIRED FOR Ca
2+
 REFILLING TO THE LYSOSOME 
 
ABSTRACT 
After concluding that the lysosomal V-ATPase and H
+
 gradient and are not responsible for 
refilling Ca
2+
 stores in lysosomes, we sought to determine the source of Ca
2+
 to the lysosome.  
The ER is the largest intracellular source of Ca
2+
 and was a likely candidate.  Using 
pharmacological and genetic depletion as well as chelation of ER Ca
2+
 stores, we show that 
lysosome Ca
2+
 refilling requires ER Ca
2+
.  Additionally, in low extracellular Ca
2+
 environments, 
the releasable Ca
2+
 from the ER is diminished, and lysosome stores do not refill, corroborating 
our pharmacologic and genetic findings.  We also show that the ER and lysosomes are in close 
contact during live cell imaging experiments and using TEM, which supports previous findings 
in the literature.  Membrane contact sites between the ER and lysosomes, possibly mediated by 
proteinaceous tethers, are likely responsible for local microdomains of Ca
2+
 that refill lysosomal 
stores.  
 
INTRODUCTION 
In Chapter 2  our data strongly indicated that that lysosome Ca
2+
 stores do not require the 
H
+
 gradient or the V-ATPase using three different assays to converge on the same findings.  The 
endoplasmic reticulum (ER) provides Ca
2+
 to mitochondria (Csordas et al., 1999), which 
suggests that it may also provide Ca
2+
 to the lysosome.  Because of this, we first examined the 
potential for the ER to be the primary source of Ca
2+
 to the lysosome. 
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Previous Studies Support the ER as a Possible Source of Ca
2+
 to the Lysosome 
An interaction between ER and lysosome Ca
2+
 stores was suggested many years ago 
(Haller et al., 1996a), but these results were overlooked due to a lack of specific tools to 
thoroughly probe individual Ca
2+
 stores.  In a study of secretory granules (SGs) and their 
interaction with the ER, a model of ER Ca
2+
 tunnelling was suggested, where store operated Ca
2+
 
entry (SOCE) after depletion of ER stores resulted in Ca
2+
 entry into the ER which was then 
“tunnelled” through the cytosol (measured as a cytosolic Ca2+  gradient) to SGs (Mogami et al., 
1997).  Studies in SGs should not be extrapolated to lysosomes, but the idea that Ca
2+
 from the 
ER, the largest Ca
2+
 store in the cell, is transmitted to smaller intracellular Ca
2+
 stores is 
supported by the high amount of Ca
2+
 that other intracellular stores contain (0.4 – 0.6 mM for 
Ca
2+
 in the lysosome, for example).   
Instead of “tunnels” of high Ca2+ in the cytosol, microdomains of high Ca2+ within small 
nanojunctions between vesicles is more likely (Lam and Galione, 2013), particularly because 
cytosolic Ca
2+
 is spatio-temporally regulated and functions as a final trigger in many signalling 
processes (Berridge et al., 2000).  These would require contact sites between organelles, which in 
recent years have come to be appreciated (Helle et al., 2013).  Indeed, mitochondria have been 
shown to receive Ca
2+
 from SOCE after its presence in the ER through close contact sites 
(Demaurex et al., 2009). 
NAADP May Target ER Ca
2+
 Stores, Not Lysosome Ca
2+
 Stores 
Ca
2+
 signalling between lysosomes and the ER has been suggested by studies examining 
nicotinic acid-adenine dinucleotide phosphate (NAADP) mediated Ca
2+
 signalling (Churchill et 
al., 2002; Kinnear et al., 2004; Calcraft et al., 2009; Fameli et al., 2014; Ronco et al., 2015).  
However the source of NAADP triggered Ca
2+
 release is highly controversial and has been 
shown in numerous studies to include the ER (Mojzisova et al., 2001; Hohenegger et al., 2002; 
Gerasimenko et al., 2003; Langhorst et al., 2004; Dammermann and Guse, 2005; Gerasimenko et 
al., 2006; Steen et al., 2007; Dammermann et al., 2009; Walseth et al., 2012; Wang et al., 2012; 
Ronco et al., 2015).  The discrepancy over the source of NAADP induced Ca
2+
 release has led to 
significant confusion in the field (Guse, 2012; Lin-Moshier et al., 2012).   
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Interestingly, many studies utilizing NAADP are examining “acidic vesicles” which are 
often not well defined, and are difficult to distinguish from other organelles in cells like sea 
urchin eggs.  Often, these studies are in fact examining secretory granules and not lysosomes 
(Gerasimenko et al., 2006), which do have similar Ca
2+
 release and refilling mechanisms to the 
ER (Dickson et al., 2012).  Secretory granules are significantly less acidic than lysosomes (pH 
6.3-5.8) and have very different functions (Tompkins et al., 2002), so these findings should not 
be extrapolated to lysosomes.  Unfortunately, the literature has often not made the distinction 
between acidic organelles, which has contributed to the misunderstanding of lysosome Ca
2+
 
stores.  
Possible Bidirectional Ca
2+
 Signalling Between the ER and Lysosomes 
Bidirectional Ca
2+
 signalling between the ER and lysosomes has been suggested in a study that 
used Baf-A and GPN to modulate lysosomal Ca
2+
 stores (Morgan et al., 2013).   Baf-A and GPN 
are problematic tools to differentiate the effects of pH from Ca
2+
 (see Chapter 2).  GPN causes 
damage to lysosomes and possibly other harmful consequences to the cell (Li et al., 2000; 
Guicciardi et al., 2004).  Agents used to alter pH also change Ca
2+
 buffering within lysosomes, 
thereby decreasing the free, releasable Ca
2+
 within the lysosome (Dickson et al., 2012).  Thus, 
bidirectional signalling between the ER and lysosomes is possible, but this should be examined 
with more specific reagents.  
Lysosomes have also been suggested to sequester Ca
2+
 from the ER and modulate IP3-
evoked signals (Lopez-Sanjurjo et al., 2013), which seems likely but again the findings were 
confounded by the lack of tools to appropriately distinguish lysosome pH from Ca
2+
.   Lysosome 
Ca
2+
 release (after GPN application) has also been implicated in stimulating ER Ca
2+
 release 
(Kilpatrick et al., 2013), which again seems possible but should be examined with more specific 
pharmacological tools.    
Limitations of Previous Studies Examining Lysosome Ca
2+
 Stores 
The prevailing view of lysosome Ca
2+
 store refilling is that the H
+
 gradient drives a 
putative Ca
2+
/H
+
 exchanger that refills Ca
2+
 to the lysosome.  In addition to the aforementioned 
studies, this conclusion was reached from a few studies performed in subcellular fractions that 
differ in important ways from intact cells (Thomas et al., 2000).  Many studies have used highly 
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specialized cell types including sea urchin eggs (Churchill et al., 2002; Morgan et al., 2013) and 
platelets (Lopez et al., 2005), which may have specialized mechanisms for Ca
2+
 store 
maintenance and release.  
Importantly, no consideration was given to additional ions in the lysosome that may 
depend on H
+
 gradients but may be more directly responsible for Ca
2+
 transport.  For example, a 
secondary pump utilizing an electrochemical gradient to transport Ca
2+
 into the lysosome may 
utilize an ion that itself depends more directly on H
+
 concentrations.  This is primarily due to the 
limitations of available tools, which are more abundant for Ca
2+
 and H
+
 than for other ions.  
Gross disruption of lysosome ion homeostasis or membrane integrity are not ideal to probe 
lysosome function under physiologic conditions, however they are the only ones available until 
recently. 
Most studies implicating H
+
 in maintaining the lysosome Ca
2+
 gradient included no direct 
measurement of lysosomal Ca
2+
.  As discussed above, cytosolic Ca
2+
 measurements are often 
used in place of a more direct method of lysosome Ca
2+
 stores or release, but these can be 
confounded by pH release from lysosomes, resulting from V-ATPase inhibitors and GPN.  
Lysosome Contact with the ER 
Endosome maturation leads to increasing contact with ER (Friedman et al., 2013), which may be 
responsible for providing Ca
2+
 to endosomes during trafficking.  Electron microscopy has also 
shown close contact between the ER and lysosomes (Kilpatrick et al., 2013).  Ca
2+
 exchange 
between these nanojunctions has not yet been demonstrated due to the limitations of microscopy, 
but nanojunctions between the ER and endosomes have been suggested to facilitate cholesterol 
exchange (Rocha et al., 2009; Du et al., 2011; Du et al., 2012) and EGFR trafficking (Eden et al., 
2010).   
Focus of the Present Study 
Nevertheless, studies are converging on an important Ca
2+
-related link between the ER and 
lysosomes that should be examined in more detail with more specific tools.  Thus, these studies 
sought to test the hypothesis that the ER was involved in refilling lysosome Ca
2+
 stores utilizing 
a more specific assay of lysosome Ca
2+
 refilling.  
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RESULTS 
As discussed in Chapter 2, blocking Ca
2+
 entry into the cell using the generic cation channel 
blocker La
3+
 did not prevent Ca
2+
 refilling to lysosomes (Fig. 2.2A).  These findings corroborate 
previous findings suggesting that Ca
2+
 in the lysosome is from an intracellular source rather than 
from store operated Ca
2+
 entry (SOCE) (Haller et al., 1996a).  Lysosomal Ca
2+
 refilling was 
drastically reduced upon removal of extracellular Ca
2+
 during refilling, however (Fig. 2.4A).  ER 
stores are passively depleted and do not release Ca
2+
 in 0 Ca
2+
 extracellular environment (Pacaud 
et al., 1994; Wu et al., 2006), which suggests that the ER could be the intracellular source of 
Ca
2+
 to the lysosome.   
ER Ca
2+
 Stores are Passively Depleted in 0 Ca
2+
 Solution. 
To confirm that releasable Ca
2+
 by the ER was reduced in 0 Ca
2+
 extracellular solution, we 
applied ATP to HEK293T cells.  ATP stimulates endogenous P2Y receptors on the HEK cell 
surface (Schachter et al., 1997) which results in the formation of intracellular inositol 
triphosphate (IP3) (Burgess et al., 1984) and triggers release of ER Ca
2+
 stores (Schulz et al., 
1989).  ATP causes a significant Ca
2+
 release into the cytosol through IP3 receptors on the ER 
membrane (Fig 3.1A) but almost no Ca
2+
 release in 0 Ca
2+
 extracellular solution (Fig 3.1A, B).  
Given that lysosome Ca
2+
 stores show dramatically reduced refilling when extracellular Ca
2+
 is 
removed (Fig. 2.4A) and because of the demonstrated role of extracellular Ca
2+
 in ER store 
refilling (Lewis, 2007; Berridge, 2012), we sought to test the hypothesis that the ER is required 
for  lysosome Ca
2+
 store refilling.  
Inhibiting SERCA Pumps on the ER Prevents Lysosome Ca
2+
 Refilling. 
Sarcoplasmic/Endoplasmic Calcium-ATPase (SERCA) pumps on the ER sequester Ca
2+
 
from the cytosol due to their affinity for Ca
2+
 (Km ~0.5-2 µM) (Lytton et al., 1992).  Because of 
this, SERCA inhibitors can be used to release Ca
2+
 from ER Ca
2+
 stores into the cytosol down 
the concentration gradient.  We first used thapsigargin (TG), a specific inhibitor of the ER 
SERCA pump that induces SOCE but does not affect cellular IP3 levels (Thastrup et al., 1990).  
TG rapidly and completely abolished Ca
2+
 refilling to lysosomes (Fig. 3.2A and C).  A rapid 
block of Ca
2+
 refilling was also observed for another SERCA pump inhibitor Cyclopiazonic Acid 
(CPA) (Fig. 3.2B and C).  The depletion of ER Ca
2+
 down its concentration gradient results in 
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Ca
2+
 leakage into the cytosol.  Because lysosomes and the ER are in close contact, this Ca
2+
 leak 
is observable on our GCaMP3-ML1 probe because it is located on the lysosome lumen.  Contact 
sites between the lysosome and ER are estimated to be between 10-50 nm.  The exit of Ca
2+
 on 
the ER, which is also observed using Fura-2, can be detected on our GCaMP3-ML1 probe.  This 
phenomenon has been observed on another lysosomally targeted, cytosolically located Ca
2+
 
indicator (McCue et al., 2013).    
CPA also reduced the response to GPN but did not completely abolish it, suggesting that 
it reduced Ca
2+
 stores but did not change the pH of the lysosome (see Chapter 2 for a discussion 
of GPN and pH in Fura-2) (Fig. 3.2D).   
Notably, TG did not affect the initial, naïve ML-SA1 response (Fig. 3.2E, compare first 
response to second response marked with an arrow; after SERCA inhibition mean=1.08±0.07 vs. 
control mean=1.39±0.09, p=0.2024) or lysosomal pH (Fig. 3.2F).  These results suggest that 
SERCA inhibitors had no direct effect on the naïve Ca
2+
 store in lysosomes, but specifically 
affected lysosomal Ca
2+
 refilling.   
Chelating ER Ca
2+
 Blocks Lysosome Ca
2+
 Refilling. 
We next turned towards ways to modulate ER Ca
2+
 stores less invasively.   [Ca
2+
]ER, but not 
cytosolic Ca
2+
,
 
can be specifically chelated by N,N,N',N'-Tetrakis(2-
pyridylmethyl)ethylenediamine (TPEN), a membrane-permeable metal chelator with a low 
affinity for Ca
2+
.  TPEN has been shown to specifically chelate ER Ca
2+
 in previous studies 
(Hofer et al., 1998; Caroppo et al., 2003; Morgan et al., 2012).  To ensure TPEN did indeed 
chelate ER Ca
2+
, a short application of TPEN was shown to quick block ER Ca
2+
 release 
stimulated by the endogenous P2Y receptor agonist ATP (Fig 3.3A compared to Fig 3.3B).  
Importantly, TPEN did not chelate the naïve lysosomal Ca
2+
 store, observed with GPN in Fura-2 
(Fig 3.3C compared to Fig 3.3B).  The magnitude of the GPN  Thus, TPEN is an ideal tool to 
examine Ca
2+
 refilling to lysosomes because it had no direct effect on the naïve Ca
2+
 store in 
lysosomes, but specifically chelated ER Ca
2+
.   
Acute application of TPEN during refilling completely blocked lysosomal Ca
2+
 refilling 
(Fig. 3.3D,E).  When TPEN was applied for 20 mins in the bath solution, however, the responses 
to ATP and GPN were both abolished, suggesting that disrupting ER Ca
2+
 stores and Ca
2+
 release 
91 
 
long-term also disrupts ongoing lysosome Ca
2+
 store maintenance (Fig 3.3F).  These findings 
suggest that disrupting ER Ca
2+
 without affecting Ca
2+
 release into the cytosol prevents Ca
2+
 
refilling to lysosomes. 
Chronic Ca
2+
 Store Reduction of the ER Prevents Lysosome Ca
2+
 Refilling. 
The ER Ca
2+
 store can also be genetically and chronically reduced without raising 
intracellular Ca
2+
 levels by transfecting cells with the IP3R ligand-binding domain with an ER 
targeting sequence (IP3R-LBD-ER) (Varnai et al., 2005).  As shown previously, IP3R-LBD-ER 
expression decreased IP3R Ca
2+
 release stimulated by the P2Y receptor agonist ATP (Fig. 3.4A 
compared to 3.3B).  Importantly, basal cytosolic levels of Ca
2+
 were not different after IP3R-
LBD-ER transfection (Fig. 3.4A), which was also found in the original study (Varnai et al., 
2005).  Interestingly, IP3R-LBD-ER also significantly reduced the GPN induced lysosomal Ca
2+ 
release in HEK293T cells, which may indicate a complete depletion of lysosomal Ca
2+
 if the pH 
artefact in Fura-2 is taken into account (Fig 3.4A compared to 3.3B).  In HEK-GCaMP3-ML1 
cells transfected with IP3R-LBD-ER, lysosomal Ca
2+
 release was significantly reduced when 
compared to untransfected cells on the same coverslip (Fig. 3.4B).  These findings show that by 
genetically reducing ER Ca
2+
 stores ongoingly, lysosomal Ca
2+
 stores are also reduced.  The ER 
is still able to release Ca
2+
 and Ca
2+
 stores refill ongoingly, but are significantly smaller (Varnai 
et al., 2005).  Here, a non-pharmacological method of reducing ER Ca
2+
 converges on findings 
using pharmacological manipulations of ER Ca
2+
 to support the notion that lysosome Ca
2+
 stores 
are maintained and refilled by ER Ca
2+
 stores. 
The ER and Lysosomes are in Close Contact which may Facilitate Ca
2+
 Exchange. 
Collectively, the aforementioned findings suggest that the ER, the major Ca
2+
 store in the cell, is 
essential for refilling and the ongoing maintenance of lysosomal Ca
2+
 stores.  Interestingly, the 
Ca
2+
 released from SERCA inhibition on the ER was detectable on our GCaMP3-ML1 probe 
(Fig. 3.2), likely due to membrane contact sites between the ER and lysosomes (Penny et al., 
2014).  Ca
2+
 release from the ER was also observed on LAMP1-YCaM, another genetically 
encoded, lysosomally targeted chameleon Ca
2+
 sensor (McCue et al., 2013).   
Using time-lapse confocal imaging, we found that the majority of lysosomes, marked by 
LAMP1-mCherry, move and traffic together with ER tubules, labelled with CFP-ER, throughout 
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the cell (Fig. 3.5A,B). White boxes highlight areas within the same cell where the ER appears to 
move and reform to maintain contact with the lysosome (Fig. 3.5A,B), and even generate new 
tubules to continue contact with lysosomes (Fig 3.5A see difference between 0:02 and 0:03).   
We also used TEM to probe potential ER-lysosome contact sites.  ER tubules (outlined in 
red) are found directly apposing lysosomes (outlined in blue) (Fig 3.5C). This has been shown 
previously with BSA loaded lysosomes (Kilpatrick et al., 2013).  In Fig. 3.5C the distance 
between the ER and lysosome membrane is 23.4 nM.  Thus, the ER could be the direct source of 
Ca
2+
 to lysosomes through nanojunctions to facilitate Ca
2+
 exchange.  
DISCUSSION 
ER is the Source of Ca
2+
 to the Lysosome 
Under conditions of low extracellular Ca
2+
, the amount of Ca
2+
 released from the ER is 
significantly reduced, which we showed to significantly decrease lysosomal Ca
2+
 refilling in 
Chapter 2.  Then, using SERCA inhibitors we depleted the ER Ca
2+
 gradient and showed that 
lysosome Ca
2+
 store refilling was abolished.  Using pharmacological chelation of ER Ca
2+
 with 
TPEN, we showed that Ca
2+
 refilling to lysosomes is again blocked when releasable Ca
2+
 from 
the ER is abolished.  Importantly, manipulations of ER Ca
2+
 do not affect the naïve lysosome 
Ca
2+
 store, but do impact Ca
2+
 store refilling to lysosomes.  We also significantly diminished ER 
Ca
2+
 ongoingly using genetic manipulation of IP3-receptors with an IP3R-LBD-ER to deplete 
releasable Ca
2+
 (Varnai et al., 2005).  Ca
2+
 refilling to lysosomes was significantly diminished 
using this genetic approach in HEK-GCaMP3-ML1 cells.  After this long-term manipulation of 
ER Ca
2+
, naïve Ca
2+
 stores in lysosomes released using GPN are also significantly decreased.  
Thus, inhibiting ER Ca
2+
 store maintenance, chelating ER Ca
2+
, and genetically reducing ER 
Ca
2+
 stores all demonstrate that ER Ca
2+
 is important for lysosome Ca
2+
 store refilling (see 
summary Fig. 3.6). 
Our results not only provide an explanation for the reported sensitivity of the Ca
2+
 stores 
of acidic organelles to long-term treatment with ER disrupting agents (Haller et al., 1996a; 
Menteyne et al., 2006; Patel and Docampo, 2010), but are also consistent with the observations 
that lysosomes may buffer cytosolic Ca
2+
 released from the ER (Lopez-Sanjurjo et al., 2013).  
Our findings suggest a new role for ER-lysosome contact sites that have already been found to 
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regulate cholesterol exchange (Rocha et al., 2009; Du et al., 2011; Toulmay and Prinz, 2011; Du 
et al., 2012) and receptor trafficking (Eden et al., 2010).   
Membrane Contact Sites May Facilitate Ca
2+
 Exchange between the ER and Lysosomes 
Our time lapse imaging and TEM findings corroborate previous findings that membrane contact 
sites exist between the ER and lysosomes (Kilpatrick et al., 2013).  Nanojunctions of 50 nm or 
less are ideal for Ca
2+
 exchange (Fameli et al., 2014), making these sites between the ER and 
lysosomes ideal to serve as “nano-domains” of Ca2+ exchange.  ER-endosome membrane 
contact, although currently still difficult to study, is proposed to facilitate cholesterol transport 
from endosomes to the ER (Rocha et al., 2009; Du et al., 2011; Du et al., 2012; van der Kant and 
Neefjes, 2014).  Given the established role of lysosomal Ca
2+
 release in cholesterol transport 
(Shen et al., 2012), lysosomal Ca
2+
 may have a direct role in regulating this ER-lysosome 
interaction.   
The ability to observe the TG induced Ca
2+
 signal on our GCaMP3-ML1 probe further 
supports the close contact of these two organelles.  A very different LAMP1-targeted Ca
2+
 
indicator was able to observe a similar phenomenon (McCue et al., 2013).  In mitochondria, the 
estimated distance of 10-25 nm has been suggested to be far enough to isolate mitochondria from 
a slow leak of Ca
2+
 from the ER (Csordas et al., 2006).  Given the widespread distribution of 
SERCA pumps on the ER, it seems likely that Ca
2+
 leak from ER SERCA pumps could be 
observed on our overexpressed GCaMP3-ML1 probe.   
Specific tethers that link IP3R Ca
2+
 release channels on the ER to the voltage dependent 
anion channel (VDAC) on the outer mitochondrial membrane may function to ensure Ca
2+
 
transfer specificity (Szabadkai et al., 2006).  Similarly, more specific Ca
2+
 transfer to lysosomes 
likely occurs in specialized regions between the ER and lysosomes, which would not be 
observable on our GCaMP3-ML1 probe. Interestingly, during ER stress, Ca
2+
 overload from 
SERCA leaks increases ER-mitochondrial contact sites and triggers the mitochondrial apoptotic 
pathway (Chami et al., 2008).  It is possible that Ca
2+
 overload during ER stress also functions at 
ER-lysosome contact sites to trigger lysosomal apoptotic pathways as well. 
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Functional Interactions between ER and Lysosome Ca
2+
 stores. 
A functional interaction between ER and lysosome Ca
2+
 stores was previously suggested 
(Haller et al., 1996b; Haller et al., 1996a), but these results have been largely ignored, 
presumably due to the lack of specific tools required for definitive interpretation.  Several recent 
studies have suggested that the ER and lysosome Ca
2+
 stores interact (Kilpatrick et al., 2013; 
Lopez-Sanjurjo et al., 2013; Morgan et al., 2013; Lopez Sanjurjo et al., 2014).  However, these 
studies used problematic methods for probing lysosome Ca
2+
 or apply more broadly to an acidic 
Ca
2+
 store that is likely not the lysosome, making their interpretation difficult.  A closer look at 
all of these papers supports an interaction between the ER and acidic Ca
2+
 stores, but raises the 
issue that these are all indirect observations of luminal Ca
2+
 release measured using cytosolic 
Ca
2+
 indicators and thus very speculative.   
In some cell types, lysosome permeabilization with GPN has been shown to trigger ER 
Ca
2+
 release (Kilpatrick et al., 2013), and in other cell types ER Ca
2+
 release has been shown to 
subsequently trigger Ca
2+
 release from acidic vesicles (Morgan et al., 2013).  Lysosomes have 
been suggested to absorb Ca
2+
 release from IP3-evoked Ca
2+
 signals on the ER, measured before 
and after Baf-A treatment (Lopez-Sanjurjo et al., 2013).  A rapid recycling between IP3-sensitive 
stores and lysosomes has also been suggested, evidenced by a difference in cytosolically 
measured Carbachol (CCh) responses before and after Baf-A treatment (Lopez Sanjurjo et al., 
2014).  Collectively, these observations can seem in direct opposition to each other, but could 
also simply suggest that the two Ca
2+
 stores are in close proximity and engage in signalling with 
each other.  Even studies closely examining the effects of NAADP on ER and lysosome Ca
2+
 
stores suggest this possibility (Ronco et al., 2015).  Indeed, many intracellular Ca
2+
 stores have 
been implicated in Ca
2+
 oscillations in the cell.  These studies do not provide a physiological 
basis for Ca
2+
 signalling because they are all based on observations following lysosome 
disrupting agents.  Our findings provide one function of ER-lysosome Ca
2+
 exchange that can be 
observed in physiological conditions in intact cells.  
The ER as the Source of Ca
2+
 to the Lysosome May Explain the NAADP Controversy 
The overlap of ER and lysosome stores, which is at the center of the NAADP controversy, is 
likely fuelled at least in part by the fact that TG does not affect the naïve Ca
2+
 store but instead 
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the refilled store (Fig 3.2E and see Fig. 3 in (Patel and Docampo, 2010).  TPEN was shown to 
block lysosome stores after 20 mins, and these findings support the hypothesis that lysosome 
stores are being released ongoingly, and refilling must be continuous.  This possibility will be 
examined in greater detail in Chapter 4, and may partly explain why the literature often sees 
overlap between pharmacological agents that affect the ER Ca
2+
 store after short-term 
application, but affect both stores after long-term application.   
A nuanced analysis of store overlap for NAADP and other Ca
2+
 mobilizing agents using 
varied time courses has not yet been performed.  NAADP may be one such case of this overlap 
confusion, especially since it has been shown to be insensitive to the lysosome specific GPN 
(Gerasimenko et al., 2006) and to require ryanodine receptors for Ca
2+
 release (Gerasimenko et 
al., 2003; Dammermann and Guse, 2005).  Another possibility is that contact sites between 
lysosomes and RYRs on the ER are the site of NAADP Ca
2+
 signalling, which has been 
suggested (Kinnear et al., 2008).  This contact site may serve a different functional purpose than 
sites to refill Ca
2+
 that involve IP3Rs. It is also possible to speculate that NAADP functions to 
couple lysosomes to the ER or to trigger ER Ca
2+
 transfer to lysosomes (Ronco et al., 2015).  
Store specific analyses and better resolution will allow for a better understanding of how 
NAADP acts to mobilize Ca
2+
 stores.  
Previously Assumed to be ER Specific Reagents also Affect Lysosome Ca
2+
 Stores 
In addition, our work reveals that, depending on the treatment conditions (acute versus prolonged 
treatment), many assumed-to-be ER-specific reagents may indirectly affect lysosome Ca
2+
 stores 
after long-term treatment, and this may impact the interpretations of a large body of literature on 
Ca
2+
 signalling.  For example, previous studies have attempted to improve LSD symptoms by 
increasing lysosomal Ca
2+
 using ER SERCA inhibitors such as Curcumin (Lloyd-Evans et al., 
2008).  In my hands, I found curcumin to increase cytosolic Ca
2+
 measured with Fura-2 as 
expected, and also to completely abolish lysosomal Ca
2+
, measured with GPN in Fura-2 as well 
as in GCaMP3-ML1 cells (data not shown).  These effects may be due to curcumin’s inhibitory 
effects on SERCA pumps (Bilmen et al., 2001), or its inhibition of IP3Rs (Dyer et al., 2002).  
Other studies have noted that SERCA inhibitors antagonize the GPN signal, but have not 
expounded upon this finding (Haller et al., 1996b; Sivaramakrishnan et al., 2012).  Notably, 
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however, any alteration of ER Ca
2+
 may affect lysosomal Ca
2+
 after a short time, and should be 
considered carefully.  
ER-to-Lysosome Ca
2+
 Transport May be altered in Diseased States. 
Dysfunction of lysosomal Ca
2+
 stores and Ca
2+
 release has been implicated in the pathogenesis of 
acute pancreatitis (Gerasimenko et al., 2009), Alzheimer’s Disease (Coen et al., 2012), and 
lysosome storage disorders (Shen et al., 2012).  The unexpected role of the ER in maintaining 
Ca
2+
 stores in lysosomes may help resolve the long-standing mystery of how impaired ER Ca
2+
 
homeostasis is commonly seen in lysosomal storage diseases (LSDs) (Cribbs and Strack, 2007; 
Coen et al., 2012), and manipulating ER Ca
2+
 reduces lysosome storage (Lloyd-Evans et al., 
2008; Mu et al., 2008; Ong et al., 2010).   
Limitations 
Pharmacological studies always have limitations that should be considered, as many 
pharmacological reagents can have multiple targets and effects within the cell.  As such, multiple 
lines of pharmacological manipulations should converge upon the same findings to rule out off 
target effects.  Although these studies did utilize multiple mechanisms of pharmacoloigical 
inhibition, additional effects of these treatments should be considered. 
SERCA pumps are localized to the ER and also reside on the Golgi, which interacts with 
lysosomes through trafficking in the trans-Golgi network (TGN) (Wuytack et al., 2002).  
Abolishing the Golgi with Brefeldin-A (Chapter 2) did not affect Ca
2+
 store refilling to 
lysosomes, suggesting that the effects of inhibition of SERCA pumps on lysosome Ca
2+
 stores is 
due to their effects on ER Ca
2+
 stores. 
TPEN has been shown previously to chelate ER Ca
2+
, but it is also known to chelate Zn
2+
 
which is a co-factor for many enzymes and a modulator of a variety of ion channels.  TPEN 
abolished Ca
2+
 release from IP3Rs but not Ca
2+
 release from lysosomes measured with GPN, 
supporting its use as an ER specific chelator.  However, an additional control could be performed 
to show that it does not abolish the naïve response to ML-SA1 in HEK-GCaMP3-ML1 cells to 
further support the notion that it does not chelate lysosomal Ca
2+
. TPEN may also be 
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contributing to abolishing Ca
2+
 refilling if Zn
2+
 is required for this process, and should be kept in 
mind.   
Future Directions 
Knowing that pharmacological agents that affected IP3-releasable pools blocked Ca
2+
  
refilling to lysosomes (Authi et al., 1993; Aulestia et al., 2011), we next sought to determine 
which ER Ca
2+
 channel was responsible for Ca
2+
  refilling to lysosomes in Chapter IV.  
 
METHODS AND MATERIALS 
Molecular biology. Genetically-encoded Ca
2+
 indicator GCaMP3 was fused directly to the N-
terminus of ML1 (GCaMP3-ML1) as described previously (Shen et al., 2012). The IP3R-LBD-
ER construct (Varnai et al., 2005) was a kind gift from Dr. Thomas Balla (National Institute of 
Child Health and Human Development, NIH).  The pECFP-ER plasmid was obtained from 
CLONTECH.  LAMP1-mCherry was made by fusing mCherry with the C terminus of LAMP1. 
Mammalian Cell Culture.  All cells were cultured in a 37˚C incubator with 5% CO2.  
HEK293T cells, Tet-On HEK293 cells stably expressing GCaMP3-ML1 (HEK-GCaMP3-ML1 
cells), and Cos-7 cells were cultured in DMEM F12 (Invitrogen) supplemented with 10% 
(vol/vol) FBS or Tet-free FBS.   
HEK293T cells, HEK-GCaMP3-ML1 cells, and Cos-7 cells were transfected using 
Lipofectamine 2000 (Invitrogen).  All cells were used for experiments 24-48 hrs after 
transfection.   
Confocal imaging.  Live imaging of cells was performed on a heated and humidified stage using 
a Spinning Disc Confocal Imaging System.  The system includes an Olympus IX81 inverted 
microscope, a 100X Oil objective NA 1.49 (Olympus, UAPON100XOTIRF), a CSU-X1 scanner 
(Yokogawa), an iXon EM-CCD camera (Andor).  MetaMorph Advanced Imaging acquisition 
software v.7.7.8.0 (Molecular Devices) was used to acquire and analyze all images.  
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Lysotracker (50nM) was loaded into cells for 30 minutes in cell culture medium 
(Chazotte, 2011).  After LysoTracker loading, coverslips were washed 3 times with Tyrode’s and 
imaged in Tyrode’s.   
TEM. Confluent Cos7 cell cultures in 10 mm dishes were prepared for TEM by washing twice 
in Sorensen’s buffer and then fixing for 30 min in 2.5% glutaraldehyde in 0.1M Sorensen’s 
buffer.  Post-fixation was performed for 15 min with 1% osmium tetroxide in 0.1M Sorensen’s 
buffer. After rinsing, cells were stained in 7% uranyl acetate dissolved in ddH20 for 15 min. 
After rinsing in ddH20, cells were dehydrated in increasing concentrations of ethanol and 
infiltrated with Epon.  After infiltration, cells were pelleted and polymerized for 24h at 60ºC.  
After pelleting and application on TEM grids, cells were post-stained with 7% Uranyl acetate.  
 A Philips CM-100 TEM microscope was used for TEM and image acquisition was 
performed with a AmtV600 camera. 
GCaMP3-ML1 Ca
2+
 imaging.  GCaMP3-ML1 expression was induced in Tet-On HEK-
GCaMP3-ML1 cells 20-24h prior to experiments using 0.01µg/mL doxycycline.  GCaMP3-ML1 
fluorescence was monitored at an excitation wavelength of 470 nm (F470) using a EasyRatio Pro 
system (PTI).  Cells were bathed in Tyrode’s solution containing 145 mM NaCl, 5 mM KCl, 2 
mM CaCl2, 1 mM MgCl2, 10 mM Glucose, and 20 mM Hepes (pH 7.4).  Lysosomal Ca
2+
 release 
was measured in a zero Ca
2+
 solution containing 145 mM NaCl, 5 mM KCl, 3 mM MgCl2, 10 
mM glucose, 1 mM EGTA, and 20 mM HEPES (pH 7.4).   Ca
2+
 concentration in the nominally 
free Ca
2+
 solution is estimated to be 1–10 μM.  With 1 mM EGTA, the free Ca2+ concentration is 
estimated to be < 10 nM based on the Maxchelator software (http://maxchelator.stanford.edu/).  
Experiments were carried out 0.5 to 6 hrs after plating.   
Fura-2 Ca
2+
 imaging. Cells were loaded with Fura-2 (3 µM) and Plurionic-F127 (3 µM) in the 
culture medium at 37˚C for 60 min.  Florescence was recorded using the EasyRatio Pro system 
(PTI) at two different wavelengths (340 and 380 nm) and the ratio (F340/F380) was used to 
calculate changes in intracellular [Ca
2+
].  All experiments were carried out 1.5 to 6 hrs after 
plating.  
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Reagents.  All reagents were dissolved and stored in DMSO or water and then diluted in 
Tyrode’s and 0 Ca2+ solutions for experiments.  ATP, CPA, Doxycycline, TG, TPEN were from 
Sigma; GPN was from Santa Cruz; ML-SA1 was from Chembridge.  
Data analysis.  Data are presented as mean ± SEM. All statistical analyses were conducted using 
GraphPad Prism.  Paired t-tests were used to compare the average of three or more experiments 
between treated and untreated conditions.  A value of P <0.05 was considered statistically 
significant.  
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Figure 3.1  ER Ca
2+
 release is significantly reduced over 5 mins in 0 Ca
2+
 extracellular 
solution.  (A) The response to ATP in HEK293T cells loaded with Fura-2 was significantly 
diminished after perfusing cells with 0 external Ca
2+
 for 5 min.  (B) 0 Ca
2+
 extracellular solution 
for 5 mins reduces ATP stimulated IP3R release from the ER Ca
2+
 store. All panels represent the 
average of 30-40 HEK cells. 
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Figure 3.2 ER SERCA inhibitors block Ca
2+
 refilling to the lysosome. (A) Acute treatment 
with the ER SERCA inhibitor Thapsigargin (TG) (2 µM) abolishes refilling to the lysosome 
(arrow marks application of ML-SA1).  (B) Cyclopiazonic Acid (CPA) is a SERCA inhibitor 
that when applied acutely (100 µM) abolishes Ca
2+
 refilling to lysosomes.  (C) TG (p=0.008) and 
CPA (p=0.0069) both significantly reduced Ca
2+
 refilling to lysosomes.  Data is presented as 
102 
 
mean ± SEM.  (D) Short application of CPA to HEK293T cells affected the amplitude of GPN 
response, suggesting that the response is only due to pH.  (E) Application of TG did not affect 
the naïve, initial response to ML-SA1, but did abolish the refilled response.  The leak of Ca
2+
 
from ER Ca
2+
 stores into the cytosol is observable on the cytosolically located GCaMP3-ML1 
probe, likely due to close contact between the ER and lysosomes. Control naïve response 
1.39±0.09 (n=3); Naïve response after TG 1.08±0.07 (n=3); p=0.2024)  (F) TG did not abolish 
LysoTracker staining in HEK293T cells.  All data represents the average of 30-40 cells.  Unless 
otherwise stated, data was collected from HEK-GCaMP3-ML1 cells.   
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Figure 3.3  TPEN chelates ER Ca
2+
 and abolishes lysosome Ca
2+
 refilling.  (A) TPEN 
treatment (2 min) chelates ER Ca
2+
 and blocks ATP induced Ca
2+
 release (compare to B).  (B) 
Untreated HEK293T cells display robust responses to ATP, which release ER Ca
2+
 and GPN, 
which permeabilizes lysosome membranes.  (C) TPEN does not change the response to GPN 
indicating it does not chelate lysosome Ca
2+
 (compare to B).  (D) In HEK-GCaMP3-ML1 cells, 
application of TPEN during Ca
2+
 refilling abolishes the response to ML-SA1.  (E) TPEN 
significantly (p=0.001) abolished Ca
2+
 refilling in HEK-GCaMP3-ML1 cells.  (F) Long-term 
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treatment with TPEN (20 mins) abolished the lysosome and ER Ca
2+
 responses.  All data 
represents the average of 30-40 cells. Unless otherwise noted, all experiments were performed in 
HEK293T cells. 
 
 
 
 
 
Figure 3.4 Transfection of IP3R-LBD-ER chronically reduced ER Ca
2+
 and also affected 
lysosome Ca
2+
 refilling.  (A) In HEK cells transfected with IP3R-LBD-ER, ER Ca
2+
 is 
significantly reduced and GPN responses are diminished.  (B) In HEK-GCaMP3-ML1 cells 
transfected with IP3R-LBD-ER, responses to ML-SA1 are significantly reduced when compared 
to untransfected cells HEK-GCaMP3-ML1 on the same coverslip. Each panel represents the 
average 20-40 cells on one coverslip. (C) The 1
st
 (p=0.0014), 2
nd
 (p=0.0004), and 3
rd
 responses 
(p<0.0001) of GCaMP3-ML1 cells transfected with the IP3R-LBD-ER were significantly 
reduced compared to untransfected cells on the same coverslip. 
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Figure 3.5 Lysosomes are in close apposition to ER tubules. (A) Live cell imaging of Cos7 
cells transfected with CFP-ER and LAMP1-mCherry show that the ER and lysosomes remain in 
close contact.  It was impossible to find a lysosome that did not appear in contact with the ER.  
(B) Additional highlighted area from the cell in panel A, again showing the ER and lysosomes in 
close contact.  (C)  TEM of a smooth ER tubule in close apposition to a lysosome-like vesicle. 
Right panel shows ER highlighted in red and lysosome outlined in blue.  Scale bar = 100 nm.  
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Figure 3.6 Model of ER-Lysosome Interaction.  TRPML1 is a Ca
2+
 channel that releases Ca
2+
 
from the lysosome into the cytosol.  Baf-A and Con-A are inhibitors of the lysosome V-ATPase 
which maintains the proton gradient in the lysosome. did not affect lysosome Ca
2+.  
However, 
inhibiting SERCA pumps with TG and CPA inhibit SERCA pumps which maintain the ER Ca
2+
 
gradient, resulting in Ca
2+
 leak from the ER down the concentration gradient.  Chelating ER Ca
2+
 
stores with TPEN chelates ER Ca
2+
 stores. Transfection with the IP3R-LBD-ER genetically 
reduces the ER Ca
2+
 store by causing ongoing constitutive Ca
2+
 release through IP3-receptors 
without increasing cytosolic Ca
2+
.  An unidentified Ca
2+
 transporter or channel on the lysosome 
membrane serves to refill lysosome Ca
2+
 stores. 
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CHAPTER IV 
THE IP3-RECEPTOR ON THE ENDOPLASMIC RETICULUM IS REQUIRED FOR 
REFILLING LYSOSOME CALCIUM STORES 
 
ABSTRACT 
Our findings suggested that ER Ca
2+
 is necessary to refill lysosome Ca
2+
 stores, so we next 
sought to test the hypothesis that blocking ER Ca
2+
 release through a specific channel or 
channels would abolish lysosome Ca
2+
 store refilling.  We examined the two primary Ca
2+
 
channels, IP3-receptors (IP3Rs) and ryanodine receptors (RYRs) on ER membranes.  
Pharmacological block of IP3Rs prevented Ca
2+
 refilling, as did blocking PLC to prevent the 
formation of IP3.  Blocking RYRs did not significantly effect on Ca
2+
 refilling.  DT40-IP3R-
TKO cells show Ca
2+
 refilling and normal acidification, but their Ca
2+
 store refilling isn’t 
affected by either IP3R or RYR antagonists.  This suggests that an alternative mechanism of Ca
2+
 
refilling exists in cells without IP3Rs.  The finding that lysosomes in DT40 cells still have Ca
2+
 
also  supports the importance of Ca
2+
 stores to lysosome and cellular function.  IP3Rs also 
transfer Ca
2+
 to mitochondria at ER-mitochondria contact sites.  Our work supports the idea that 
one role of IP3Rs on the ER is to regulate Ca
2+
 transfer and store maintenance of other 
organelles in the cell.  These findings also suggest that a subset of assumed to be IP3R mediated 
functions could potentially be mediated by lysosome Ca
2+
.  
 
INTRODUCTION 
Ca
2+
 ions are the most versatile and widely used signaling molecules within and between cells 
(Berridge et al., 2000).  Ca
2+
 is highly buffered within the cytosol to keep cytosolic 
concentrations very low (100 nM), which allow for precise spatiotemporal control of Ca
2+
 
signals that are involved everything from gene expression to cell death (Clapham, 2007).  
Indeed, at prolonged high concentrations, Ca
2+
 is known to be toxic to the cell.  The two primary 
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methods of mobilizing Ca
2+
 for intracellular signaling are through the plasma membrane from 
the high Ca
2+
 in the extracellular environment, or from intracellular Ca
2+
 stores.  Many 
intracellular vesicles are known to contain stores of Ca
2+
, the largest store being the endoplasmic 
reticulum (ER). 
ER Ca
2+
 Signaling 
The highly dynamic ER takes up about 10 – 40% of the cell volume depending on the 
cell type.  [Ca
2+
]ER is about 0.3-0.7 mM, making it the largest contiguous Ca
2+
 store in the cell.  
For comparison, lysosomes make up about 3 – 5% of cell volume and [Ca2+]Ly is about 0.4-0.6 
mM.  The ER has many distinct domains and regions that are connected but have different 
functions and structures (Lynes and Simmen, 2011; English and Voeltz, 2013).  Likewise, Ca
2+
 
released from the ER seems to have segregated pools that are released by specific receptors 
triggered by distinct signals (Mozhayeva and Mozhayeva, 1996; Guerrero-Hernandez et al., 
2010; Aulestia et al., 2011).  An ER-centric view of the cell lends itself to the suggestion that the 
ER, particularly because it is known to make contact with the plasma membrane and all other 
organelles in the cell, is a master coordinator of all cell functions using Ca
2+
  as its most 
universal signaling tool.  An understanding of the function of ER Ca
2+
 release channels may shed 
light on ER-lysosome Ca
2+
 interactions.  
IP3R and RYR Ca
2+
 Channels of the Endoplasmic Reticulum 
The ER has two primary Ca
2+
 release channels, ryanodine receptors (RYRs) and inositol-1,4,5-
triphosphate receptors (IP3Rs).  Because ER Ca
2+
 stores are implicated in lysosomal Ca
2+
 
regulation (see Chapter 3), a basic understanding of the primary Ca
2+
 channels on the ER 
membrane is helpful in thinking about how they may provide Ca
2+
 to the lysosome.  Because of 
this, important and relevant aspects of RYR and IP3R channel structure and function will be 
reviewed here briefly. 
IP3Rs and RYRs are large, tetrameric channels located primarily on the ER.  Both IP3Rs 
and RYRs have large cytoplasmic, mushroom shaped regions to detect a wide variety of signals 
from the cytosol and smaller stalk regions that extend into the ER lumen to detect intraluminal 
signals as well.  These two Ca
2+
 release channels have structural and functional commonalities, 
as well as similar activation and gating mechanisms (Seo et al., 2012). 
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Ryanodine Receptors 
RYR receptors are the largest known ion channels, almost twice the size of IP3Rs, composed of 
about 5000 amino acids (~2.2MDa) (Van Petegem, 2012).  At concentrations around 10 nM 
ryanodine binds to RYRs and permits Ca
2+
 efflux, but at concentrations higher than 10 µM, 
ryanodine inhibits RYRs (Meissner, 1986).  RYRs are best known for their involvement in 
excitation-contraction coupling in the sarcoplasmic reticulum (SR) of muscle cells.  There are 
three known isoforms of RYRs, which have all been found in a variety of tissues although 
certain tissues contain predominately one isoform (Van Petegem, 2012).   
The primary trigger for RYR opening is Ca
2+
, for which RYRs have multiple binding 
sites.  Ca
2+
 modulation of RYRs can be plotted in a bell-shaped curve, where higher 
concentrations can cause channel closing (Meissner et al., 1986).  RYRs are often found in 
clusters with other ion channels, and can be opened by the activity of other ion channels. In fact, 
RYRs can detect high luminal Ca
2+
 levels in the ER and open to prevent Ca
2+
 overloading in the 
ER.  Furthermore, RYR channel opening is controlled by a wide array of post-translational 
modification events, proteins, small molecules, and binding proteins from the cytosol and ER/SR 
lumen, undoubtedly facilitated by the enormous surface area of the cytosolic portion of the 
channel (Van Petegem, 2012).  More than 300 disease mutations of RYRs are known, most of 
which result in a gain of function that is found in skeletal muscle disorders, seizure disorders, 
and cardiac arrhythmias typical of RYR mutations (Van Petegem, 2012). 
Inositol Trisphosphate (IP3) Receptors 
If the ER is considered the largest Ca
2+
 store in the cell, then IP3R receptors are increasingly 
being appreciated as the master signal integrators to regulate the Ca
2+
 store (Patterson et al., 
2004; Mikoshiba, 2007).  IP3Rs themselves have the ability to integrate a wide variety of signals 
from kinases, nucleotides, proteins, and phosphatases, whereby the IP3R forms a scaffold to 
form macro-signaling complexes (Mikoshiba, 2007).  This is supported by the fact that more 
than 50 structural, scaffolding, and motor proteins have already been identified to interact with 
IP3Rs (Parys and De Smedt, 2012).  Adding to the complexity, kinases and phosphatases can 
regulate both the IP3R and its interacting proteins (Parys and De Smedt, 2012).   
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The IP3R is a very large protein with an open reading frame of more than 2700 amino 
acids (~1 MDa) (Patterson et al., 2004).  Inositol 1,4,5-triphosphate (IP3) is a second messenger 
formed by phospholipase C metabolism of phosphoinositol-4,5-biphosphate (PIP2) as a result of 
stimulation of G-protein coupled receptors (GPCRs) or receptor tyrosine kinases (RTKs) 
(Berridge et al., 2000).  IP3 binds to IP3Rs which transduces and/or amplifies cellular signals to 
rapidly release Ca
2+
 from the ER (Patterson et al., 2004).  There are four presumed IP3 binding 
sites on the IP3R, about 2000 amino acids away from the channel pore, which are assumed to 
induce conformational changes to affect channel gating (Patterson et al., 2004).  IP3Rs are also 
bi-phasically regulated by Ca
2+
, partly through a feedback mechanism whereby Ca
2+
 released 
inhibits further release (Patterson et al., 2004).  Up to seven cytosolic Ca
2+
 binding sites on 
IP3Rs have been posited, and IP3R regulation has been shown to be conferred by both luminal 
ER Ca
2+
  and cytosolic Ca
2+
 levels (Parys and De Smedt, 2012).   
There are three isoforms of the IP3R and a few splice variants.  The three isoforms of 
IP3R display differing levels of sensitivity to IP3 (IP3R-2 > IP3R-1 > IP3R-3) (Newton et al., 
1994) and different sensitivities to a variety of other regulatory mechanisms (Iwai et al., 2007; 
Parys and De Smedt, 2012).  It has been difficult to deduce definitive and separate functions for 
each of these isoforms because almost all cell types contain more than one isoform.  IP3R-2 and 
-3 isoform knockout mice display few phenotypic abnormalities.  However, IP3R-1 knockout 
mice that survive past birth display severe defects, possibly because the cerebellum only 
expresses the IP3R-1 isoform.  The cerebellum is the only region found to exhibit one isoform, 
and the three isoforms may on many levels exhibit functional redundancy to protect important 
functions within the cell (Newton et al., 1994; Patterson et al., 2004).   
IP3Rs have been located in all regions of the ER, including the nuclear envelope or 
“neoplasmic reticulum” (Echevarria et al., 2003), as well as to a much lower extent, the plasma 
membrane, Golgi, and secretory vesicles (Patterson et al., 2004).  Whether IP3Rs are functional 
when they are on the plasma membrane is not known and remains controversial (Patterson et al., 
2004), and perhaps they are a result of secretory vesicle fusion with the plasma membrane.  
IP3Rs are often found in clusters of 20-30, which plays a role in their regulation and the ability 
to produce localized microdomains of Ca
2+
 (Parys and De Smedt, 2012; Rahman, 2012).   
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The ability of IP3Rs to be regulated by such a wide variety of molecules allows for them 
to have many specific roles in Ca
2+
 release and exchange.  For example, IP3Rs have been shown 
to provide Ca
2+
 to mitochondria at membrane contact sites, and may play larger signaling roles at 
these ER-mitochondrial junctions (Hayashi et al., 2009).  Given the known role of IP3Rs in 
regulating ER-mitochondrial Ca
2+
 exchange, it is possible that they play a role in the regulation 
of membrane contact sites between the ER and the various other membranes, including the 
plasma membrane, Golgi, endosomes, lysosomes, lipid droplets, and perixosomes. 
Other ER Ca
2+
 Channels 
There are several other ion channels known to affect Ca
2+
 signaling in the ER that are not well 
characterized, but that undoubtedly affect ion homeostasis and Ca
2+
 release (Takeshima et al., 
2014).  For example, several non-selective cation channels exist that may function as Ca
2+
 leak 
channels including presenilins, pannexin channels, and several TRP family members, many of 
which are thought to affect the activity of IP3Rs and RYRs (Takeshima et al., 2014). There is 
data to support the existence of other putative exchangers and ion channels for K
+
, H
+
, Cl
-
, Na
2+
, 
and other ions, but many of these have yet to be definitively identified (Takeshima et al., 2014). 
Focus of the Present Study 
Our findings in Chapter 3 suggested that the ER Ca
2+
 store was important for lysosome Ca
2+
 
store maintenance and refilling, so we next sought to test the hypothesis that blocking an ER 
Ca
2+
 channel or channels could abolish Ca
2+
 refilling to the lysosome.  HEK cells possess both 
the primary Ca
2+
 release channels on the ER, IP3-receptors and ryanodine receptors (Querfurth et 
al., 1998; Jurkovicova et al., 2008), so we began by testing those (Fig 4.1A).  
RESULTS 
IP3-Receptor antagonist Xestospongin blocks Ca
2+
 refilling of lysosomes.  
IP3-receptors on the ER provide Ca
2+
 to mitochondria through membrane contact sites at 
the mitochondrial associated membrane (MAM) (Hayashi et al., 2009).  Many of the antagonists 
used in Chapter 3 to block ER Ca
2+
 release act on the pool of Ca
2+
 in the ER sensitive to IP3.  
Because of this, we first examined IP3-receptors to determine if they were involved in Ca
2+
 
refilling to the lysosome.   
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We sought the most specific, fast-acting IP3 receptor blocker available, Xestospongin-C 
(Xesto) (Gafni et al., 1997; Cardenas et al., 2010).  Importantly, Xesto washes out rapidly.  Xesto 
blocked the ATP induced Ca
2+
 response in HEK cells as expected (Fig. 4.2A).  When applied 
during Ca
2+
 refilling to the lysosome, Xesto significantly blocked Ca
2+
 refilling to the lysosome 
(Fig. 4.2B,C).  These findings suggest IP3-receptor involvement in Ca
2+
 refilling, but did not 
rule out ryanodine receptors. 
Ca
2+
 refilling to lysosomes is blocked by IP3-Receptor inhibitor Xestospongin-C using the 
luminal Ca
2+
 indicator Fura-Dextran. 
We also tested the effects of the IP3R blocker Xesto in an alternative assay using the 
intraluminal Ca
2+
 indicator Fura-Dextran (see Chapter 2 for a detailed description and Fig. 2.7).  
After a pulse/chase protocol in cell medium, Fura-Dextran localizes to lysosomes (Fig. 4.5A).  
As we found in our GCaMP3-ML1 assay, Xesto completely blocked the decrease in lysosome 
luminal Ca
2+
, supporting the finding that IP3Rs are essential for lysosome Ca
2+
 store refilling 
(Fig. 4.3B).  
IP3-Receptors on the ER are required for Ca
2+
 refilling of lysosomes.  
The importance of IP3Rs in Ca
2+
 refilling was confirmed using additional 
pharmacological antagonists.  This also allowed us to rule out any off-target effects of Xesto.  2-
Aminoethoxydiphenyl borate (2-APB) rapidly inhibits IP3Rs (Maruyama et al., 1997).  2-APB 
may also affect Ca
2+
 refilling to the ER during store operated Ca
2+
 entry (SOCE) (Peppiatt et al., 
2003), possibly because activation of IP3Rs is important for SOCE (Ma et al., 2000).  2-APB 
during Ca
2+
 refilling to the lysosome significantly blocked Ca
2+
 refilling (Fig. 4.4A,B).  2-APB 
can be difficult to washout (Peppiatt et al., 2003), which might be the cause of the diminished 
response to the third application of ML-SA1 that we observed (Fig. 4.4A).   
U73122 is a PLC inhibitor that blocks the constitutive production of IP3 (Cardenas et al., 
2010) and prevents IP3R-mediated Ca
2+
 release induced by the P2Y receptor agonist ATP (Fig. 
4.5A).  U73122 also completely prevented Ca
2+
 refilling of lysosomes (Fig. 4.5B,C).  These 
findings may suggest that basal production of IP3 is essential for Ca
2+
 refilling of lysosomes, 
however the effects may simply be due to the fact that U73122 blocked IP3R Ca
2+
 release (Fig. 
4.5A).  Because U73122 also caused some Ca
2+
 leak from the ER, observed on our probe, it is 
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possible that it also acts as a SERCA inhibitor, which has been shown at least in smooth muscle 
(Hollywood et al., 2010).   
Ryanodine Receptors on the ER are not required for Ca
2+
 refilling to lysosomes. 
Ryanodine receptors (RYRs) are Ca
2+
 permeable channels on the ER membrane whose 
primary trigger for activation is Ca
2+
, although they are activated by a variety of other 
endogenous molecules (Van Petegem, 2012).  Because they are Ca
2+
 activated, their involvement 
in Ca
2+
 refilling is plausible, given that Ca
2+
 released from lysosomes could be sensed by RYRs 
and trigger ER Ca
2+
 release to lysosomes.  Low concentrations of ryanodine activate RYRs, but 
high (>10 µM) concentrations of ryanodine block the channel (Pessah and Zimanyi, 1991; 
Berridge, 2012).  Application of a high concentration of ryanodine during Ca
2+
 refilling did not 
significantly affect Ca
2+
 refilling to the lysosome (Fig. 4.4A,C).  An additional ryanodine 
receptor antagonist, 1,1′-diheptyl-4,4′-bipyridinium (DHBP) (Kang et al., 1994), also showed no 
effect to Ca
2+
 refilling of lysosomes (Fig. 4.4B,C).  These results suggest that RYRs are not the 
primary Ca
2+
 release channel involved in Ca
2+
 refilling to lysosomes.  
The close-apposition of the ER and lysosomes raised the possibility that the large ML-
SA1 responses we observed might be mediated by lysosomal Ca
2+
-induced Ca
2+
 release from the 
ER.  In certain cell types, releasing even small amounts of Ca
2+
 from lysosomes into the cytosol 
may trigger Ca
2+
 waves from the ER (Kilpatrick et al., 2013).  Because of this concern, we co-
applied IP3R and RYR blockers with ML-SA1 in all experiments with these antagonists (Figs. 
4.1B, 4.2A, 4.4A,B).  Co-application did not reduce the initial, naïve response to ML-SA1 before 
refilling, suggesting that Ca
2+
 release measured by GCaMP3-ML1 was not from RYRs or IP3Rs 
directly.  
DT40-IP3R-TKO chicken B cells exhibit Ca
2+
 refilling to lysosomes. 
We next sought a way to abolish IP3R Ca
2+
 release without using pharmacological 
methods.  Transfecting cells with the IP3R-LBD-ER ongoingly released Ca
2+
 and reduced ER 
Ca
2+
 stores (Varnai et al., 2005).  The IP3R-LBD-ER also reduced lysosome Ca
2+
 stores and 
refilling (Fig. 3.4).  However, the IP3-LBD-ER did not abolish IP3R activation, but instead 
reduced ER Ca
2+
 ongoingly through ongoing stimulation of the IP3 receptor.  Inspired by studies 
examining the role of IP3R Ca
2+
 release in mitochondrial bioenergetics (Cardenas et al., 2010), 
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we obtained triple IP3R knockout DT40 cells (DT40-TKO).  Both WT (Fig. 4.6A) and DT40-
TKO (Fig. 4.6B) cells exhibited responses to GPN  and lysosomal Ca
2+
 store refilling occurs in 
both WT (Fig. 4.6C and E) and TKO DT40 chicken B cells (Fig. 4.6D and E) that were 
transfected with GCaMP3-ML1.  DT40 and DT40-TKO cells exhibited no overt differences in 
lysosome acidification, size, and number as measured by LysoTracker staining (Xu et al., 2014) 
(Fig. 4.6F).   
In WT DT40 cells, the IP3R-specific antagonist Xesto completely blocked Ca
2+
 refilling 
(Fig. 4.7A and C).  However, Xesto had no obvious blocking effect in DT40-TKO cells (4.7B 
and C).  Refilling in DT40-TKO cells was not blocked by DHBP (Fig. 4.7D) or a combination of 
Dantrolene or Ditilizam (Fig. 4.7E).  Results in DT40 cells are consistent with the notion that in 
normal conditions, IP3Rs are the primary source of Ca
2+
 refilling of lysosomes.  When IP3Rs are 
genetically deleted, however, IP3R-independent mechanisms contribute to lysosomal Ca
2+
 
refilling.  The ER has multiple Ca
2+
 channels that could compensate for the lack of IP3Rs in 
DT40 cells and play the role of Ca
2+
 transfer to lysosomes (Takeshima et al., 2014). 
Ca
2+
 stores are released ongoingly for normal physiological processes. 
After examining refilling time (see Chapter 2 for details), we were also curious about ongoing 
Ca
2+
 release in lysosomes.  Ca
2+
 store depletion in lysosomes could occur as a result of Ca
2+
 
release for fusion and/or fission of vesicles, as a counterflux to other ion transporters in the 
lysosome, and for signaling to other vesicles about cell nutrient levels.  To test whether ongoing 
Ca
2+
 release was occurring in HEK-GCaMP3-ML1 cells, we first allowed Ca
2+
 refilling to occur, 
then applied the IP3R blocker Xesto.  After 2 mins, no effect on refilled Ca
2+
 stores was 
observed (Fig. 4.8A).  Xesto treatment for 5 minutes after refilling showed a moderate decrease 
in Ca
2+
 released from lysosomes, below typical levels (Fig. 4.8B).  After 10 minutes of Xesto 
treatment following store refilling, lysosome Ca
2+
 stores were significantly reduced (Fig 4.8C).  
These results suggest that slow, ongoing lysosomal Ca
2+
 release occurs under resting conditions 
that gradually depletes lysosome Ca
2+
 stores if refilling is prevented (Fig. 4.8D).  
The results of Chapters 2 and 3 as well as those found in this chapter support the working 
model depicted in Figure 4.9.  Within lysosomes and the ER, Ca
2+
 buffers regulate free and 
releasable Ca
2+
, and play a role in modulating the specificity of Ca
2+
 release by different 
120 
 
channels and triggers.  Ca
2+
 is released from the lysosome by TRPML1 and other Ca
2+
 channels 
(not depicted).  Ca
2+
 release and/or other signals to IP3Rs trigger IP3R Ca
2+
 release within the 
tight nanojunction between ER and lysosome membranes.  This Ca
2+
 release recruits additional 
Ca
2+
 channels (possibly more IP3Rs) to refill lysosome Ca
2+
 stores.  Tethers link ER membranes 
to lysosomes for a variety of purposes, and tethers possibly exist between IP3Rs and lysosomes 
to facilitate ER Ca
2+
 transfer to lysosomes.  A putative, low-affinity Ca
2+
 pump or exchanger, 
located on the lysosome membrane that does not depend on the proton gradient, moves Ca
2+
 into 
lysosomes.   
DISCUSSION 
IP3Rs on the ER refill lysosome Ca
2+
 stores. 
By measuring both Ca
2+
 release and luminal Ca
2+
 in the lysosome, we found evidence that 
normally functioning IP3Rs are required for lysosomal Ca
2+
 refilling, but when IP3Rs are 
lacking, alternative Ca
2+
 channels or mechanisms may refill lysosome Ca
2+
 stores.  Regardless of 
whether IP3Rs were blocked using Xesto or 2-APB, or whether IP3 production was directly 
inhibited using U73122, Ca
2+
 refilling to the lysosome and subsequent Ca
2+
 release measured by 
the GCaMP3-ML1 probe was abolished when IP3R Ca
2+
 release was blocked.  These findings 
were corroborated using Fura-Dextran, again showing that IP3R block with Xesto during 
refilling results in no Ca
2+
 refilling to lysosomes.   
While IP3Rs reside predominately on the ER, they can be found to a lesser extent in the 
Golgi and secretory vesicles and sometimes have low expression in the plasma membrane 
(Vermassen et al., 2004).  Chapter 3 uses pharmacological and genetic methods to show that ER 
Ca
2+
 is specifically required for Ca
2+
 refilling to lysosomes, which supports IP3R localization on 
the ER for lysosome refilling.  We showed that extracellular Ca
2+
 depletion affects lysosome 
Ca
2+
 refilling, but also that it abolishes ER IP3R Ca
2+
 release, again suggesting that extracellular 
Ca
2+
 is not directly required for refilling Ca
2+
 to lysosomes.  Furthermore, blocking plasma 
membrane Ca
2+
 channels, including IP3Rs (Palade et al., 1989), with La
3+
 did not affect Ca
2+
 
refilling.  Ablating Golgi using Brefeldin-A also showed little impact on Ca
2+
 refilling to 
lysosomes (Fig. 2.9).  Taken together, these results suggest that IP3Rs residing on the ER 
membrane are responsible for Ca
2+
 refilling to lysosomes.  
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Although ER chelation using TPEN, disrupting ER Ca
2+
 store maintenance using SERCA 
inhibitors, and blocking IP3 production using U73122 all completely abolished Ca
2+
 refilling, 
very slight levels of Ca
2+
 remained when using IP3R blockers Xesto and 2-APB.  It is possible 
that an incomplete block of IP3Rs, or one particular IP3R subtype, was responsible for this, 
particularly because low concentrations of each drug were used intentionally to avoid off-target 
effects.  Perhaps less likely but worth considering, IP3R Ca
2+
 release may be initially required 
for refilling but then additionally recruit other Ca
2+
 release channels to aid in lysosome Ca
2+
 store 
refilling.  Because blocking RYR channels increased Ca
2+
 refilling to lysosomes, it seems 
unlikely that RYRs play this role. 
Ryanodine Receptors are not required for Ca
2+
 refilling.  
Blocking RYRs did not prevent Ca
2+
 refilling to lysosomes, suggesting they are not the primary 
Ca
2+
 channel on the ER for lysosome Ca
2+
 refilling.  Notably, blocking RYRs increased Ca
2+
 
refilling to lysosome slightly, especially with Ryanodine, although this increase was not 
significant.  Blocking RYRs is known to increase Ca
2+
 in the ER (Ong et al., 2010), which may 
explain why refilling increased slightly.  This increase parallels the decrease in lysosome Ca
2+
 
that was observed when ER Ca
2+
 levels are reduced using IP3R-LBD-ER (Chapter 3).  These 
findings suggest that ER Ca
2+
 refilling to lysosomes occurs continuously and the amount refilled 
is affected by the available store of Ca
2+
 in the ER. 
DT40-IP3R-TKO cells have alternative lysosome Ca
2+
 refilling mechanisms. 
DT40-IP3R-TKO lysosomes transfected with GCaMP3-ML1 released and refilled Ca
2+
 and were 
acidified similarly when compared to WT DT40 cells (Fig 4.6).  Both DT40-TKO and WT cells 
responded to GPN, albeit their responses were smaller than those compared to HEK293T or 
Cos7 cells.  While Xesto blocked refilling in WT DT40 cells, Xesto had no effect on refilling in 
DT40-TKO cells (Fig 4.7A-C).  These results rule out potential off-target effects of Xesto 
because Xesto only blocks Ca
2+
 refilling in cells with functioning IP3Rs.  Block of RYRs using 
three different antagonists in DT40-TKO cells did not block refilling (Fig 4.7D,E).  These 
findings suggest that an alternative mechanism exists to support Ca
2+
 store refilling when the 
IP3R is unable to.  That lysosomes in DT40-TKO cells still have luminal Ca
2+
 stores that refill 
highlights the importance of the lysosome Ca
2+
 store to proper lysosome function and cellular 
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health.  Ca
2+
 refilling in DT40-TKO cells also raises the important question of what alternative 
mechanisms may exist to refill Ca
2+
 stores in these cells.   
DT40-WT cells transfected with GCaMP3-ML1 exhibited similar Ca
2+
 store refilling 
when compared to other cell types in that their second response to ML-SA1 was slightly higher 
than the first, and the third response was slightly reduced.  However, Ca
2+
 refilling in DT40-
TKO cells transfected with GCaMP3-ML1 was slightly different than in WT, showing a reduced 
second response and a further reduced third response, although these effects were not statistically 
significant.  These findings support the possibility that different mechanisms exist to refill Ca
2+
 
stores in cells lacking IP3Rs, although the kinetics of refilling were not closely examined.  
Mitochondria-ER contact sites still exist in DT40-TKO cells (Csordas et al., 2006), and even 
dramatically altering ER morphology in healthy cells does not abolish the contact sites with 
mitochondria (Friedman et al., 2011).  Thus, contact sites still exist and can likely respond 
dynamically to facilitate Ca
2+
 exchange by alternative mechanisms.     
There are two main possibilities for alternative Ca
2+
 store refilling mechanisms in DT40-
TKO cells.  First, lysosomes in DT40-TKO cells may refill their Ca
2+
 stores via ER independent 
mechanisms.  Second, and more likely, is that lysosomes in DT40-TKO cells may refill Ca
2+
 
stores using alternative Ca
2+
 channels on the ER membrane.   
If DT40 cells refill Ca
2+
 stores by a mechanism other than ER Ca
2+
 transfer, what could 
this mechanism be?  The most feasible explanation is that fusion with other intracellular vesicles 
through membrane trafficking, including autophagosomes or transport vesicles from the trans-
Golgi network, could provide Ca
2+
 to lysosomes in DT40 cells.  Fusion with other Ca
2+
 
containing intracellular vesicles may provide less Ca
2+
 to the lysosome than transfer from the 
ER, however.  Supporting this possible mechanism, DT40 WT and IP3R-TKO cells may have 
smaller Ca
2+
 stores compared to other cell types.  GPN responses were small in DT40 WT and 
IP3R-TKO cells.  However, this possibility should be more closely examined with BAPTA-AM 
during GPN application to determine how much of the GPN response was due to pH versus Ca
2+
.  
Differences in the size of Ca
2+
 stores are not possible to elucidate with GCaMP3-ML1 which 
does not directly measure the amount of Ca
2+
 released.  While the amplitude of Ca
2+
 stores were 
smaller in both DT40 WT and TKO cells transfected with GCaMP3-ML1, it is difficult to tell if 
this is due to negative consequences of transient transfection and/or the manipulations required 
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to ensure DT40 cells adhere to glass coverslips (DT40 cells normally exist in suspension 
culture).  Thus, luminal Ca
2+
 indicators should also be used to directly measure Ca
2+
 stores in 
DT40 cells.  If Ca
2+
 stores are smaller in DT40 cells, mechanisms of Ca
2+
 store refilling that do 
not involve the ER could support their store maintenance because less Ca
2+
 would be required to 
refill their stores.   
An alternative possibility, and one that is more likely, is that a Ca
2+
 channel other than 
IP3Rs may be involved in Ca
2+
 store refilling, and that this channel may not be the RYR.  Given 
the redundancy of Ca
2+
 release channels (Marder and Goaillard, 2006) and numerous other 
potential Ca
2+
 channels on the ER (Takeshima et al., 2014) compensation by an alternative Ca
2+
 
channel in DT40-IP3R-TKO cells seems like a real possibility.  It is known that ion channels of 
different identities can produce similar phenomenon in order to maintain homeostasis, 
particularly when normal homeostasis is disrupted by the ablation or blockade of a normally 
occurring ion channel (Marder and Goaillard, 2006).  Additionally, studies have shown vast 
differences between short-term pharmacological blockade of ion channels vs. long-term 
deletions of the same current (Marder and Goaillard, 2006).  While acute inhibition with 
antagonists often reduces or abolishes ion release, knockout of particular ion channels often do 
not show any physiological phenotype (Marder and Goaillard, 2006).  For example, a seminal 
study showed that long-term reductions in Na
+
 currents had little effect on patterns of electrical 
activity in purkinje neurons when compared with short-term blockade (Swensen and Bean, 
2005).  Similar effects have been found for Ca
2+
 channels, where knock-out of the P/Q type Ca
2+
 
channel had little effect on synaptic transmission due to compensatory changes in the mRNA 
expression levels of a vast array of genes (Piedras-Renteria et al., 2004).  DT40 cells are easy to 
manipulate genetically because they have the highest rate of homologous recombination of any 
mammalian cell line, with a ratio of targeted to random integration of DNA of 1:2 (Winding and 
Berchtold, 2001).  Thus, particularly in DT40 cells, the possibility of compensatory mechanisms 
to upregulate the expression of alternative Ca
2+
 channels to refill lysosome Ca
2+
 stores seems 
likely.  
One possible candidate for an alternative ER Ca
2+
 channel to provide Ca
2+
 to the 
lysosome in DT40-TKO cells is Alzheimer’s (AD)-causing presenilin.  Presenilin is a proposed 
ER Ca
2+
 leak channel whose mutations result in impaired lysosomal Ca
2+
 homeostasis (Coen et 
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al., 2012).  However, numerous other ER Ca
2+
 releasing channels and factors aiding in Ca
2+
 
release exist and have unknown functions, and more are likely to be discovered (Takeshima et 
al., 2014).  Thus, the identity of the compensatory ion channel is possible to speculate but may 
not yet be known.   
Constitutive Ca
2+
 release from lysosomes may explain bidirectional interaction between ER 
and lysosome Ca
2+
 stores.  
Several groups have recently suggested interactions between ER and lysosome Ca
2+
 
stores, but these observations were based on indirect measurements of lysosome or acidic vesicle 
Ca
2+
 derived from cytosolic signals.  For example, lysosomes have been suggested to buffer ER 
Ca
2+
 , which was based on the observation that larger cytosolic Ca
2+
 signals from the ER were 
observed after inhibiting the lysosome V-ATPase (Lopez-Sanjurjo et al., 2013).  Shortly 
thereafter, the same group suggested that Ca
2+
 is rapidly recycled between the ER and 
lysosomes, again based on the size of cytosolic Ca
2+
 signals (Lopez Sanjurjo et al., 2014).  Other 
groups have shown bidirectional Ca
2+
 signaling between acidic organelles in sea urchin eggs 
(Morgan et al., 2013).  Another found that osmotic permeabilization of lysosome membranes 
using GPN could provoke cytosolic Ca
2+
 signals they suggested to be from the ER (Kilpatrick et 
al., 2013).  These findings and others suggesting the involvement of  the ER in lysosome Ca
2+
 
stores (Haller et al., 1996b; Haller et al., 1996a) could be due to the fact that lysosomes are 
constitutively releasing Ca
2+
 for ongoing signaling in the cell and require ER Ca
2+
 transfer to 
maintain their stores.  
Tethers may exist to functionally link ER-lysosome Ca
2+
 transfer microdomains. 
The idea that IP3Rs are responsible for providing Ca
2+
 to the lysosome is also supported by the 
extensive research showing that IP3Rs play a significant role in mitochondrial Ca
2+
 homeostasis 
(Hayashi et al., 2009).  Tethering protein GRP-75 links IP3Rs directly to mitochondrial VDAC 
channels (Szabadkai et al., 2006) presumably for the purpose of providing Ca
2+
 to mitochondria 
to regulate cellular bioenergetics (Cardenas et al., 2010).  However, there are numerous tethering 
proteins linking the ER to the mitochondria, and others that have been specifically shown to 
regulate mitochondrial Ca
2+
 (De Vos et al., 2012).  ER-mitochondrial contact is surprisingly 
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resilient, as is contact between the ER and plasma membrane.  Treatments to alter ER 
morphology or knock-down of particular tethers do not abolish these contact sites.   
Similar tethers may also link IP3Rs with the putative lysosomal Ca
2+
 transporter 
specifically for the purpose of Ca
2+
 store refilling (see Fig. 4.9).  ER-endosome contact has been 
shown to increase as endosomes mature, and up to 99% of late-endosomes are in contact with the 
ER (Friedman et al., 2013).   Most of the known ER–late-endosome contact sites involve 
cholesterol sensors and transporters, highlighting the important role of cholesterol/sterol 
transport between late-endosomes/lysosomes and the ER.   
Although the ER is in constant contact with lysosomes, transient contact sites have also 
been observed.  The ER has been shown to contact endosomes at constriction sites that form 
restricted cargo domains within endosomes prior to endosome fission events.  Elegant confocal 
microscopy studies reveal that the ER appears to define the timing and positioning of endosome 
fission, and these contact sites may provide precise triggers, including Ca
2+
 to trigger fission 
(Rowland et al., 2014).   
Cholesterol transport between the ER and lysosomes may be affected by Ca
2+
 transfer. 
Cholesterol loading of late endosomes and lysosomes seems to impact lysosome Ca
2+
 levels 
(Lloyd-Evans et al., 2008; Shen et al., 2012), and may be due to decreased lysosome-ER contact.   
RYR blockers have been suggested to ameliorate lipid storage in NPC disease fibroblasts (Yu et 
al., 2012), possibly because they increase ER Ca
2+
 (Ong et al., 2010) which could then promote 
additional Ca
2+
 transfer to lysosomes.  
Limitations 
The major limitation of the aforementioned findings is that they are mostly pharmacological 
manipulations of ER Ca
2+
 release.  Off-target effects of any pharmacological manipulation 
should be considered. While we use multiple pharmacological manipulations to examine each 
receptor, additional results using deletion of IP3Rs would be ideal.  SIRNA deletion or 
CRISPR/Cas9 gene knockout experiments would lend additional support to the idea that IP3Rs 
play an important role in Ca
2+
 refilling.  It is also possible that IP3Rs are required for Ca
2+
 
refilling but are not the primary Ca
2+
 channel to refill lysosome stores.  Theoretically, stimulation 
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of IP3Rs could trigger an additional Ca
2+
 release channel on the ER that primarily refills 
lysosome Ca
2+
 stores. 
There are many alternative explanations for why DT40 IP3R TKO cells still have Ca
2+
 
refilling to lysosomes.  In support of our hypothesis, lysosome Ca
2+
 stores may be so important 
to cell health that compensation using another ER Ca
2+
 channel or an alternative mechanism 
altogether serves to ensure lysosome stores are refilled.  Ryanodine receptors may function to 
refill Ca
2+
 stores in DT40 IP3R TKO cells but may not be blocked by our pharmacological 
manipulations.  Further characterization of RYR Ca
2+
 release in DT40 IP3R TKO cells should be 
performed to determine if this is possible.  Additional pharmacological characterization of ER 
Ca
2+
 stores in DT40 cells should be performed using SERCA inhibitors, TPEN, and other IP3R 
and RYR inhibitors to further confirm that ER Ca
2+
 release is still the mechanism of Ca
2+
 store 
refilling in DT40-TKO cells.   The kinetics of DT40 IP3R TKO Ca
2+
 refilling should be tested to 
determine whether they differ from WT cells.  This is possible given the different kinetics of 
Ca
2+
 release from Ca
2+
 channels on the ER other than IP3Rs and RYRs (Takeshima et al., 2014).   
Future Directions 
 Knowing that ER Ca
2+
 is aberrant in many lysosome storage disorders, in Chapter 5 we 
test the hypothesis that blocking Ca
2+
 transfer from the ER to lysosomes would have negative 
consequences on lysosome function or cell health.  
 
METHODS AND MATERIALS 
Molecular biology. Genetically-encoded Ca
2+
 indicator GCaMP3 was fused directly to the N-
terminus of ML1 (GCaMP3-ML1) as described previously (Shen et al., 2012).  LAMP1-
mCherry was made by fusing mCherry with the C terminus of LAMP1. 
Mammalian Cell Culture.  HEK293 cells stably expressing GCaMP3-ML1 (HEK-GCaMP3-
ML1 cells) were generated using the Flip-In T-Rex 293 cell line (Invitrogen).  DT40-WT and 
IP3R-TKO cells were a generous gift from Dr. Darren Boehning (The University of Texas 
Health Sciences Center at Houston).  We also thank Serena Lynn Clark (The University of Texas 
Health Sciences Center at Houston) for her guidance on best practices for DT40 cell culture.  All 
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cells were cultured in a 37˚C incubator with 5% CO2.  HEK293T cells, Tet-On HEK293 cells 
stably expressing GCaMP3-ML1 (HEK-GCaMP3-ML1 cells), Cos-7 cells, and human 
fibroblasts were cultured in DMEM F12 (Invitrogen) supplemented with 10% (vol/vol) FBS or 
Tet-free FBS.  DT40 cells were kept in suspension in RPMI 1640 (Invitrogen) supplemented 
with 450 µL β-mercaptoethanol, 2 mM L-glutamine, 10% FBS, and 1% chicken serum (Varnai 
et al., 2005; Cardenas et al., 2010). 
DT40 cells were transiently transfected using the Invitrogen Neon electroporation kit 
(1200V, 1 pulse, 30s).  HEK293T cells and HEK-GCaMP3-ML1 cells were transfected using 
Lipofectamine 2000 (Invitrogen).  All cells were used for experiments 24-48 hrs after 
transfection.   
Confocal imaging.  Live imaging of cells was performed on a heated and humidified stage using 
a Spinning Disc Confocal Imaging System.  The system includes an Olympus IX81 inverted 
microscope, a 100X Oil objective NA 1.49 (Olympus, UAPON100XOTIRF), a CSU-X1 scanner 
(Yokogawa), an iXon EM-CCD camera (Andor).  MetaMorph Advanced Imaging acquisition 
software v.7.7.8.0 (Molecular Devices) was used to acquire and analyze all images.  LysoTracker 
(50 nM; Invitrogen) was dissolved in culture medium and loaded into cells for 30 min before 
imaging. MitoTracker Coverslips were washed 3 times with Tyrode’s and imaged in Tyrode’s.   
GCaMP3-ML1 Ca
2+
 imaging.  GCaMP3-ML1 expression was induced in Tet-On HEK-
GCaMP3-ML1 cells 20-24h prior to experiments using 0.01µg/mL doxycycline.  GCaMP3-ML1 
fluorescence was monitored at an excitation wavelength of 470 nm (F470) using a EasyRatio Pro 
system (PTI).  Cells were bathed in Tyrode’s solution containing 145 mM NaCl, 5 mM KCl, 2 
mM CaCl2, 1 mM MgCl2, 10 mM Glucose, and 20 mM Hepes (pH 7.4).  Lysosomal Ca
2+
 release 
was measured in a zero Ca
2+
 solution containing 145 mM NaCl, 5 mM KCl, 3 mM MgCl2, 10 
mM glucose, 1 mM EGTA, and 20 mM HEPES (pH 7.4).   Ca
2+
 concentration in the nominally 
free Ca
2+
 solution is estimated to be 1–10 μM.  With 1 mM EGTA, the free Ca2+ concentration is 
estimated to be < 10 nM based on the Maxchelator software (http://maxchelator.stanford.edu/).  
Experiments were carried out 0.5 to 6 hrs after plating.   
Fura-2 Ca
2+
 imaging. Cells were loaded with Fura-2 (3 µM) and Plurionic-F127 (3 µM) in the 
culture medium at 37˚C for 60 min.  Florescence was recorded using the EasyRatio Pro system 
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(PTI) at two different wavelengths (340 and 380 nm) and the ratio (F340/F380) was used to 
calculate changes in intracellular [Ca
2+
].  All experiments were carried out 1.5 to 6 hrs after 
plating.  
Reagents.  All reagents were dissolved and stored in DMSO or water and then diluted in 
Tyrode’s and 0 Ca2+ solutions for experiments.  2-APB, ATP, Doxycycline, and DHBP were 
from Sigma; GPN and U73122 were from Santa Cruz; Ryanodine was from Abcam; 
LysoTracker, Fura-2, Plurionic F-127, and Fura-Dextran were from Invitrogen; ML-SA1 was 
from Chembridge; and Xestospongin-C was from Cayman Chemical, AG Scientific, and Enzo.   
Data analysis.  Data are presented as mean ± SEM. All statistical analyses were conducted using 
GraphPad Prism.  Paired t-tests were used to compare the average of three or more experiments 
between treated and untreated conditions.  A value of P <0.05 was considered statistically 
significant.  
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Figure 4.1 HEK cells have ryanodine receptors (RYRs) and IP3-receptors (IP3Rs). (A) 
Caffeine stimulates Ca
2+
 release through RYRs and ATP stimulates Ca
2+
 release through IP3Rs 
in HEK293T cells loaded with Fura-2.  Representative traces are shown from an experiment that 
contained 30-40 cells.  
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Figure 4.2 Specific IP3R antagonist Xestospongin-C prevented Ca
2+
 refilling to lysosomes. 
(A) Xestospongin-C (Xesto) application (5 min, 25 µM) blocked ER Ca
2+
 release stimulated by 
ATP in HEK293 cells loaded with Fura-2.  Importantly, Xesto washes out rapidly. (B) The IP3-
receptor (IP3R) antagonist Xesto (10 µM) prevented Ca
2+ 
refilling of lysosomes in HEK-
GCaMP3-ML1 cells.  Note that Xesto was co-applied with ML-SA1. (C)  Xesto significantly 
reduced lysosomal Ca
2+
 refilling in HEK-GCaMP3-ML1 cells (n=5; p=0.007). Panels A and B 
show the average response of 30-40 cells from one representative experiment. 
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Figure 4.3 Xesto abolishes Ca
2+
 refilling to lysosomes measured with luminal Ca
2+
 indicator 
Fura-Dextran.  (A) Fura-Dextran was pulse/chased into HEK293T cells transfected with 
Lamp1-mCherry.  Fura-Dextran dyes were co-localized well with Lamp1-mCherry after 12h 
pulse and 4h chase, although not all lysosomes were loaded with the dye, evidenced by many 
Lamp1-mCherry vesicles without Fura-Dextran co-localization.  Scale bar = 5 µm.  (B) Xesto 
(25 µM) treatment for 5 minutes prevented Ca
2+
 refilling to lysosomes.  Right panels show the 
zoomed-in images of ML-SA1-induced responses before and after Xesto treatment. Data 
represent the average of 30-40 cells from a representative experiment.  
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Figure 4.4 IP3R antagonist 2-APB inhibits lysosomal Ca
2+
 refilling. (A) IP3R antagonist 2-
APB (200 µM) blocked lysosomal Ca
2+ 
refilling in HEK-GCaMP3-ML1 (p=0.013).  Panel shows 
the average of 36 cells from one representative experiment.  (B) Quantification of the responses 
to ML-SA1 in HEK-GCaMP3-ML1 cells after treatment with 2-APB (mean ± SEM; n=5).  
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Figure 4.5 PLC inhibitor U73122 blocked Ca
2+
 refilling to the lysosome. (A) PLC inhibitor 
U73122 (10 µM) blocked Ca
2+
 release from IP3Rs stimulated by ATP.  (B) U73122 treatment 
abolished Ca
2+ 
refilling of lysosomes.  (C) Quantification of the responses to ML-SA1 in HEK-
GCaMP3-ML1 cells after treatment with u-73122 (n=5; p=0.0070). The data represents mean ± 
SEM. 
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Figure 4.6 Ryanodine receptor blockers did not affect Ca
2+
 refilling to lysosomes. (A) 
Ryanodine (100 µM), which blocks Ryanodine receptors at high concentrations, did not block 
Ca
2+ 
refilling to lysosomes.  Note that Ryanodine was co-applied with ML-SA1. (B) Ryanodine 
receptor blocker DHBP (50 µM) did not block Ca
2+ 
refilling of lysosomes.  (C) Quantification of 
the responses to ML-SA1 in HEK-GCaMP3-ML1 cells after treatment with Ryanodine (Ry) 
(p=0.8293) and DHBP (p=0.0682). Data in panel C represents mean ± SEM. Panels A and B 
show the average response of 30-40 cells from one representative experiment. 
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Figure 4.7 DT40 IP3R-TKO cells show typical responses to GPN, normal acidification, and 
release and refill Ca
2+
 like WT DT40 cells. (A) DT40-WT cells respond to GPN (400 µM) in 
Fura-2. (B) DT40-IP3R-TK0 cells respond to GPN (400 µM) in Fura-2. (C) DT40 WT cells 
transiently transfected with GCaMP3-ML1 show Ca
2+
 refilling.  (D) DT40 IP3R triple KO 
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(TKO) cells transiently transfected with GCaMP3-ML1 also show Ca
2+
 refilling. (E) 
Quantification of the 1
st
, 2
nd
 and 3
rd
 ML-SA1 responses in GCaMP3-ML1-transfected WT and 
IP3R-TKO DT40 cells (mean ± SEM).  Note that the 2
nd
 and 3
rd
 responses between each WT 
(p=0.1221) and DT40-TKO (p=0.1927) response were not significantly different, although they 
did decrease.  There were no significant differences between WT and TKO 2
nd
 (p=0.0548) and 
3
rd
 responses (p=0.6036).  (F) DT40-WT and DT40-IP3R-TKO cells showed similar 
LysoTracker staining patterns.  Panels C and D show the average of 30-40 cells form one 
experiment. 
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Figure 4.8 Xestospongin-C blocked lysosome Ca
2+
 store refilling in DT40-WT but not 
IP3R-TKO cells. (A) IP3R antagonist Xesto completely blocked Ca
2+ 
refilling of lysosomes in 
DT40 WT cells (p=0.0278).  (B) Xesto did not block Ca
2+ 
refilling of lysosomes in IP3R-TKO 
cells (p=0.9646).  (C) Quantification of ML-SA1 responses with or without Xesto in WT and 
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IP3R-TKO DT40 cells (mean ± SEM; n=5). (D) GCaMP3-ML1-transfected DT40 IP3R-TKO 
cells still showed refilling after 5 min of DHBP application to block RYRs. (E) A combination 
of RYR blockers Diltiazem and Dantrolene did not block Ca
2+
 refilling to GCaMP3-ML1-
transfected DT40 IP3R-TKO cells.  Panels A, B, D, and E, are the average of 30-40 cells from 
one representative experiment.   
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Figure 4.9 Lysosome Ca
2+
 stores are emptied and refilled ongoingly.   (A) After 5 min of 
refilling, which is expected to fully refill the lysosomal Ca
2+
 stores, acute treatment of Xesto (10 
µM) for 2 min did not significantly reduce lysosomal Ca
2+
 release.  Lysosomal Ca
2+
 release was 
induced by ML-SA1 in HEK-GCaMP3-ML1 cells.  (B) After 5 min of refilling of lysosomal 
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Ca
2+
 stores, subsequent acute treatment of Xesto (10 µM) for 5 min reduced lysosomal Ca
2+
 
release.  (C) After 5 min of refilling of lysosomal Ca
2+
 stores, acute treatment of Xesto (10 µM) 
for 10 min abolished lysosomal Ca
2+
 release.  (D) Time-dependent depletion of lysosomal Ca
2+
 
stores by pharmacological inhibition of IP3-receptors.   
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Figure 4.10 A proposed model of Ca
2+
 transfer from the ER to lysosomes.  The ER is a Ca
2+
 
store with [Ca
2+
]ER ~ 0.3-0.7 mM; lysosomes are acidic (pHLy ~ 4.6) Ca
2+
 stores ([Ca
2+
]Ly ~ 0.5 
mM).  IP3Rs on the ER release Ca
2+
 to produce a local high Ca
2+
 concentration, from which an 
unknown low-affinity Ca
2+
 transport mechanism refills Ca
2+
 to the lysosome.  Unidentified tether 
proteins may link the ER membrane proteins to lysosomal membrane proteins to maintain 
contact sites of 20-30 nm for purposes of Ca
2+
 transfer.  Ca
2+
 released from lysosomes or a 
reduction/depletion in [Ca
2+
]Ly may regulate ER-lysosome interaction and trigger Ca
2+
 refilling 
from the ER to lysosomes.  Xesto and 2APB are IP3R blockers; U73122 is a PLC inhibitor that 
blocks the production of IP3; DHBP and Ryanodine (> 10 M) are specific RyR blockers.  
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CHAPTER V 
INHIBITION OF IP3-RECEPTORS ON THE ER CAUSES A LYSOSOME STORAGE 
PHENOTYPE 
 
ABSTRACT 
Endoplasmic reticulum (ER) Ca
2+
 deregulation is found in lysosome storage disorders (LSDs) 
and neurodegenerative disorders.  We discovered that maintenance of lysosome Ca
2+
 stores is 
disrupted by inhibiting IP3Rs on the ER and sought to determine whether this could impact 
lysosome storage phenotypes.  Antagonising IP3Rs and ER Ca
2+
 chelation increased lysosome 
associated membrane protein-1 (LAMP-1). LAMP-1 upregulation is a phenotype of lysosome 
dysfunction found in LSDs and neurodegenerative disorders.  Previous studies have shown that 
the relative volume of lysosomal compartments is a valid biomarker for lysosome storage when 
measured using LysoTracker.  After inhibition of IP3Rs, we found increased LysoTracker 
staining, suggesting that inhibiting ER IP3Rs results in lysosome dysfunction.  Finally, we 
observed significantly increase accumulation of lipofuscin-like non-degraded materials in 
lysosomes after inhibiting IP3Rs.  These findings suggest that impairing ER Ca
2+
 transfer to 
lysosomes has negative consequences on lysosome function, resulting in increased lysosome 
storage.  Aberrant ER Ca
2+
 transfer to lysosomes may be responsible for altered Ca
2+
 
homeostasis and the accumulation of toxic materials in LSDs and common neurodegenerative 
disorders.  
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INTRODUCTION 
Aberrant lysosome Ca
2+
 store maintenance in LSDs and neurodegeneration  
Lysosomal Ca
2+
 is important to lysosomal function and membrane trafficking (Cribbs and Strack 
2007; Lloyd-Evans, Morgan et al. 2008; Shen, Wang et al. 2012).   Lysosome Ca
2+
 levels are 
often reduced in lysosome storage diseases (LSDs) (Lloyd-Evans and Platt 2011).  For example, 
Ca
2+
 levels have been shown to be reduced by 70% in Niemann-Pick Disease, type C (NPC) 
cells (Lloyd-Evans, Morgan et al. 2008).  Some LSDs result from the inability of lysosomes to 
release Ca
2+
, as is the case with NPC1 (Shen, Wang et al. 2012) and Mucolipidosis type IV, 
which results in a mutation in the lysosome Ca
2+
 channel TRPML1 (Cheng, Shen et al. 2010).  
Interestingly, impaired ER Ca
2+
 homeostasis is associated with a variety of other LSDs including 
Gaucher’s disease, Sandhoff Disease, Niemann-Pick A disease, and GM1 gangliosidosis (Vitner, 
Platt et al. 2010).  Although the underlying cause of Ca
2+
 alterations varies, Ca
2+
 dyshomeostasis 
is a commonality of many LSDs. 
 The presence of Ca
2+
 dyshomeostases in Alzheimer’s disease (AD) is clear, although 
precise mechanisms altering Ca
2+
 remain to be elucidated.  Most of the focus on Ca
2+
 in AD has 
been on ER Ca
2+
 stores, although lysosome Ca
2+
 stores have recently been appreciated as an 
important site of Ca
2+
 deregulation as well (Bezprozvanny 2012; McBrayer and Nixon 2013).   
Additional biomarkers of lysosome storage 
Lysosomal dysfunction is often associated with a compensatory increase of lysosome 
biogenesis, manifested as increased expression of essential lysosomal genes (Settembre, Fraldi et 
al. 2013).  For example, the expression of LAMP1, a house-keeping gene in the lysosome, is 
elevated in most LSDs (Cribbs and Strack 2007; Shen, Wang et al. 2012).  The Coordinated 
Lysosomal Expression and Regulation (CLEAR) gene network regulates lysosomal biogenesis 
and function, and is dysregulated in LSDs as well as in neurodegenerative diseases (Settembre, 
Fraldi et al. 2013).  Lysosome enlargement and an increase in lysosome number are also 
characteristic of LSDs (Cribbs and Strack 2007).  The accumulation of undigested materials is 
often found in LSDs, which can further impair lysosome function and other cellular processes 
including lysosome acidification, lysosome Ca
2+
 homeostasis, vesicular trafficking, autophagy, 
exocytosis, endocytosis, and synaptic release (Schultz, Tecedor et al. 2011). 
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Altered lysosome function in Alzheimer’s disease 
 Lysosomal dysfunction and altered autophagy are clearly present in AD and other 
neurodegenerative diseases (Nixon, Yang et al. 2008).  However, there are few mechanistic links 
between AD and lysosomal and autophagy defects (Bezprozvanny 2013).  The efficiency of 
protein degradation decreases with age (Butler, Nixon et al. 2006) and endocytic dysfunction is 
also found early in AD (Nixon and Cataldo 2006).  It is possible that ER Ca
2+
 transfer to 
endosomes and lysosomes is dysfunctional, resulting in the early pathologies of AD and 
influencing disease progression.  Indeed, recent evidence links presenilin loss of function in AD 
with ER and lysosome Ca
2+
 homeostasis (Coen, Flannagan et al. 2012). 
Focus of the current study 
Our findings suggest that the  ER provides Ca
2+
 to lysosomes through IP3Rs.  Thus we 
sought to test the hypothesis that blocking ER Ca
2+
 or antagonizing IP3Rs would impact 
lysosome function, which is the focus of the following experiments. 
RESULTS 
LAMP-1 is upregulated after IP3R inhibition 
The size and number of lysosomes can increase dramatically as a result of lysosome dysfunction, 
which causes the accumulation of undigested materials in lysosomal compartments (Appelqvist, 
Waster et al. 2013).  Increases in LAMP1 are used as diagnostic marker of lysosome storage 
(Meikle, Brooks et al. 1997), as LAMP1 is the most abundant lysosomal membrane protein 
(Eskelinen, Tanaka et al. 2003).  We first sought to determine if inhibiting ER Ca
2+
 or IP3Rs 
affected LAMP1 levels.  We treated cells with low concentrations of ER inhibitors for 24h and 
then measured the amount of LAMP1 using western blotting when compared to DMSO treated 
controls.  LAMP1 expression was significantly elevated in cells treated with IP3R blockers 2-
APB and Xesto, as well as the ER Ca
2+
 chelator TPEN.  The RYR blocker DHBPdid not affect 
LAMP1 expression significantly (Fig. 5.1A,B).  Because lysosomal membrane proteins are 
relatively stable, these effects are likely due to transcriptional upregulation of LAMP1, however 
this possibility was not examined further. 
Lysotracker staining is increased after blocking Ca
2+
 transfer from the ER to lysosomes 
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Lysosomal dysfunction is also often associated with lysosomal enlargement due to the 
accumulation of various incompletely digested biomaterials (Cribbs and Strack 2007; Dong, 
Cheng et al. 2008; Shen, Wang et al. 2012).   LysoTracker is a red fluorescent dye that contains a 
weak base that is only weakly protonated at neutral pH.  Thus, LysoTracker can permeate live 
cell membranes, and it is highly selective for acidic vesicles within the cell.  LysoTracker 
staining is used as a phenotypic assay to screen for enlarged lysosomes in LSDs (Xu, Liu et al. 
2014) and is considered an additional biomarker of lysosome storage (te Vruchte, Speak et al. 
2014).  Consistent with our western blot analyses, LysoTracker staining was significantly 
increased in cells treated with Xesto for 24h, but not DHBP (Fig. 5.2A,B).  These results suggest 
that either lysosome size or number increases, although this possibility was not investigated 
further.  IP3R inhibitor Xesto  increases accumulation of lipofuscin-like non-degradable 
material in lysosomes 
In addition to the enlargement of lysosomal compartments after abolishing Ca
2+
 transfer to 
lysosomes, we noticed that in unstained cells treated with IP3R blockers, lysosomal 
compartments displayed a high level of autofluorescence during our live cell imaging 
experiments.  Autofluorescence was significantly increased in cells treated with Xesto when 
compared to those treated with DMSO (Fig. 5.3A,B,D).  These findings are suggestive of the 
presence of non-degradable, lipofuscin-like materials accumulated within lysosomes (Schroder, 
Elsasser et al. 2007) (Fig. 5.3A,B).  Notably, Xesto treated cells are reminiscent of cells with 
defective lysosomal Ca
2+
 release as shown with TRPML1 KO cells (Dong, Cheng et al. 2008) 
(Fig. 5.3C).   
DISCUSSION  
The lysosome compartment increases when Ca
2+
 stores are not maintained 
Here we show that long-term (24h) application of IP3R inhibitors and ER Ca
2+
 chelators results 
in a lysosome storage phenotype in the cell, demonstrated using three different assays of 
lysosome storage.  A plausible mechanism to account for our  findings is that impaired Ca
2+
 
transfer from the ER to lysosomes is responsible.  If so, these findings suggest that Ca
2+
 transfer 
from the ER to lysosomes is an unappreciated phenomenon that, if altered or impaired, has a 
significant impact on lysosome function.  We found that lysosome resident protein LAMP1 is 
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upregulated when IP3Rs and ER Ca
2+
 is inhibited, and that the overall volume of lysosomes was 
significantly enlarged.  Interestingly, there were no obvious impairments in lysosome 
acidification, demonstrated by LysoTracker staining.  Finally, we found undegraded, lipofusin-
like material accumulates within cells that have been treated with IP3R antagonist Xesto.  These 
findings highlight the importance of Ca
2+
 to lysosome function and suggest that it is not just H
+
 
ions that are required for normal lysosome degradation and/or export of unwanted materials in 
the cell. 
 The increase in lysosome membrane proteins, number, and volume could be due to 
several factors.  First, lysosomes may have increased fusion with other vesicles resulting in their 
enlargement.  Lysosome fusion has been shown to be Ca
2+
 dependent,  however, so this 
possibility is unlikely.  Second, lysosome reformation through fission of larger lysosomes into 
smaller ones may be decreased.  Lysosome fission has been shown to be Ca
2+
 dependent, making 
this possibility more likely (Durchfort, Verhoef et al. 2012; Zou, Hu et al. 2015). 
Lipofuscin accumulation increases in lysosome storage 
Lysosome storage material, summarized by the term lipofuscin, characterizes aged cells because 
its presence increases as aging progresses.  The presence of lipofuscin has been found to be 
increased in many aging related diseases including Parkinson’s and Alzheimer’s diseases, 
macular degeneration, and a variety of other neurodegenerative diseases (Seehafer and Pearce 
2006).  Although lipofuscin is also termed the “aging pigment,” accumulation of lipofuscin 
occurs to a lesser degree even in healthy cells (Schroder, Wrocklage et al. 2010).   Inhibition of 
lysosomal enzymes in young rat brains for one to two weeks induced lipofuscin accumulation, 
suggesting that loss of lysosomal enzymatic activity can result in lipofuscin accumulation (Ivy, 
Schottler et al. 1984).   Analysis of accumulated lipofuscin-like materials in cells has revealed 
that these inclusions contain ~27-121 different proteins, many of which originate in other 
organelles (Schutt, Ueberle et al. 2002; Warburton, Southwick et al. 2005; Schroder, Elsasser et 
al. 2007).  These findings support the idea that accumulated lipofuscin results from the buildup 
of materials from autophagic turnover of organelles and other unwanted materials in the cell 
(Schroder, Wrocklage et al. 2010).  This may explain why lipofuscin is characterized by a wide 
range of fluorophores, typically between 320 to 480 nm and 460 to 630 nm (Seehafer and Pearce 
2006; Schroder, Wrocklage et al. 2010).  The buildup of accumulated materials further impairs 
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lysosomal degradative functions (Seehafer and Pearce 2006; Schroder, Wrocklage et al. 2010).  
Our findings that merely inhibiting ER IP3Rs for 18-24 h results in accumulated lipofuscin-like 
material supports the idea that ER Ca
2+
 transfer to lysosomes is essential to normal lysosome 
degradative function. 
Lysosome Ca
2+
 homeostasis does not impact lysosome pH, but does affect lysosome 
function 
Increased lysotracker staining suggests that lysosomes remain acidified after prolonged 
IP3R block.  This suggests that Ca
2+
 entry into lysosomes may not be directly required for 
lysosome acidification, or that altered ion homeostasis can compensate for lack of Ca
2+
 to ensure 
lysosome acidification.  Normal acidification is often the only factor examined when 
determining lysosome health and function, but our results suggest that Ca
2+
 is also required for 
lysosomal digestion.  It is possible that Ca
2+
 activated enzymes exist in the lysosome, and this 
may be one way the ER communicates intracellular needs to the lysosome to match cellular 
degradation and recycling to production of necessary substrates in the cell.  
Altered ER Ca
2+
 homeostasis in LSDs 
Ca
2+
 homeostasis is altered in a variety of LSDs.  ER Ca
2+
 is important for protein folding 
of key lysosomal enzymes so that they may be properly trafficked and delivered to the lysosome.  
Improper delivery of lysosomal enzymes results in the accumulation of that enzyme’s substrates 
within lysosomal membranes.  For example, Gaucher’s disease, the most common LSD, is 
characterized by the buildup of glucosylceramide within lysosomes as a result of lysosomal 
glucocerebrosidase deficiency (Ong, Mu et al. 2010).  Several LSDs result from specific enzyme 
deficiency and benefit from enzyme replacement therapies.  Interestingly, in Gaucher’s disease, 
accumulated glucosylceramide in lysosomes in turn increases agonist induced Ca
2+
 release from 
RYR receptors on the ER (Korkotian, Schwarz et al. 1999; Lloyd-Evans, Pelled et al. 2003; 
Pelled, Trajkovic-Bodennec et al. 2005).  Even more, ER morphology is significantly altered in 
Gaucher’s disease (Korkotian, Schwarz et al. 1999).   
In light of our results, it is possible to speculate that signals from the lysosome that 
modulate  ER Ca
2+
 release are altered when lysosomes have accumulated undigested contents.  
Indeed, decreased IP3 production has been observed when increases in glucosylceramide are 
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induced in cell culture (Mahdiyoun, Deshmukh et al. 1992).  This may result in upregulation of 
RYRs to ensure ER Ca
2+
 levels are stable (Korkotian, Schwarz et al. 1999), but then may result 
in aberrant Ca
2+
 release and decreased Ca
2+
 transfer to organelles like lysosomes and 
mitochondria.  Similar mechanisms may also play a role in the alterations in lysosomal Ca
2+
 
storage and release seen in NPC1 cells (Lloyd-Evans, Morgan et al. 2008; Shen, Wang et al. 
2012),  as accumulated sphingomyelins have been shown to alter Ca
2+
 release from 
TRPML1(Shen, Wang et al. 2012).  This suggests that the benefits seen by abolishing RYR Ca
2+
 
release and thereby increasing ER Ca
2+
 in Gaucher’s disease and other LSDs may extend beyond 
just protein folding in the ER (Ong, Mu et al. 2010). 
Some LSDs also have mitochondrial Ca
2+
 defects.  Pompe disease is characterized by 
profound mitochondrial Ca
2+
 dyshomeostasis indicated by Ca
2+
 overload, decreased in 
membrane potential, decreased ATP production, an increase in reactive oxygen species, and 
increased apoptosis (Lim, Li et al. 2015).  It is possible that increased ER Ca
2+
 transfer to 
mitochondria diverts Ca
2+
 transfer to lysosomes and contributes to the disease pathogenesis.  
Alternatively, reduced ER-lysosome Ca
2+
 transfer may result in the Ca
2+
 overload seen in 
mitochondria to ensure ER Ca
2+
 store homeostasis is maintained, as mitochondria do buffer ER 
Ca
2+
, at least in polarized cells (Rizzuto, De Stefani et al. 2012).  Increased ER-mitochondrial 
connectivity has also been shown in Alzheimer’s disease (Schon and Area-Gomez 2013), and it 
is possible that Ca
2+
 in this case is diverted from lysosomes to reduce lysosome fusion and 
digestion and facilitate the accumulation of toxic proteins. 
Altered ER Ca
2+
 homeostasis in Alzheimer’s disease 
Missense mutations in presenilins are responsible for early-onset AD.  Presenilins 
provide catalytic substrates for various -secretases, but more recently additional roles for 
presenilins have been discovered including Ca
2+
 homeostasis and protein trafficking (De 
Strooper, Iwatsubo et al. 2012).  Presenilins are primarily localized to the ER membrane 
(Stutzmann 2007; Honarnejad and Herms 2012), and there is compelling evidence that presenilin 
depletion disrupts the ER Ca
2+
 store, but the mechanisms by which this occurs are disputed 
(Bezprozvanny and Mattson 2008; De Strooper, Iwatsubo et al. 2012).  Presenilins themselves 
may act as Ca
2+
 leak channels on the ER (Tu, Nelson et al. 2006; Nelson, Tu et al. 2007; 
Bezprozvanny 2013).  Presenilins have also been suggested to modify the activity of existing ER 
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Ca
2+
 channels.  Mutations in presenilin have been shown to increase Ca
2+
 leak from the ER in 
part by increasing RYR expression (Chan, Mayne et al. 2000).  Presenilins have also been shown 
to increase the activity of RYR channels through a direct interaction between the two proteins 
(Hayrapetyan, Rybalchenko et al. 2008).  Presenilins have been suggested to modify Ca
2+
 
signaling through IP3R channels as well (Leissring, Parker et al. 1999; Leissring, Paul et al. 
1999), possibly by altering gating to increase Ca
2+
 signaling (Cheung, Shineman et al. 2008; 
Cheung, Mei et al. 2010).  There is also some evidence to support diminished ER SERCA 
activity that normally maintains the ER Ca
2+
 as a result of presenilin loss of function (McBrayer 
and Nixon 2013).  Whatever the final mechanism by which presenilins modify ER Ca
2+
, it is 
clear that ER Ca
2+
 is affected by loss of presenilin function and this is a common pathology in 
AD.   
Recently, presenilins have been implicated as the mechanistic link between ER and 
lysosome Ca
2+
 store alterations in AD (Bezprozvanny 2012).  Lysosome dysfunction and 
autophagy defects are clear hallmarks of Alzheimer’s disease, but a cause for these defects has 
been elusive (Schultz, Tecedor et al. 2011).  Presenilins were originally  suggested to play a role 
in lysosomal acidification (Lee, Yu et al. 2010), however several groups have since thoroughly 
demonstrated normal acidification of lysosomes in cells lacking presenilins (Neely, Green et al. 
2011; Coen, Flannagan et al. 2012; Zhang, Garbett et al. 2012; Bezprozvanny 2013).  Presenilin 
deficient cells have enlarged lysosomes and decreased lysosomal Ca
2+
, measured with GPN as 
well as a low-affinity Rhodamine-2 dextran Ca
2+
 probe (Bezprozvanny 2012; Coen, Flannagan et 
al. 2012).  Notably, Coen et al’s GPN measurements of lysosome Ca2+ stores are consistent with 
a small GPN signal remaining due to pH in presenilin deficient cells (Coen, Flannagan et al. 
2012).  In agreement with Coen et al’s suggestion, this decrease in lysosomal Ca2+ may result in 
the impairments seen previously in lysosome fusion in presenilin deficient cells, which may be 
the cause of increased autophagy markers in these cell (Coen, Flannagan et al. 2012).  Taken 
together, these findings may suggest that ER Ca
2+
 transfer to lysosomes may play a role in AD 
pathology.  
Another interesting possibility is that in disorders where altered Ca
2+
 homeostasis is a 
hallmark, unknown tethers between organelles may be altered or abolished, thereby reducing the 
ability or efficiency of ER Ca
2+
 transfer to lysosomes.  This may be a cause of increased Ca
2+
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transfer to mitochondria in LSDs and AD, and may also be responsible for increased cytosolic 
Ca
2+
 release in AD that would instead be diverted to lysosomes in healthy circumstances.  
ER to lysosome Ca
2+
 transfer as a potential therapeutic target 
The possibilities for enhanced ER Ca
2+
 transfer to lysosomes as a potential therapeutic 
target are interesting to consider.  For example, TFEB enhances lysosomal exocytosis and 
therefore lysosome clearance (Medina, Fraldi et al. 2011), which has been shown to require 
lysosomal Ca
2+
 (Samie, Wang et al. 2013) and the TRPML1 Ca
2+
 channel (Medina, Di Paola et 
al. 2015).  While inducing exocytosis itself may be dangerous to cells (Schultz, Tecedor et al. 
2011), enhancing lysosome Ca
2+
 to ensure effective exocytosis could be equally efficacious.  
Given that RYR antagonism increases ER Ca
2+
 (Ong, Mu et al. 2010), and even our results 
suggest that it may increase lysosomal Ca
2+
 and degradation, this may be one route to consider.  
Given that the master regulator of lysosomes, TFEB, requires Ca
2+
 release from lysosomes 
(Medina, Di Paola et al. 2015), one can imagine a whole host of unexplored negative 
consequences of reduced lysosome Ca
2+
.  
Limitations 
Pharmacological studies are limited by potential off-target effects of each antagonist used.  In the 
case of the aforementioned findings, it is possible that impairing ER Ca
2+
 release may impair ER 
function.  Impaired ER function may affect lysosome degradative functions not because of 
impaired Ca
2+
 transfer, but for an alternative reason.  While these possibilities are difficult to 
separate, we showed that both chelation of ER Ca
2+
 and block of Ca
2+
 release through IP3Rs 
both resulted in impaired lysosome degradation.   
METHODS AND MATERIALS 
Western blotting.  Standard western blotting protocols were used.  A Bradford assay was 
performed prior to adding DTT in order to ensure the loading of equal loading.  HEK293T cells 
were treated every 4 hrs for 24 hrs with IP3R antagonists 2-APB and Xestospongin-C, ER Ca
2+
 
chelator TPEN, and RyR antagonist DHBP.  LAMP1 and tubulin antibodies were from 
Developmental Studies Hybridoma Bank (Iowa).  LAMP1 was normalized to tubulin amounts to 
ensure quantifications were not affected by loading concentrations. 
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Mammalian Cell Culture.  All cells were cultured in a 37˚C incubator with 5% CO2.  
HEK293T cells and human fibroblasts were cultured in DMEM F12 (Invitrogen) supplemented 
with 10% (vol/vol) FBS or Tet-free FBS.   
Confocal imaging.  Live imaging of cells was performed on a heated and humidified stage using 
a Spinning Disc Confocal Imaging System.  The system includes an Olympus IX81 inverted 
microscope, a 100X Oil objective NA 1.49 (Olympus, UAPON100XOTIRF), a CSU-X1 scanner 
(Yokogawa), an iXon EM-CCD camera (Andor).  MetaMorph Advanced Imaging acquisition 
software v.7.7.8.0 (Molecular Devices) was used to acquire and analyze all images.  LysoTracker 
(50 nM) was dissolved in culture medium and loaded into cells for 30 min before imaging. 
Coverslips were washed 3 times with Tyrode’s and imaged in Tyrode’s.  LysoTracker staining 
was quantified as described previously, using Image J.  
Reagents.  All reagents were dissolved and stored in DMSO or water and then diluted in cell 
culture medium for experiments.  2-APB, DHBP, and TPEN were from Sigma; LysoTracker, 
was from Invitrogen; and Xestospongin-C was from Cayman Chemical, AG Scientific, and 
Enzo.   
Data analysis.  Data are presented as mean ± SEM. All statistical analyses were conducted using 
GraphPad Prism.  Paired t-tests were used to compare the average of three or more experiments 
between treated and untreated conditions.  A value of P <0.05 was considered statistically 
significant.  
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Figure 5.1 LAMP1 increased significantly after inhibiting ER Ca
2+
 and IP3Rs. (A) Western 
blotting analyses of LAMP1 in HEK293T cells treated with 2-APB (50 µM), TPEN (0.1 µM), 
Xesto (10 µM), and DHBP (5 µM) compared to DMSO for 24 hrs (n=4 separate experiments 
using one dish of cells and separate protein extractionsfor each condition).  (B) Treating 
HEK293T cells with 2-APB (p=0.05) and Xesto (p=0.012), as well as TPEN (p=0.02), 
significantly increased LAMP1 expression.  DHBP did not significantly change LAMP1 
expression (p=0.23).   
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Figure 5.2 LysoTracker staining increased, suggestive of a LSD phenotype, in cells treated 
with IP3R blocker Xesto.  (A) The effects of Xesto (10 µM, 18 h; p= 0.0001) and DHBP (50 
µM, 18 h; p= 0.063) treatment compared to DMSO on the lysosomal compartments detected by 
LysoTracker staining in HEK293T cells (average of 20-30 cells in each of 3 experiments).  Scale 
bar = 15 µm.  (B) The effect of Xesto (10 µM, 18 h) treatment on accumulation of the 
autofluorescent lipofuscin materials in non-transfected HEK293T cells.   
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Figure 5.3 Autofluorescent, lipofuscin-like accumulation in cells treated with IP3R blocker 
Xesto mimics TRPML1 KO cells. (A) Human fibroblasts treated with DMSO for 18h. (B) 
Human fibroblasts treated with Xesto (2.5 µM) for 18h. (C) ML1 KO MEFs are shown for 
comparison. (D) Quantification of DMSO and Xesto (p<0.0001) treated cells. Autofluorescence 
was observed in a wide spectrum but shown at two excitation wavelengths (488 and 561 nm).  
Scale bar = 15 µm.   
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CHAPTER VI 
CONCLUSIONS AND FUTURE DIRECTIONS 
INTRODUCTION 
Lysosomes are significant Ca
2+
 stores in the cell, with higher Ca
2+
 than all other 
organelles except the endoplasmic reticulum (ER).  How the ER maintains and refills its Ca
2+
 
store has been the subject of intense study for over a decade beginning around 2000, though store 
operated Ca
2+
 entry (SOCE) has been appreciated since the early 1980’s.  How lysosomes 
acquire their Ca
2+
 stores has been misattributed to their pH gradient for over a decade.  Because 
Ca
2+
 stores are integral to lysosome membrane trafficking and degradative functions, 
understanding how lysosomes acquire their Ca
2+
 answers a basic question of cell biology.  
Furthermore, it highlights new potential therapeutic targets for lysosome storage disorders 
(LSDs) and neurodegenerative disorders, both of which have disrupted Ca
2+
 stores. 
This research shows that the lysosomal V-ATPase and pH gradient are not required for 
the refilling of lysosome Ca
2+
 stores (Chapter 2).  We developed a new assay to measure 
lysosome Ca
2+
 store refilling that allows us to release lysosome Ca
2+
 stores in a physiological 
manner that is uninhibited by low lysosome pH.  This assay allows us to apply pharmacological 
agonists and antagonists during refilling to directly assess the source of Ca
2+
 to the lysosome.  
This assay has numerous advantages over previously used methods to study lysosomes in that it 
does not affect ion homeostasis or disrupt lysosome membranes.   
We found that a commonly used lysosome disrupting reagent, GPN, induces a signal on 
GCaMP3 and Fura-2 Ca
2+
 indicators that is not due to Ca
2+
, which has likely obscured the 
conclusions of many studies examining lysosome Ca
2+
 stores.  Because GPN has been used as 
the primary method to examine lysosome Ca
2+
 stores, our findings suggest that many studies 
may have misattributed effects of GPN on pH to the release of Ca
2+
.  This is also likely the 
reason that many studies have failed to appreciate the effects of ER Ca
2+
 on lysosome Ca
2+
.  Our 
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findings support the need to use the Ca
2+
 chelator BAPTA with all studies examining lysosome 
Ca
2+
 to ensure the effects are due to Ca
2+
.  
We showed for the first time that Ca
2+
 stores in the lysosome require ER Ca
2+
 stores to be 
maintained (Chapter 3).  Using SERCA inhibitors to prevent ER Ca
2+
 store maintenance, we 
showed that lysosome stores are no longer refilled when ER Ca
2+
 stores are abolished.  Chelating 
ER Ca
2+
 had the same effect, preventing lysosome Ca
2+
 refilling.  Genetically reducing ER Ca
2+
 
stores also prevented lysosome Ca
2+
 store refilling.  We corroborate the findings of others 
showing that the ER and lysosomes are in close contact, which could facilitate Ca
2+
 transfer from 
the ER to lysosomes through membrane contact sites.  
More specifically, we found that the IP3-receptor (IP3R) on the ER membrane is a 
candidate for transferring Ca
2+
 to the lysosome (Chapter 4).  Using three different IP3R 
inhibitors, we show that lysosome Ca
2+
 stores do not refill when ER IP3R Ca
2+
 release is 
blocked.  Ryanodine receptors are not required for lysosome Ca
2+
 store refilling, because their 
block had no impact on Ca
2+
 store refilling.  We found that IP3R blockers prevented Ca
2+
 
refilling in DT40-WT cells, but not in DT40-IP3R-TKO cells, which may suggest that a 
compensatory mechanism accounts for Ca
2+
 refilling in cells without IP3Rs.   
Finally, disrupting lysosome Ca
2+
 store maintenance by blocking ER Ca
2+
 release through 
IP3Rs results in an upregulation of lysosome associated membrane protein 1 (LAMP1), which is 
a marker for lysosome dysfunction.  IP3R antagonism also results in an increase in lysosome 
volume, another biomarker of lysosome storage disorders.  Finally, an accumulation of 
lipofuscin results from blocking ER IP3Rs.  These results highlight the importance of ER Ca
2+
 
transfer to lysosome Ca
2+
 store maintenance and proper lysosome function.  Because Ca
2+
 store 
dysregulation is found in lysosome storage disorders and neurodegeneration, these findings 
suggest that increasing ER Ca
2+
 release to lysosomes could improve or prevent lysosome 
pathogensis.  
Limitations 
Studies of lysosome Ca
2+
 stores are difficult because of the high acidity of the lysosome lumen, 
which is known to affect a number of Ca
2+
 indicators (Rudolf et al., 2003).  Indeed, many of our 
experiments confirmed this.  Our lysosome-membrane targeted GCaMP3-ML1 probe avoids pH 
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effects of the lysosome lumen and allows us to measure Ca
2+
 release from lysosomes.  A 
disadvantage of this probe is that it does not directly measure the amount of Ca
2+
 in the lysosome 
lumen and it does not allow us to observe Ca
2+
 refilling in real-time.  Additionally, 
overexpression of a Ca
2+
 channel is not ideal, as it likely results in an increase in Ca
2+
 release 
when compared to typical Ca
2+
 release from lysosomes.  This may increase the amount of Ca
2+
 
refilled to lysosomes, increase the time it takes to refill Ca
2+
 stores, and may change signaling 
between lysosomes and the ER. 
 Many of our manipulations of ER Ca
2+
 are pharmacologic, which has significant 
limitations due to the potential of off-target effects of each treatment.  While we utilized different 
treatments with the same target, future studies should attempt to genetically deplete IP3Rs 
further support their importance in Ca
2+
 store refilling. 
 The finding that DT40 IP3R TKO cells still have lysosome Ca
2+
 stores even without 
IP3Rs does not support our hypothesis.  While we believe a compensatory mechanism is at play, 
this possibility should be further examined in future studies.  
 We attempted to measure ER Ca
2+
 levels during lysosome Ca
2+
 store refilling with two 
different luminal ER Ca
2+
 indicators, but we had difficulty with the sensitivity of these probes 
and were thus unable to observe all but the largest changes in ER Ca
2+
 due to complete depletion 
of ER Ca
2+
 stores with SERCA inhibitors.  Future studies should use newly developed ER 
luminal Ca
2+
 indicators to observe ER Ca
2+
 decreases during lysosome Ca
2+
 refilling.  Most 
of our studies are performed in HEK cells, which may limit their application to other cell types.  
It is possible that  lysosomes function differently in different cell types. 
Future Directions 
These results form the basis for a stronger understanding of lysosome biology, but raise 
many yet to be answered questions, which will be discussed below.   
Additional Assays of Lysosomal Ca
2+
   
While our GCaMP3-ML1 probe has advantages for measuring lysosomal Ca
2+
 over previously 
used methods, there are disadvantages as well.  In cases where TRPML1 is inhibited, as in NPC 
(Shen et al., 2012), lysosome Ca
2+
 store refilling cannot be accurately measured.  Recently, 
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several new  Ca
2+
 sensors have been developed that should be used to confirm our findings.  A 
new endosomal Ca
2+
 indicator to measure luminal Ca
2+
 levels should be tested in lysosomes 
(Albrecht et al., 2015).  Calcium orange is a newly used Ca
2+
 dye for acidic compartments that 
should also be tested (Zou et al., 2015).  
How is Ca
2+
 Transfer from the ER to Lysosomes Regulated? 
The existence of a Ca
2+
 sensor dedicated to sensing lysosome Ca
2+
 stores and regulating their 
refilling remains to be shown.  In the ER,  STIM1 senses when Ca
2+
 stores are being depleted 
using an EF-hand-like motif, and relocalizes when stores are reduced to trigger Ca
2+
 channel 
opening on the plasma membrane (Luik et al., 2008).  This suggests that a similar molecule may 
exist on lysosomes to trigger ER Ca
2+
 transfer to lysosomes.   
Phosphinositides are known to be regulated at membrane contact sites with the ER and 
plasma membrane (Stefan et al., 2011).  Because phosphoinositides can activate/regulate ion 
channels (Dong et al., 2010; Wang et al., 2012), it is possible that phosphoinositide localization 
plays a role in Ca
2+
 exchange between the ER and lysosomes.   
The question remains as to what other triggering factors are required for Ca
2+
 refilling to 
lysosomes.  Is Ca
2+
 release from lysosomes sensed by the ER which leads to tighter contact and 
Ca
2+
 refilling?  Our results showing that refilling is mediated by IP3Rs, but not RYRs, suggest 
that ER Ca
2+
 release induced by lysosomal Ca
2+
 release may not operate through Ca
2+
-induced 
Ca
2+
 release, as RyRs are better suited for this role than IP3Rs.   This suggests that other 
signalling molecules may be involved in triggering IP3R Ca
2+
  release to refill lysosome stores. 
Ca
2+
 exchange between the ER and lysosomes could also be continuous to maintain the 
lysosome Ca
2+
 store at a constant level.  In mitochondria, constitutive Ca
2+
 transfer to 
mitochondria prevents autophagy, and when IP3R Ca
2+
 signaling is decreased, autophagy is 
induced (Cardenas et al., 2010).  Ca
2+
 transfer from ER to mitochondria is therefore involved in 
ER coordination of cellular bioenergetics, which could also be true for the lysosome.  
 
How do Membrane Contact Sites Regulate ER-Lysosome Ca
2+
 Transfer? 
Our time lapse imaging and TEM findings corroborate previous findings that membrane contact 
sites exist between the ER and lysosomes (Kilpatrick et al., 2013).  Nanojunctions of 50 nm or 
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less are ideal for Ca
2+
 exchange (Fameli et al., 2014), making these sites between the ER and 
lysosomes ideal to serve as “nano-domains” of Ca2+ exchange.   
Linker proteins have been shown to exist to facilitate ER-lysosome contact sites (Rocha 
et al., 2009; Alpy et al., 2013), but similar to ER-mitochondrial junctions, there may be many 
proteins that create contact sites, and abolishing just one may not impact Ca
2+
 exchange (Lynes 
and Simmen, 2011).  It has been hypothesized that different distances between membranes are 
required for lipid, protein, and Ca
2+
 exchange and that different subsets of contact sites may exist 
to facilitate different functions (Csordas et al., 2010).   Whether specific signalling molecules 
exists to increase contact sites or decrease contact length to facilitate the ER-lysosome 
nanojunction, or to trigger ER Ca
2+
 release to lysosomes is also a mystery.   
ER-endosome membrane contact, although currently still difficult to study, is proposed to 
facilitate cholesterol transport from endosomes to the ER (Rocha et al., 2009; Du et al., 2011; Du 
et al., 2012; van der Kant and Neefjes, 2014).  Given the established role of lysosomal Ca
2+
 
release in cholesterol transport (Shen et al., 2012), lysosomal Ca
2+
 may have a direct role in 
regulating this ER-lysosome interaction.  For example, cytosolic cholesterol sensor ORP1L 
detects cholesterol in late endosomes which subsequently facilitates a membrane contact site 
using VAP complexes on the ER and the Rab7-RILP complex on late endosomes.  Low 
cholesterol levels increases contact sites, whereas high cholesterol decreases these contact sites, 
and positioning of late-endosomes is more peri-nuclear when cholesterol levels are higher 
(Rocha et al., 2009).   
Cholesterol binding protein NPC1 on late-endosome and lysosome membranes has been 
shown to interact with and be required for ER-localized sterol carrier protein ORP5 to transport 
cholesterol out of late-endosomes and lysosomes (Du et al., 2011).  In fact, ORP proteins can 
simultaneously bind two membranes at once, suggesting that membranes must be in close 
contact for its function as a sterol transporter (Schulz et al., 2009).  Separately, Hrs-Vps27 
regulates cholesterol transfer from late-endosomes/lysosomes independently of NPC1 and NPC2 
(Du et al., 2012).   
Late endosome/lysosome lipid binding proteins STARD3 and STARD3NL, using a 
conserved FFAT-like motif, contact ER proteins VAP-A and VAP-B to form membrane contact 
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sites that separate the ER and late-endosomes by about 8.3 nm (Alpy et al., 2013).  It may be that 
different subpopulations of late-endosomes and lysosomes use different cholesterol transporters, 
as has been suggested (van der Kant et al., 2013), that these contact sites have different purposes 
that are not yet clear, or that there is functional redundancy for cholesterol transport at these 
membrane contact sites.   
Notably, VAP-A and VAP-B on the ER are involved in membrane contact sites between 
the ER and mitochondria (De Vos et al., 2012) and the ER and golgi (Kawano et al., 2006), in 
addition to late-endosomes (Rocha et al., 2009), as discussed above.  Although siRNA knock-
down of ER VAP proteins does not completely abolish membrane contact sites (Alpy et al., 
2013), it does reduce them, and therefore ER VAP proteins could be a starting point of future 
studies examining ER-lysosome Ca
2+
 transfer. 
Do Specific Isoforms of IP3Rs Transfer Ca
2+
 to Lysosomes? 
These results also raise the question of whether specific IP3R isoforms contribute Ca
2+
 to the 
lysosome for different purposes and whether some are more involved in Ca
2+
 refilling than 
others.  This question may prove difficult to answer, however.  All three IP3R isoforms can 
transmit Ca
2+
 to mitochondria, and knock-down of a particular isoform only reduces but does not 
abolish Ca
2+
 transfer to mitochondria (Mendes et al., 2005).  Also, knocking down IP3Rs does 
not abolish ER-mitochondria contact, which may suggest that other Ca
2+
 channels can transfer 
Ca
2+
 from the ER to mitochondria as well.   
GRP75 tethers the ligand binding domain of the type I IP3R isoform on the ER to the 
VDAC on the OMM of mitochondria (Szabadkai et al., 2006).  Both type I and III IP3R isoforms 
are involved in Ca
2+
 signaling in apoptosis, although the type III isoform seems to play a larger 
role.  The type III IP3R isoform has been suggested to be enriched at the MAM as well (Mendes 
et al., 2005).   
Making it more complicated, IP3R subtypes are dynamically regulated in the cell and 
their expression levels and localization seem to depend on the physiological state of the cell 
(Vermassen et al., 2004).  Even though MAMs are a high Ca
2+
 release site, many studies have 
found that IP3Rs are not specifically enriched on the MAM of the ER compared to other parts of 
the ER membrane (Lynes and Simmen, 2011).  This may suggest that ER Ca
2+
 buffering within 
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the ER membrane may function to more directly regulate ER Ca
2+
 release rather than the 
location of IP3Rs.  Enrichment and spatiotemporal regulation of Ca
2+
 buffering proteins has been 
shown for ER Ca
2+
 buffering proteins calreticulin and calsequestrin (Means et al., 2006; Lynes 
and Simmen, 2011).  
IP3Rs are known to cluster into groups of 20-30, and clustering has also been shown to 
be dynamically regulated (Rahman and Taylor, 2009; Rahman, 2012).  It is possible that increase 
in Ca
2+
 release seen between the first and second responses in HEK-GCaMP3-ML1 cells is due 
to an increase in or formation of IP3R clusters.  Alternatively, it is probable that overexpression 
of the TRPML1 channel in HEK cells stably expressing GCaMP3-ML1 increases the amount of 
Ca
2+
 released by lysosomes.  This may result in an increased transfer of Ca
2+
 back to lysosomes, 
particularly because many Ca
2+
 channels on the ER, including IP3Rs, are regulated by Ca
2+.
  
Possible Subdomains of Ca
2+
 Release in the ER to Regulate Membrane Contact Sites? 
Subdomains of Ca
2+
 release, or pools of Ca
2+
 released by different factors, are beginning 
to be understood within the contiguous ER (Orci et al., 2009; Aulestia et al., 2011; Penny et al., 
2014; Petersen, 2015).  These findings raise the question of whether a separate pool of Ca
2+
 
exists in the ER that is releasable for refilling to organelles or even lysosomes specifically.  
Specific membrane domains of the ER for specialized functions are also being more closely 
examined (Lynes and Simmen, 2011).  
It is possible that local subdomains of ions regulate site specific processes even in smaller 
vesicles.  Given that lysosomes make transient and on-going membrane contact sites with a 
variety of different organelles (Penny et al., 2014), intraluminal ion subdomains would facilitate 
appropriate fusion and communication between each of these vesicles and allow for multiple 
membrane contact sites on each organelle.  These spatiotemporal sites are likely regulated in part 
by membrane lipids that can in turn regulate ion channels on vesicular membranes like 
lysosomes (Dong et al., 2010; Wang et al., 2012; Zhang et al., 2012).  The balance of ions and 
thus tightly regulated membrane potential may also indicate lysosomal function and health to 
other organelles.   
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